{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "authorship_tag": "ABX9TyOyAKe/9+m5StePdX0I7Vb6",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/agsilver108/mimic-code/blob/main/Amit_Gujrathi_(asg4338)_Mimic3_NLPv1.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9PiLA_DgP8Jy",
        "outputId": "ddb0a0c6-0a2c-4d16-a190-0aaa00a8135a"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Authenticated\n",
            "PROJECT_ID                  NAME                        PROJECT_NUMBER\n",
            "asg4338-mimic3-v1           ASG4338 MIMIC3 v1           176181609696\n",
            "clinical-entity-extraction  clinical-entity-extraction  321960627270\n",
            "elaborate-art-449407-m0     ASG4338 MIMIC3 v1           340556621126\n",
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ],
      "source": [
        "from google.colab import auth\n",
        "auth.authenticate_user()\n",
        "print('Authenticated')\n",
        "\n",
        "!gcloud projects list\n",
        "\n",
        "from google.cloud import bigquery\n",
        "import os\n",
        "\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')\n",
        "\n",
        "mimic_filespath = \"/content/drive/MyDrive/mimic3_data\"\n",
        "os.chdir(mimic_filespath)\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd\n",
        "\n",
        "# Load patients data\n",
        "patients_df = pd.read_csv('PATIENTS.csv.gz')\n",
        "patients_df.head()\n",
        "\n",
        "# Load admissions data\n",
        "admissions_df = pd.read_csv('ADMISSIONS.csv.gz')\n",
        "admissions_df.head()\n",
        "\n",
        "# Load noteevents data\n",
        "noteevents_df = pd.read_csv('NOTEEVENTS.csv', low_memory=False).set_index('ROW_ID')\n",
        "noteevents_df.head()\n",
        "\n",
        "#Load diagnoses_icd data\n",
        "diagnoses_icd_df = pd.read_csv('DIAGNOSES_ICD.csv.gz').set_index('ROW_ID')\n",
        "diagnoses_icd_df.head()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 238
        },
        "id": "nEY0aG9mV-_A",
        "outputId": "b803a5e1-8132-4426-85e1-028269663919"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "        SUBJECT_ID  HADM_ID  SEQ_NUM ICD9_CODE\n",
              "ROW_ID                                        \n",
              "1297           109   172335      1.0     40301\n",
              "1298           109   172335      2.0       486\n",
              "1299           109   172335      3.0     58281\n",
              "1300           109   172335      4.0      5855\n",
              "1301           109   172335      5.0      4254"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-9d30e0fe-5d89-42ec-8149-8f4313d6cafa\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>SUBJECT_ID</th>\n",
              "      <th>HADM_ID</th>\n",
              "      <th>SEQ_NUM</th>\n",
              "      <th>ICD9_CODE</th>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>ROW_ID</th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "      <th></th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>1297</th>\n",
              "      <td>109</td>\n",
              "      <td>172335</td>\n",
              "      <td>1.0</td>\n",
              "      <td>40301</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1298</th>\n",
              "      <td>109</td>\n",
              "      <td>172335</td>\n",
              "      <td>2.0</td>\n",
              "      <td>486</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1299</th>\n",
              "      <td>109</td>\n",
              "      <td>172335</td>\n",
              "      <td>3.0</td>\n",
              "      <td>58281</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1300</th>\n",
              "      <td>109</td>\n",
              "      <td>172335</td>\n",
              "      <td>4.0</td>\n",
              "      <td>5855</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1301</th>\n",
              "      <td>109</td>\n",
              "      <td>172335</td>\n",
              "      <td>5.0</td>\n",
              "      <td>4254</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-9d30e0fe-5d89-42ec-8149-8f4313d6cafa')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-9d30e0fe-5d89-42ec-8149-8f4313d6cafa button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-9d30e0fe-5d89-42ec-8149-8f4313d6cafa');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-e1075cc2-27f3-4040-9322-c5a2a63ddd24\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-e1075cc2-27f3-4040-9322-c5a2a63ddd24')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-e1075cc2-27f3-4040-9322-c5a2a63ddd24 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "diagnoses_icd_df"
            }
          },
          "metadata": {},
          "execution_count": 3
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Filter NoteEvents by Discharge Summary and Extract Text\n",
        "\n",
        "# Filter NoteEvents by Discharge Summary\n",
        "discharge_summaries_flt_df = noteevents_df.loc[noteevents_df['CATEGORY'] == 'Discharge summary',\n",
        "                                               ['SUBJECT_ID', 'HADM_ID', 'TEXT']]\n",
        "\n",
        "# Print discharge_summaries_flt_df top 10\n",
        "#print(discharge_summaries_flt_df.head(10))\n",
        "\n",
        "# Extract Text\n",
        "discharge_summaries_text = discharge_summaries_flt_df['TEXT']\n",
        "#print(discharge_summaries_text.head(10))\n"
      ],
      "metadata": {
        "id": "0ZMlomzAWGDJ"
      },
      "execution_count": 4,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Load d_icd_diagnoses data\n",
        "icd_diagnoses_df = pd.read_csv('D_ICD_DIAGNOSES.csv.gz')\n",
        "icd_diagnoses_df.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "7fmHePy7ZGbf",
        "outputId": "7bceee21-7248-40c4-abad-742ca4a24d30"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   ROW_ID ICD9_CODE               SHORT_TITLE  \\\n",
              "0     174     01166     TB pneumonia-oth test   \n",
              "1     175     01170    TB pneumothorax-unspec   \n",
              "2     176     01171   TB pneumothorax-no exam   \n",
              "3     177     01172  TB pneumothorx-exam unkn   \n",
              "4     178     01173  TB pneumothorax-micro dx   \n",
              "\n",
              "                                          LONG_TITLE  \n",
              "0  Tuberculous pneumonia [any form], tubercle bac...  \n",
              "1              Tuberculous pneumothorax, unspecified  \n",
              "2  Tuberculous pneumothorax, bacteriological or h...  \n",
              "3  Tuberculous pneumothorax, bacteriological or h...  \n",
              "4  Tuberculous pneumothorax, tubercle bacilli fou...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-bdfa94ea-0daa-4d26-be3b-5d3b048b20bd\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>ROW_ID</th>\n",
              "      <th>ICD9_CODE</th>\n",
              "      <th>SHORT_TITLE</th>\n",
              "      <th>LONG_TITLE</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>174</td>\n",
              "      <td>01166</td>\n",
              "      <td>TB pneumonia-oth test</td>\n",
              "      <td>Tuberculous pneumonia [any form], tubercle bac...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>175</td>\n",
              "      <td>01170</td>\n",
              "      <td>TB pneumothorax-unspec</td>\n",
              "      <td>Tuberculous pneumothorax, unspecified</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>176</td>\n",
              "      <td>01171</td>\n",
              "      <td>TB pneumothorax-no exam</td>\n",
              "      <td>Tuberculous pneumothorax, bacteriological or h...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>177</td>\n",
              "      <td>01172</td>\n",
              "      <td>TB pneumothorx-exam unkn</td>\n",
              "      <td>Tuberculous pneumothorax, bacteriological or h...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>178</td>\n",
              "      <td>01173</td>\n",
              "      <td>TB pneumothorax-micro dx</td>\n",
              "      <td>Tuberculous pneumothorax, tubercle bacilli fou...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bdfa94ea-0daa-4d26-be3b-5d3b048b20bd')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-bdfa94ea-0daa-4d26-be3b-5d3b048b20bd button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-bdfa94ea-0daa-4d26-be3b-5d3b048b20bd');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-c5150a3c-e00a-4541-895e-ea1907dc89d0\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-c5150a3c-e00a-4541-895e-ea1907dc89d0')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-c5150a3c-e00a-4541-895e-ea1907dc89d0 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "icd_diagnoses_df",
              "summary": "{\n  \"name\": \"icd_diagnoses_df\",\n  \"rows\": 14567,\n  \"fields\": [\n    {\n      \"column\": \"ROW_ID\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 4205,\n        \"min\": 1,\n        \"max\": 14567,\n        \"num_unique_values\": 14567,\n        \"samples\": [\n          54,\n          4405,\n          2225\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ICD9_CODE\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14567,\n        \"samples\": [\n          \"0064\",\n          \"42090\",\n          \"2813\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"SHORT_TITLE\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14328,\n        \"samples\": [\n          \"Rabies\",\n          \"Cns TB NOS-no exam\",\n          \"Chr rapid progr nephrit\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"LONG_TITLE\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 14562,\n        \"samples\": [\n          \"Smooth muscle relaxants causing adverse effects in therapeutic use\",\n          \"Carcinoma in situ of other and unspecified digestive organs\",\n          \"Other specified slow virus infection of central nervous system\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 5
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Join icd_diagnoses_df with diagnoses_icd_df and filter the icd9 code on short_title\n",
        "# for \"Lymphoma\"\n",
        "\n",
        "import pandas as pd\n",
        "# Merge the two dataframes\n",
        "merged_df = pd.merge(icd_diagnoses_df, diagnoses_icd_df, how='inner')\n",
        "#print(merged_df.head(10))\n",
        "\n",
        "# Filter the merged dataframe\n",
        "lymphoma_df = merged_df[merged_df['SHORT_TITLE'].str.contains(\"lymphoma\", na=False)]\n",
        "#print(lymphoma_df.head(100))\n",
        "\n",
        "# Print the filtered dataframe (optional)\n",
        "print(lymphoma_df.head(20))\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GA_3z1gMcEMO",
        "outputId": "67f5422d-1882-4e80-9cb5-d9a73f2098b6"
      },
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "       ROW_ID ICD9_CODE               SHORT_TITLE  \\\n",
            "36699    1699     20201     Nodular lymphoma head   \n",
            "36700    1699     20201     Nodular lymphoma head   \n",
            "36701    1701     20203    Nodular lymphoma abdom   \n",
            "36702    1701     20203    Nodular lymphoma abdom   \n",
            "36703    1703     20205   Nodular lymphoma inguin   \n",
            "36704    1704     20206   Nodular lymphoma pelvic   \n",
            "36705    1706     20208     Nodular lymphoma mult   \n",
            "36706    1706     20208     Nodular lymphoma mult   \n",
            "36707    1706     20208     Nodular lymphoma mult   \n",
            "36708    1706     20208     Nodular lymphoma mult   \n",
            "45486    2148     20071  Large cell lymphoma head   \n",
            "\n",
            "                                              LONG_TITLE  SUBJECT_ID  HADM_ID  \\\n",
            "36699  Nodular lymphoma, lymph nodes of head, face, a...       24483   126391   \n",
            "36700  Nodular lymphoma, lymph nodes of head, face, a...       56552   196064   \n",
            "36701      Nodular lymphoma, intra-abdominal lymph nodes       70754   116929   \n",
            "36702      Nodular lymphoma, intra-abdominal lymph nodes       96779   132235   \n",
            "36703  Nodular lymphoma, lymph nodes of inguinal regi...       40775   132572   \n",
            "36704          Nodular lymphoma, intrapelvic lymph nodes       73693   177173   \n",
            "36705    Nodular lymphoma, lymph nodes of multiple sites       15907   191122   \n",
            "36706    Nodular lymphoma, lymph nodes of multiple sites       56552   132888   \n",
            "36707    Nodular lymphoma, lymph nodes of multiple sites       76812   152711   \n",
            "36708    Nodular lymphoma, lymph nodes of multiple sites       80927   179544   \n",
            "45486  Large cell lymphoma, lymph nodes of head, face...       30084   162715   \n",
            "\n",
            "       SEQ_NUM  \n",
            "36699      4.0  \n",
            "36700      5.0  \n",
            "36701      1.0  \n",
            "36702      1.0  \n",
            "36703      3.0  \n",
            "36704      6.0  \n",
            "36705      4.0  \n",
            "36706      1.0  \n",
            "36707      9.0  \n",
            "36708      1.0  \n",
            "45486      1.0  \n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# merge lymphoma_df and discharge_summaries_flt_df on subject_id and hadm_id\n",
        "\n",
        "import pandas as pd\n",
        "lymphoma_patients_disch_summaries_df = pd.merge(lymphoma_df,\n",
        "                                                discharge_summaries_flt_df,\n",
        "                                                on=['SUBJECT_ID', 'HADM_ID'], how='inner')\n",
        "print(lymphoma_patients_disch_summaries_df.head(20))\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "VKffOl0Xehbs",
        "outputId": "a4b1e032-6c05-4ebb-fc71-29e154cdbfef"
      },
      "execution_count": 7,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "    ROW_ID ICD9_CODE               SHORT_TITLE  \\\n",
            "0     1699     20201     Nodular lymphoma head   \n",
            "1     1699     20201     Nodular lymphoma head   \n",
            "2     1699     20201     Nodular lymphoma head   \n",
            "3     1701     20203    Nodular lymphoma abdom   \n",
            "4     1701     20203    Nodular lymphoma abdom   \n",
            "5     1703     20205   Nodular lymphoma inguin   \n",
            "6     1704     20206   Nodular lymphoma pelvic   \n",
            "7     1706     20208     Nodular lymphoma mult   \n",
            "8     1706     20208     Nodular lymphoma mult   \n",
            "9     1706     20208     Nodular lymphoma mult   \n",
            "10    2148     20071  Large cell lymphoma head   \n",
            "\n",
            "                                           LONG_TITLE  SUBJECT_ID  HADM_ID  \\\n",
            "0   Nodular lymphoma, lymph nodes of head, face, a...       24483   126391   \n",
            "1   Nodular lymphoma, lymph nodes of head, face, a...       56552   196064   \n",
            "2   Nodular lymphoma, lymph nodes of head, face, a...       56552   196064   \n",
            "3       Nodular lymphoma, intra-abdominal lymph nodes       70754   116929   \n",
            "4       Nodular lymphoma, intra-abdominal lymph nodes       96779   132235   \n",
            "5   Nodular lymphoma, lymph nodes of inguinal regi...       40775   132572   \n",
            "6           Nodular lymphoma, intrapelvic lymph nodes       73693   177173   \n",
            "7     Nodular lymphoma, lymph nodes of multiple sites       56552   132888   \n",
            "8     Nodular lymphoma, lymph nodes of multiple sites       76812   152711   \n",
            "9     Nodular lymphoma, lymph nodes of multiple sites       80927   179544   \n",
            "10  Large cell lymphoma, lymph nodes of head, face...       30084   162715   \n",
            "\n",
            "    SEQ_NUM                                               TEXT  \n",
            "0       4.0  Admission Date:  [**2177-9-27**]              ...  \n",
            "1       5.0  Admission Date:  [**2150-11-25**]             ...  \n",
            "2       5.0  Admission Date:  [**2150-11-27**]             ...  \n",
            "3       1.0  Admission Date:  [**2147-7-4**]              D...  \n",
            "4       1.0  Admission Date:  [**2163-6-1**]              D...  \n",
            "5       3.0  Admission Date:  [**2184-9-9**]              D...  \n",
            "6       6.0  Admission Date:  [**2195-10-14**]             ...  \n",
            "7       1.0  Admission Date:  [**2151-1-5**]              D...  \n",
            "8       9.0  Admission Date:  [**2163-4-24**]              ...  \n",
            "9       1.0  Admission Date:  [**2155-3-26**]              ...  \n",
            "10      1.0  Admission Date:  [**2197-5-31**]              ...  \n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Limit the result set to ICD9_CODE, SHORT_TITLE, SUBJECT_ID, HADM_ID, and TEXT\n",
        "\n",
        "lymphoma_patients_disch_summaries_df = lymphoma_patients_disch_summaries_df[\n",
        "    ['ICD9_CODE', 'SHORT_TITLE', 'SUBJECT_ID', 'HADM_ID', 'TEXT']]\n",
        "#print(lymphoma_patients_disch_summaries_df.head(20))\n",
        "\n",
        "lymphoma_patients_disch_summaries_df.to_csv('lymphoma_patients_disch_summaries.csv',\n",
        "                                            index=False)"
      ],
      "metadata": {
        "id": "uKWywBISg7nh"
      },
      "execution_count": 8,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: visualize the number of lymphoma_patients_disch_summaries_df by SHORT_TITLE using horizontal bar chart with colorful bars\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "\n",
        "# Count the occurrences of each SHORT_TITLE\n",
        "title_counts = lymphoma_patients_disch_summaries_df['SHORT_TITLE'].value_counts()\n",
        "\n",
        "# Create the horizontal bar chart\n",
        "plt.figure(figsize=(10, 6))  # Adjust figure size as needed\n",
        "sns.countplot(y='SHORT_TITLE', data=lymphoma_patients_disch_summaries_df, palette='viridis', order=title_counts.index) # Use a colorful palette\n",
        "plt.xlabel('Number of Patients')\n",
        "plt.ylabel('Type of Lymphoma')\n",
        "plt.title('Number of Lymphoma Patients Discharge Summaries by types of Lymphoma')\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 694
        },
        "id": "HmELTOJ5h0ZD",
        "outputId": "3eca0795-bf1c-4e5d-f891-994cd1473d2c"
      },
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-9-bb532a70bf3f>:11: FutureWarning: \n",
            "\n",
            "Passing `palette` without assigning `hue` is deprecated and will be removed in v0.14.0. Assign the `y` variable to `hue` and set `legend=False` for the same effect.\n",
            "\n",
            "  sns.countplot(y='SHORT_TITLE', data=lymphoma_patients_disch_summaries_df, palette='viridis', order=title_counts.index) # Use a colorful palette\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1000x600 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# load the spaCy model for Clinical notes\n",
        "\n",
        "!pip install spacy\n",
        "!python -m spacy download en_core_web_sm # or a larger model if needed, e.g., en_core_web_lg\n",
        "\n",
        "import spacy\n",
        "\n",
        "# Load the spaCy model\n",
        "nlp = spacy.load(\"en_core_web_sm\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GHha_H80mxGJ",
        "outputId": "a6162d43-5e19-44be-91a2-70a669158ea6"
      },
      "execution_count": 10,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: spacy in /usr/local/lib/python3.11/dist-packages (3.4.4)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.10 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.0.12)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.11)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.2.0,>=8.1.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (8.1.12)\n",
            "Requirement already satisfied: wasabi<1.1.0,>=0.9.1 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.10.1)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.5.1)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: typer<0.8.0,>=0.3.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.7.0)\n",
            "Requirement already satisfied: pathy>=0.3.5 in /usr/local/lib/python3.11/dist-packages (from spacy) (0.11.0)\n",
            "Requirement already satisfied: smart-open<7.0.0,>=5.2.1 in /usr/local/lib/python3.11/dist-packages (from spacy) (6.4.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (4.67.1)\n",
            "Requirement already satisfied: numpy>=1.15.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.26.4)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<1.11.0,>=1.7.4 in /usr/local/lib/python3.11/dist-packages (from spacy) (1.10.21)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.1.5)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.11/dist-packages (from spacy) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.11/dist-packages (from spacy) (3.5.0)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.11/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy) (1.3.0)\n",
            "Requirement already satisfied: pathlib-abc==0.1.1 in /usr/local/lib/python3.11/dist-packages (from pathy>=0.3.5->spacy) (0.1.1)\n",
            "Requirement already satisfied: typing-extensions>=4.2.0 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<1.11.0,>=1.7.4->spacy) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.4.1)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2.3.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2025.1.31)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.11/dist-packages (from thinc<8.2.0,>=8.1.0->spacy) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.11/dist-packages (from thinc<8.2.0,>=8.1.0->spacy) (0.1.5)\n",
            "Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.11/dist-packages (from typer<0.8.0,>=0.3.0->spacy) (8.1.8)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.11/dist-packages (from jinja2->spacy) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.11/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy) (1.2.1)\n",
            "2025-02-15 08:39:22.838019: E external/local_xla/xla/stream_executor/cuda/cuda_fft.cc:477] Unable to register cuFFT factory: Attempting to register factory for plugin cuFFT when one has already been registered\n",
            "WARNING: All log messages before absl::InitializeLog() is called are written to STDERR\n",
            "E0000 00:00:1739608763.116479   28479 cuda_dnn.cc:8310] Unable to register cuDNN factory: Attempting to register factory for plugin cuDNN when one has already been registered\n",
            "E0000 00:00:1739608763.189826   28479 cuda_blas.cc:1418] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
            "2025-02-15 08:39:23.778695: I tensorflow/core/platform/cpu_feature_guard.cc:210] This TensorFlow binary is optimized to use available CPU instructions in performance-critical operations.\n",
            "To enable the following instructions: AVX2 FMA, in other operations, rebuild TensorFlow with the appropriate compiler flags.\n",
            "2025-02-15 08:39:31.979526: E external/local_xla/xla/stream_executor/cuda/cuda_driver.cc:152] failed call to cuInit: INTERNAL: CUDA error: Failed call to cuInit: UNKNOWN ERROR (303)\n",
            "Collecting en-core-web-sm==3.4.1\n",
            "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_sm-3.4.1/en_core_web_sm-3.4.1-py3-none-any.whl (12.8 MB)\n",
            "\u001b[2K     \u001b[90m\u001b[0m \u001b[32m12.8/12.8 MB\u001b[0m \u001b[31m90.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: spacy<3.5.0,>=3.4.0 in /usr/local/lib/python3.11/dist-packages (from en-core-web-sm==3.4.1) (3.4.4)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.10 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (1.0.12)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (2.0.11)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.2.0,>=8.1.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (8.1.12)\n",
            "Requirement already satisfied: wasabi<1.1.0,>=0.9.1 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (0.10.1)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (2.5.1)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (2.0.10)\n",
            "Requirement already satisfied: typer<0.8.0,>=0.3.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (0.7.0)\n",
            "Requirement already satisfied: pathy>=0.3.5 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (0.11.0)\n",
            "Requirement already satisfied: smart-open<7.0.0,>=5.2.1 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (6.4.0)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (4.67.1)\n",
            "Requirement already satisfied: numpy>=1.15.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (1.26.4)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<1.11.0,>=1.7.4 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (1.10.21)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.1.5)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.11/dist-packages (from spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.5.0)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.11/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (1.3.0)\n",
            "Requirement already satisfied: pathlib-abc==0.1.1 in /usr/local/lib/python3.11/dist-packages (from pathy>=0.3.5->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (0.1.1)\n",
            "Requirement already satisfied: typing-extensions>=4.2.0 in /usr/local/lib/python3.11/dist-packages (from pydantic!=1.8,!=1.8.1,<1.11.0,>=1.7.4->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.4.1)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (2.3.0)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.11/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (2025.1.31)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.11/dist-packages (from thinc<8.2.0,>=8.1.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.11/dist-packages (from thinc<8.2.0,>=8.1.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (0.1.5)\n",
            "Requirement already satisfied: click<9.0.0,>=7.1.1 in /usr/local/lib/python3.11/dist-packages (from typer<0.8.0,>=0.3.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (8.1.8)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.11/dist-packages (from jinja2->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.11/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy<3.5.0,>=3.4.0->en-core-web-sm==3.4.1) (1.2.1)\n",
            "Installing collected packages: en-core-web-sm\n",
            "  Attempting uninstall: en-core-web-sm\n",
            "    Found existing installation: en-core-web-sm 3.7.1\n",
            "    Uninstalling en-core-web-sm-3.7.1:\n",
            "      Successfully uninstalled en-core-web-sm-3.7.1\n",
            "Successfully installed en-core-web-sm-3.4.1\n",
            "\u001b[38;5;2m Download and installation successful\u001b[0m\n",
            "You can now load the package via spacy.load('en_core_web_sm')\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "lymphoma_summary_df = pd.read_csv('lymphoma_patients_disch_summaries.csv')\n",
        "lymphoma_summary_df.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 206
        },
        "id": "jayo3GaYnKDU",
        "outputId": "41df9e6d-46b3-461c-a7d9-b662e9d77ad5"
      },
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   ICD9_CODE             SHORT_TITLE  SUBJECT_ID  HADM_ID  \\\n",
              "0      20201   Nodular lymphoma head       24483   126391   \n",
              "1      20201   Nodular lymphoma head       56552   196064   \n",
              "2      20201   Nodular lymphoma head       56552   196064   \n",
              "3      20203  Nodular lymphoma abdom       70754   116929   \n",
              "4      20203  Nodular lymphoma abdom       96779   132235   \n",
              "\n",
              "                                                TEXT  \n",
              "0  Admission Date:  [**2177-9-27**]              ...  \n",
              "1  Admission Date:  [**2150-11-25**]             ...  \n",
              "2  Admission Date:  [**2150-11-27**]             ...  \n",
              "3  Admission Date:  [**2147-7-4**]              D...  \n",
              "4  Admission Date:  [**2163-6-1**]              D...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-df6cf432-fd83-495b-baaf-8e6343526d62\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>ICD9_CODE</th>\n",
              "      <th>SHORT_TITLE</th>\n",
              "      <th>SUBJECT_ID</th>\n",
              "      <th>HADM_ID</th>\n",
              "      <th>TEXT</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>20201</td>\n",
              "      <td>Nodular lymphoma head</td>\n",
              "      <td>24483</td>\n",
              "      <td>126391</td>\n",
              "      <td>Admission Date:  [**2177-9-27**]              ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>20201</td>\n",
              "      <td>Nodular lymphoma head</td>\n",
              "      <td>56552</td>\n",
              "      <td>196064</td>\n",
              "      <td>Admission Date:  [**2150-11-25**]             ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>20201</td>\n",
              "      <td>Nodular lymphoma head</td>\n",
              "      <td>56552</td>\n",
              "      <td>196064</td>\n",
              "      <td>Admission Date:  [**2150-11-27**]             ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>20203</td>\n",
              "      <td>Nodular lymphoma abdom</td>\n",
              "      <td>70754</td>\n",
              "      <td>116929</td>\n",
              "      <td>Admission Date:  [**2147-7-4**]              D...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>20203</td>\n",
              "      <td>Nodular lymphoma abdom</td>\n",
              "      <td>96779</td>\n",
              "      <td>132235</td>\n",
              "      <td>Admission Date:  [**2163-6-1**]              D...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-df6cf432-fd83-495b-baaf-8e6343526d62')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-df6cf432-fd83-495b-baaf-8e6343526d62 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-df6cf432-fd83-495b-baaf-8e6343526d62');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-250adf6d-179a-4532-93f1-80111f3838b4\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-250adf6d-179a-4532-93f1-80111f3838b4')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-250adf6d-179a-4532-93f1-80111f3838b4 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "lymphoma_summary_df",
              "summary": "{\n  \"name\": \"lymphoma_summary_df\",\n  \"rows\": 11,\n  \"fields\": [\n    {\n      \"column\": \"ICD9_CODE\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 40,\n        \"min\": 20071,\n        \"max\": 20208,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          20201,\n          20203,\n          20071\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"SHORT_TITLE\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"Nodular lymphoma head\",\n          \"Nodular lymphoma abdom\",\n          \"Large cell lymphoma head\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"SUBJECT_ID\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 22218,\n        \"min\": 24483,\n        \"max\": 96779,\n        \"num_unique_values\": 9,\n        \"samples\": [\n          80927,\n          56552,\n          73693\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"HADM_ID\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 28826,\n        \"min\": 116929,\n        \"max\": 196064,\n        \"num_unique_values\": 10,\n        \"samples\": [\n          179544,\n          196064,\n          177173\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"TEXT\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 11,\n        \"samples\": [\n          \"Admission Date:  [**2184-9-9**]              Discharge Date:   [**2184-9-15**]\\n\\n\\nService: MEDICINE\\n\\nAllergies:\\nPatient recorded as having No Known Allergies to Drugs\\n\\nAttending:[**First Name3 (LF) 7333**]\\nChief Complaint:\\nShortness of breath\\n\\nMajor Surgical or Invasive Procedure:\\narterial line\\nPacemaker Placement\\n\\nHistory of Present Illness:\\nMrs. [**Known lastname **] is a 88yo F with history of follicular lymphoma\\n(treated by Dr. [**First Name (STitle) **], atrial fibrillation, aortic stenosis and\\nhistory of CVA in [**2179**] who started cycle 4 of of R-CVP chemo\\nyesterday. This was uneventful and she denied fevers, chills,\\nsweats, diarrhea and emesis. She developed shortness of breath\\nand substernal chest pressure this morning after awakening and\\nhaving a bowel movement at 4:30am. The chest pain did not\\nradiate to the neck/arms/back, not pleuritic, no\\nnausea/vomiting/diarrhea or epigastric pain. She did not cough\\nor have a fever and denies any sick contacts. There was no\\nunilateral leg swelling or pain. By the time EMS arrived, she\\nreported resolution of her symptoms except continued weakness.\\n.\\nIn the ED, initial vs were: 98.4, 80, 127/55, 16, 98% 2L.\\nPatient was given a full dose of aspirin and later developed\\nhypotension to SBP 80s, but developed no new symptoms.  She\\nreceived 1500 cc of IVF through two large bore peripheral IVs\\nand was placed on neo for pressure support.  She had a CXR which\\nshowed persistent small right pleural effusion with right lower\\nlobe atelectasis and mediastinal lymphadenopathy.  CTA did not\\nshow any evidence of pulmonary embolism. Initial EKG was sinus\\nand unremarkable but a second EKG in setting of hypotension\\nshowed atrial flutter/fibrillation with a stable rate.  No ST\\nchanges.  At time of transfer, vitals were  75, 110/50 at 0.8\\nmcg/kg/min, 100% on RA. The patient is DNR/DNI.\\n.\\nOn the floor, the pt was placed on a heart monitor which showed\\npauses. The patient's eyes rolled back and her eyelids sagged\\nduring the pauses. The family reports that they have seen pauses\\nbefore when using the patient's home BP cuff.\\n\\n\\nPast Medical History:\\nMrs. [**Known lastname **] and her family report that since [**Month (only) 547**] of this year,\\nshe has had a slow decline in her activity and functioning.  She\\nusually walks with a walker with curvature of the spine, but\\nthis has become more and more difficult.  She also has had\\ndecreased appetite with weight loss, night sweats, cough, and\\nincreasing fatigue.  She noted no fevers or shaking chills, and\\nover the past one to two weeks prior to admission to [**Hospital1 31548**], her family also noted some changes in mental status.\\nHer family also reports that since she broke her wrist in\\n[**8-/2183**], she has had a overall slow decline as well, as she\\nneeded more help with activities of daily living and this had\\nprevented her from being more independent.  Because of her\\nincreased lethargy and decreased appetite and intake along with\\nnight sweats, she did follow up with her primary care provider.\\n[**Name10 (NameIs) **] work at that time showed pancytopenia, and a chest x-ray\\ndone on [**2184-6-9**] showed a new large right pleural effusion.\\nShe was subsequently admitted to [**Hospital1 5991**]/[**Hospital 8**] Hospital, for further evaluation on [**2184-6-10**].\\n CTA of the chest on [**2184-6-10**] revealed no evidence of pulmonary\\nembolism with a confirmation of the large right pleural\\neffusion.  There was also note of subcarinal and paratracheal\\nadenopathy.  CT scan of the abdomen and pelvis on [**2184-6-11**]\\nrevealed a large mesenteric soft tissue mass and right\\nparaaortic and retroperitoneal lymphadenopathy as well as\\ninguinal lymphadenopathy.  The paraaortic lymph nodes measure up\\nto 7.1 cm x 3.9 cm and the mesenteric soft tissue mass measures\\n7.6 x 3.2 cm.  Note is made of atherosclerotic disease of the\\naorta with a 4.9 cm infrarenal abdominal aortic aneurysm, as\\nwell as a right common iliac artery aneurysm with focal\\ndissection.  There are also multiple hypodense lesions within\\nthe spleen which were nonspecific.\\n.\\nMrs. [**Known lastname **] then underwent a thoracentesis on [**2184-6-12**] with\\nremoval of 1.5 liters of fluid from the right lung. Results of\\nflow cytometry and cytology from the pleural fluid are not\\navailable, but Mrs. [**Known lastname **] subsequently underwent a right\\ninguinal lymph node excision on [**2184-6-18**].  This revealed a\\nfollicular lymphoma, grade IIIA.  The entire lymph node is\\nreplaced by homogenous population of lymphocytes, of relatively\\nuniform size and shape with focal extension into perinodal\\ntissue. Flow cytometry revealed a monoclonal population of kappa\\npositive B cells, positive for CD19 (dim), CD20, CD10, CD23,\\nFMC7, CD22, and CD38.  The cells are negative for CD5.  Mrs.\\n[**Known lastname **] was discharged to [**Location 24442**] Nursing Facility for\\nrehabilitation and was seen by Dr. [**Last Name (STitle) 31549**] yesterday for a\\nconsultation regarding treatment. Dr. [**Last Name (STitle) 31549**] recommended\\nrituximab, however, the family wished for a second opinion so\\nthey presented.\\n.\\n<I>Past medical/surgical history:</I>\\n1.  CVA in [**2179**] with left-sided weakness.  Although this\\nimproved, she used a cane for ambulation for a while, but has\\nmoved more to a walker due to increasing weakness.\\n2.  Atrial fibrillation, on Coumadin and digoxin.\\n3.  Seizures at the time of her CVA in [**2179**], currently on\\nDilantin.\\n4.  Aortic stenosis.\\n5.  Hypertension.\\n6.  Osteoporosis with osteoarthritis.\\n7.  Venous stasis, status post varicose vein surgery.\\n8.  Skin cancer on the left cheek.\\n9.  Hypothyroidism.\\n10.  Wrist fracture in 9/[**2182**].\\n11.  Depression.\\n12.  Thrombocytopenia since [**2174**].\\n13.  Anemia since [**2179**].\\n14.  Leukopenia since [**77**]/[**2183**].\\n\\n\\nSocial History:\\nMrs. [**Known lastname **] lives in [**Hospital1 8**] in a two-family\\nhome with her children, one daughter lives on one floor with her\\nfamily, with a second daughter on the upper floor with her\\nfamily. The daughter who she lives with is her primary\\ncaregiver, but her other daughter cares for her and assists with\\nher activities of daily living during the daytime. Mrs. [**Known lastname **]\\nwas married. Her husband died 20 years ago of a heart attack.\\nShe had six children, one of whom died of heart failure. She has\\nbeen in the United States for many years. She worked on a farm\\nin [**Country 6257**], then worked as a seamstress at [**Doctor First Name 31550**] and also\\nin a shoemaker's facility.\\n\\n\\nFamily History:\\nSignificant for heart disease, high cholesterol,\\nand hypertension, as well as diabetes and CVA's.  An older\\ndaughter had breast cancer.  No other reported cancers in the\\nfamily.\\n\\nPhysical Exam:\\n[**Hospital Unit Name 153**] Admission Exam\\nVitals: T: 98.7 BP: 131/45 P: 74 R: 18 O2: 100% on 2L NC\\nGeneral: Alert, oriented, anxious, but in no acute distress.\\nkyphotic.\\nHEENT: PERLA, Sclera anicteric, oropharynx clear\\nNeck: supple, JVP not elevated, no cervical LAD\\nLungs: nearly absent breath sounds bilaterally in the rear, but\\nup to a higher level on the right.\\nCV: Irregular rate, normal S1 + S2, with a mid systolic murmur\\n[**2-14**], not late peaking, no paradoxical splitting.\\nAbdomen: soft, non-tender, non-distended, bowel sounds present,\\nno rebound tenderness or guarding, no organomegaly\\nGU: no foley\\nExt: warm, well perfused, 2+ pulses, no cyanosis or pedal edema\\n\\n\\nDischarge Exam\\nVitals: Tm 97.3, Tc96.8, 110s-130s/60s-70s, 60s-100s, 24, 98/RA\\n\\nGeneral: Portuguese speaking elderly female who is currently\\nalert and oriented times 3 and in NAD.\\nHEENT: PERRLA, sclera anicteric, oropharynx clear\\nNeck: supple\\nLungs: Decreased breath sounds on the right, otherwise clear to\\nauscultation bilaterally.\\nChest: Hematoma soft, superficial tracking across chest.\\nCV: Irregular rate, normal S1 + S2, with a [**2-14**] mid systolic late\\npeaking murmur\\nAbdomen: soft, non-tender, non-distended, bowel sounds present,\\nno rebound tenderness or guarding\\nGU: no foley\\nExt: warm, well perfused, no cyanosis or pedal edema\\n\\n\\nPertinent Results:\\nADMISSION LABS\\n[**2184-9-9**] 05:23PM   LACTATE-1.3\\n[**2184-9-9**] 05:16PM   CK(CPK)-22*\\n[**2184-9-9**] 05:16PM   CK-MB-2 cTropnT-<0.01\\n[**2184-9-9**] 10:25AM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.011\\n[**2184-9-9**] 10:25AM URINE  [**Month/Day/Year 3143**]-NEG NITRITE-NEG PROTEIN-NEG\\nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0\\nLEUK-NEG\\n[**2184-9-9**] 08:00AM   GLUCOSE-102* UREA N-25* CREAT-1.0 SODIUM-142\\nPOTASSIUM-4.5 CHLORIDE-107 TOTAL CO2-27 ANION GAP-13\\n[**2184-9-9**] 08:00AM   CK(CPK)-31\\n[**2184-9-9**] 08:00AM   cTropnT-0.02*\\n[**2184-9-9**] 08:00AM   CK-MB-3 cTropnT-<0.01 proBNP-3083*\\n[**2184-9-9**] 08:00AM   CALCIUM-8.4 PHOSPHATE-3.9 MAGNESIUM-2.0\\n[**2184-9-9**] 08:00AM   TSH-1.9\\n[**2184-9-9**] 08:00AM   FREE T4-1.3\\n[**2184-9-9**] 08:00AM   WBC-5.7# RBC-3.14* HGB-10.9* HCT-34.0*\\nMCV-108* MCH-34.7* MCHC-32.0 RDW-17.1*\\n[**2184-9-9**] 08:00AM   NEUTS-92.5* LYMPHS-3.5* MONOS-2.1 EOS-0.9\\nBASOS-0.9\\n[**2184-9-9**] 08:00AM   PLT COUNT-103*\\n[**2184-9-9**] 08:00AM   PT-12.4 PTT-27.3 INR(PT)-1.0\\n[**2184-9-8**] 11:05AM   GLUCOSE-95\\n[**2184-9-8**] 11:05AM   UREA N-26* CREAT-0.9 SODIUM-141 POTASSIUM-4.6\\nCHLORIDE-105 TOTAL CO2-30 ANION GAP-11\\n[**2184-9-8**] 11:05AM   estGFR-Using this\\n[**2184-9-8**] 11:05AM   ALT(SGPT)-7 AST(SGOT)-16 LD(LDH)-182 ALK\\nPHOS-109* TOT BILI-0.3\\n[**2184-9-8**] 11:05AM   ALBUMIN-3.7 CALCIUM-8.7 PHOSPHATE-4.7*\\nMAGNESIUM-2.1\\n[**2184-9-8**] 11:05AM   WBC-3.7*# RBC-3.00* HGB-10.2* HCT-32.1*\\nMCV-107* MCH-34.1* MCHC-31.9 RDW-17.0*\\n[**2184-9-8**] 11:05AM   NEUTS-76.5* LYMPHS-16.3* MONOS-5.7 EOS-0.8\\nBASOS-0.7\\n[**2184-9-8**] 11:05AM   PLT COUNT-109*\\n\\nECHOCARDIOGRAM [**9-10**]\\nThe left atrium is moderately dilated. The right atrium is\\nmoderately dilated. There is mild symmetric left ventricular\\nhypertrophy with normal cavity size. Due to suboptimal technical\\nquality, a focal wall motion abnormality cannot be fully\\nexcluded. Overall left ventricular systolic function is normal\\n(LVEF>55%). The estimated cardiac index is normal\\n(>=2.5L/min/m2). The right ventricular cavity is mildly dilated\\nwith borderline normal free wall function. The aortic arch is\\nmildly dilated. The aortic valve leaflets are severely\\nthickened/deformed. There is critical aortic valve stenosis\\n(valve area <0.8cm2). Mild (1+) aortic regurgitation is seen.\\nThe mitral valve leaflets are mildly thickened. Mild (1+) mitral\\nregurgitation is seen. The tricuspid valve leaflets are mildly\\nthickened. There is borderline pulmonary artery systolic\\nhypertension. There is no pericardial effusion.\\n\\nIMPRESSION: Suboptimal image quality. Critical aortic stenosis.\\nMild mitral and aortic regurgitation. Mild symmetric left\\nventricular hypertrophy with preserved global left ventricular\\nsystolic function. Right ventricular dilation/dysfunction. Mild\\npulmonary hypertension.\\n\\nCTA [**9-9**]\\nIMPRESSION:\\n1. No evidence of pulmonary embolism.\\n2. Diffuse smooth septal thickening is most consistent with\\nhydrostatic edema in the setting of effusions and anarsarca.\\n3. Enlarging moderately large right pleural effusion and new\\nsmall left\\npleural effusion.\\n4. Mediastinal lymphadenopathy, stable since [**2184-8-12**].\\n\\nCXR [**9-14**]\\nIMPRESSION:\\n1. Persistent right pleural effusion, unchanged in size with\\nincreased\\nassociated right lower lobe atelectasis.\\n2. Leads appropriately placed in apex of the right ventricle as\\nwell as\\nwithin the right atrium.\\n\\n\\nBrief Hospital Course:\\nMs. [**Known lastname **] is an 88 year old female with history of follicular\\nlymphoma, atrial fibrillation, aortic stenosis and history of\\nCVA in [**2179**] who started cycle 4 of R-CVP chemo 20 hours before\\npresenting to ED with SOB and substernal CP after a bowel\\nmovement.  She was admitted to the ICU on a phenylephrine drip\\nfor hypotension that developed in the ED.\\n\\n.\\n\\n# Hypotension: This may be cardiogenic, or secondary to volume\\ndepletion or infection. ECHO showed critical AS which likely\\ncontributed.  CXR is not typical of left ventricular failure,\\nbut the patient's fluctuating heart rate with pauses may be\\nleading to drops in cardiac output. The elevated BNP is of\\nlittle use in the context of chronic aortic stenosis. The\\npatient was bolused 500cc NS and phenylephrine d/c'ed. Since\\nthen her pauses have been much less frequent and her BP more\\nstable.  Art line was inserted for BP monitoring and was removed\\nprior to transfer.  UA was suggestive of UTI so pt was started\\non Ciprofloxacin PO 500 mg [**Hospital1 **], urine cx showed E. coli so 3 day\\ncourse of abx was completed.  In light of the pt's pauses on\\ntele, cardiology c/s (EP) was called, and the pt was ultimately\\ntransferred to the EP service for pacemaker placement on [**2184-9-13**]\\n(see below). Her BP was stable for floor transfer and remained\\nnormotensive on the floor.  Her Metoprolol was decreased to 12.5\\nmg PO BID.\\n\\n.\\n\\n# Arrhythmia: Pauses in Heart rate and Afib - likely due to sick\\nsinus syndrome that is not new. Her sick sinus syndrome and poor\\nvolume status together may have dropped her cardiac output\\nleading to SOB and low BP while in ICU.  Evaluated by cardiology\\nand a pacemaker was placed on [**2184-9-13**].  The pacer was\\ninterrogated on [**9-14**] without incidence.  As for the pt's Afib,\\nas her Metop dose was decreased to 12.5 mg PO BID, and in the\\nsetting of this decreased dose, her afib went into RVR.  As per\\nEP, she was started on an amiodarone load to be finished after\\ndischarge.  Briefly, she is to get 200 mg of Amiodarone TID x 7\\ndays, and then 400 mg PO daily x 3 weeks, and finally 200 mg PO\\ndaily afterward.  Of note, a hematoma formed on the pt's chest\\nafter PPM placement, likely [**1-13**] her thrombocytopenia after\\nchemo.  Her Hct remained stable, and Ms. [**Known lastname **] was treated with\\npain medication.  Of note, the pt's risk of stroke from Afib is\\nquite high given her h/o stroke.  A calculated CHADS2 score\\nwould recommend anticoagulation, however when the pt was on\\ncardiology, we contact[**Name (NI) **] her Oncologist who recommended against\\nall anticoagulation/antiplatelet agents.  We would recommend\\nstarting the pt on anticoagulation at a later date if it is\\ndeemed safe to do so by her Oncologist.  We continued her low\\ndose BB at 12.5 mg PO BID of metoprolol tartrate.\\n\\n.\\n\\n# Agitation/delerium: Particularly at night. Pt often agitated\\nin the few days after chemo according to children.  Zyprexa was\\ngiven PRN at night for agitation, and soft mitts were used for\\nrestraints for one instance of attempting to pull her lines.\\nAgitation improved and she was able to sleep through the night.\\n\\n.\\n\\n# Episode of Chest pain: [**Month (only) 116**] represent an episode of unstable\\nangina in a pt with a strong family history of CAD, but more\\nlikely caused by decreased cardiac output secondary to the\\npatient's sick sinus syndrome and hypovolemia. MI, PE ruled out.\\ntrops and CTA neg.  Chest pain did not return after transfer to\\nthe floor.\\n\\n.\\n\\n# Follicular lymphoma: She just received a dose of R-CVP chemo\\nprior to admission and was continued on her scheduled prednisone\\nand zofran. In addition, she was started on neupogen daily by\\nthe BMT team to increase her WBC.  She was not neutropenic after\\nher chemotherapy, but in the setting of her sick sinus syndrome\\nand need for pacemaker placement, she was placed on neupogen in\\norder to increase her counts and lower her infection risk.  She\\nwill continue to be followed by her primary outpatient\\noncologist, Dr. [**First Name (STitle) **], who will determine her future course as\\nfar as further cycles of R-CVP.\\n\\n.\\n\\n# Anemia: Pt's Hct was noted to have dropped after the procedure\\nand in light of the hematoma.  Multiple causes are possible,\\nalthough most likely is a combination of chemotherapy (nadir\\nwhen Hct was 22-23) as well as slight [**First Name (STitle) **] loss from the PPM\\nplacement and the hematoma.  When the pt was on the cardiology\\nteam, her BMT attending was asked regarding this and she was\\ntransfused 2 units pRBCs on the day prior to discharge and her\\nhematocrit rose appropriately to 26.2.\\n\\n.\\n\\n# Persistent right pleural effusion and smaller left pleural\\neffusion. These are present on CT chest of 1 month ago. Most\\nlikely secondary to the patient's lymphoma, they are probably\\nnot large enough to cause respiratory distress or hemodynamic\\ncomprimise. Did not tap or drain these this admission.\\n\\n\\n# Hypothyroidism: continued her home synthroid.\\n.\\n\\n# Seziures s/p CVA: continued home dilantin.\\n\\n\\nMedications on Admission:\\nZyprexa 10 mg qHS PRN agitation\\nSenna 8.6 mg Cap 2 at bedtime\\nAcetaminophen 500 mg q6 PRN pain\\nOmeprazole 20 mg daily\\nPrednisone 60 mg daily until [**9-11**], then taper\\nMetoprolol Tartrate 75 mg [**Hospital1 **]\\nColace 100 mg [**Hospital1 **] PRN\\nLevothyroxine 88 mcg daily\\nDilantin Extended 200 mg qOD alternating with 300mg\\nGabapentin 200 mg qHS\\nAcyclovir 400 mg [**Hospital1 **]\\nOndansetron HCl 8 mg daily x 2 days after chemo, then [**Hospital1 **] PRN\\n\\nDischarge Medications:\\n1. senna 8.6 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime).\\n2. acetaminophen 500 mg Tablet Sig: One (1) Tablet PO every six\\n(6) hours as needed for pain.\\n3. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1)\\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).\\n4. levothyroxine 88 mcg Tablet Sig: One (1) Tablet PO DAILY\\n(Daily).\\n5. Zyprexa Zydis 10 mg Tablet, Rapid Dissolve Sig: One (1)\\nTablet, Rapid Dissolve PO at bedtime as needed for insomnia.\\n6. docusate sodium 100 mg Tablet Sig: One (1) Capsule PO BID (2\\ntimes a day) as needed for constipation.\\n7. gabapentin 100 mg Capsule Sig: Two (2) Capsule PO HS (at\\nbedtime).\\n8. acyclovir 400 mg Tablet Sig: One (1) Tablet PO twice a day.\\n9. amiodarone 200 mg Tablet Sig: One (1) Tablet PO TID (3 times\\na day): x 7 days (last day should be [**2184-9-20**]).\\n10. amiodarone 400 mg Tablet Sig: One (1) Tablet PO once a day\\nfor 3 weeks: To be started on [**2184-9-21**] until [**2184-10-11**].\\n11. amiodarone 200 mg Tablet Sig: One (1) Tablet PO once a day:\\nstarting [**2184-10-12**].\\n12. Zofran 8 mg Tablet Sig: One (1) Tablet PO twice a day as\\nneeded for nausea.\\n13. phenytoin sodium extended 200 mg Capsule Sig: One (1)\\nCapsule PO 3 times a week: On M, W, Fr.\\n14. phenytoin sodium extended 300 mg Capsule Sig: One (1)\\nCapsule PO 4 times a week: Tu, Th, [**Last Name (LF) **], [**First Name3 (LF) **].\\n15. filgrastim 300 mcg/mL Solution Sig: One (1) ml Injection\\nQ24H (every 24 hours).\\n16. cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q8H (every\\n8 hours) as needed for post pacemaker for 2 days: started on\\n[**9-14**] with one dose. Needs to be continued until [**9-16**] (for two\\ndoses on that day).\\n17. cholecalciferol (vitamin D3) 400 unit Tablet Sig: Two (2)\\nTablet PO DAILY (Daily).\\n18. metoprolol tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2\\ntimes a day).\\n19. Outpatient Lab Work\\nPlease check a CBC with diff and ANC on Friday, [**9-17**] and\\nfax the results to [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] at [**Telephone/Fax (1) 30658**].\\n20. Calcium 500 500 mg (1,250 mg) Tablet, Chewable Sig: One (1)\\nTablet, Chewable PO three times a day.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Hospital6 15967**] Facility - [**Hospital1 8**]\\n\\nDischarge Diagnosis:\\nSick Sinus Syndrome s/p Pacemaker placement\\n\\n\\nDischarge Condition:\\nMental Status: Confused - sometimes.\\nLevel of Consciousness: Lethargic but arousable.\\nActivity Status: Out of Bed with assistance to chair or\\nwheelchair.\\n\\n\\nDischarge Instructions:\\nIt was a pleasure taking care of you during your\\nhospitalization.  You were admitted to [**Hospital1 18**] with chest pain and\\nlow [**Hospital1 **] pressure.  You were first admitted to the ICU because\\nof these issues, and a medication was used to keep your [**Hospital1 **]\\npressure normal. Then, since you had just started cycle four of\\nyour chemotherapy, you were admitted to the Bone Marrow\\nTransplant Unit.  Since the cause of your low [**Hospital1 **] pressure and\\nchest pain was thought to be because of your arrhythmia\\n(abnormal pattern of heart beats), you were transferred to the\\nCardiology service for a pacemaker to be placed.  This was done\\non [**2184-9-13**], and you were discharged on [**2184-9-15**] to a\\nrehabilitation facility.\\n\\nPLEASE MAKE THE FOLLOWING CHANGES TO YOUR MEDICATIONS\\n1) CHANGE your METOPROLOL to 12.5 mg twice daily\\n2) START taking AMIODARONE 200 mg by mouth three times a day for\\n6 more days, then 400 mg by mouth daily for 3 weeks, then 200 mg\\nby mouth daily\\n3) START taking Vitamin D 800 units daily\\n4) START taking Calcium Carbonate 500 mg three times a day\\n5) START taking Cephalexin 500 mg by mouth every 8 hours for 4\\nmore doses.\\n\\nPLEASE FOLLOW UP WITH YOUR PHYSICIANS AS YOU SEE BELOW\\n\\nFollowup Instructions:\\nPlease follow-up with all of your outpatient medical\\nappointments listed below:\\n\\n1. Department: CARDIAC SERVICES\\nWhen: WEDNESDAY [**2184-9-22**] at 10:00 AM\\nWith:  DEVICE CLINIC [**Telephone/Fax (1) 62**]\\nBuilding: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **]\\nCampus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage\\n\\n2. Department: HEMATOLOGY/BMT\\nWhen: WEDNESDAY [**2184-9-22**] at 12:00 PM\\nWith: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 3919**], RNC [**Telephone/Fax (1) 3241**]\\nBuilding: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **]\\nCampus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage\\n\\n3. Department: HEMATOLOGY/BMT\\nWhen: WEDNESDAY [**2184-9-22**] at 12:00 PM\\nWith: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 4380**], MD [**Telephone/Fax (1) 3237**]\\nBuilding: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **]\\nCampus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage\\n\\n4. Name: [**Last Name (LF) **],[**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **]. [**Last Name (NamePattern1) 3947**].\\nLocation: [**Name2 (NI) **] FAMILY HEALTH [**Last Name (NamePattern1) 31551**]Address: [**Street Address(2) 31552**] [**Hospital1 8**] MA\\nPhone: [**Telephone/Fax (1) 31553**]\\nAppointment: Wednesday [**2184-9-22**] 6:00pm\\n\\n5. Department: CARDIAC SERVICES\\nWhen: MONDAY [**2184-10-18**] at 11:00 AM\\nWith: [**First Name11 (Name Pattern1) 539**] [**Last Name (NamePattern4) 13861**], NP [**Telephone/Fax (1) 62**]\\nBuilding: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **]\\nCampus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage\\n\\n6. Department: CARDIAC SERVICES\\nWhen: MONDAY [**2184-10-18**] at 11:40 AM\\nWith: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **], MD [**Telephone/Fax (1) 62**]\\nBuilding: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **]\\nCampus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage\\n\\n\\n\\n\",\n          \"Admission Date:  [**2177-9-27**]              Discharge Date:   [**2177-10-6**]\\n\\nDate of Birth:  [**2113-10-4**]             Sex:   M\\n\\nService: MEDICINE\\n\\nAllergies:\\nPatient recorded as having No Known Allergies to Drugs\\n\\nAttending:[**First Name3 (LF) 6169**]\\nChief Complaint:\\nWeakness, fatigue\\n\\nMajor Surgical or Invasive Procedure:\\nNone.\\n\\nHistory of Present Illness:\\n63 year-old male with follicular lymphoma who was recently\\ndischarged one week ago after being treated for L3 thecal sac\\ncompression who now presents with generalized weakness for one\\nday prior to admission.  He had been well at rehab until he\\nbegan to feel a generalized fatigue and weakness.  Initially,\\nthis resolved on its own, but then returned the following day.\\nAt the time, he denied any fever, chills, lightheadedness, chest\\npain, cough, shortness of breath, nausea or vomiting.  He was\\nthen transfered to the [**Hospital1 18**].  However, during transport, he\\nbecame hypontensive to the 80's systolic, tachycardic to the\\n140's, and hypoxemic to the 70's.  He was diverted to [**Hospital1 3793**] and was found to have pneumonia on chest x-ray.  He was\\ngiven one dose of ceftriaxone and received 2L of normal saline\\nwith improvement in vital signs.  He was transfered to [**Hospital1 18**].\\nIn the Emergency Department, he was normotensive, afebrile, and\\nhis oxygen saturations were in the mid-90's on 4L nasal cannula.\\n He also had an elevated lactate.  He was given vancomycin and\\nazithromycin.  He was transfered to the Intensive care unit for\\nfurther care given that he appeared septic since he was\\ninitially hypotensive with an elevated lactate.\\n\\n\\nPast Medical History:\\nPast oncology history: He was diagnosed with low-grade\\nfollicular lymphoma in [**2168**] when he presented with a large right\\nneck mass. He was treated with 6 cycles of CHOP chemotherapy\\nfollowed by 4 cycles of Rituxan. He had a good initial resonse\\nto chemotherapy; however, his disease recurred in [**2172**].  He\\nunderwent 2 more cycles of CHOP followed by CEPP. He was\\nsubsequently treated with Bexxar radiolabeled antibody and\\nattained a complete remission for about 3 years.  In [**Month (only) 956**]\\n[**2176**], he noted the gradual increase of his right neck mass,\\nwhich showed follicular lymphoma on biopsy.  He underwent [**3-5**]\\ncycles of R-CEPP responded well.  This chemotherapy was\\nitnerupted secondart to a hip fracture.  He was notd to have\\ncervical spine involvement of imaging and was place in a soft\\ncervical collar.  He underwent 2 cycles of [**Hospital1 **] salvage\\nchemotherapy in [**7-4**] and [**8-4**].  He recently was admitted thecal\\nsac compression at the L3 level for which he received 10 doses\\nof radiation therapy.\\n.\\nPast Medical History:\\n1. Follicular lymphoma as above\\n2. Status post cholecystectomy\\n3. Neuropathy secondary to chemotherapy\\n4. Status post left hip fracture [**5-/2177**]\\n\\nSocial History:\\nThe patient is married and lives at home with his wife in\\n[**Name (NI) 43018**]. He has three children, none of whom live at home. His\\nwife has [**Name (NI) 2481**] dementia and receives a lot of care from\\nher children. The patient's daughter died at age 20 from\\nlymphoma (He thinks ALL).  He previously worked for NSTAR\\nswitching lines.  He denies any tobacco or drug use.  He reports\\noccasional alchohol with about 1 beer per week.\\n\\n\\nFamily History:\\nHis daughter died at age 20 of lymphoma (he believes ALL). He\\nhas an Aunt with melanoma.\\n\\nPhysical Exam:\\nVitals: Temperature:98.4 Pulse:100 Blood Pressure:125/70\\nRespiratory Rate:20 Oxygen Saturation:96% on 15L Non-rebreather.\\nGeneral:pleasant elderly gentleman wearing soft c-spine collar\\nin no acute distress.\\nHEENT: Pupils equal and reactive, extraoccular movements intact,\\nanicteric sclera, oropharynx clear, moist mucous membranes.\\nCardiac: Regular rate and rhythm without murmurs, rubs, or\\ngallops.\\nPulmonary: Coarse breath sounds throughout with rhonchi at the\\nbases, with left greater than right.\\nAbdomen: Normoactive bowel sounds, soft, nontender,\\nnondistended, no hepatosplenomegaly.\\nextremities: Warm and well perfused without cyanosis, trace\\nedema at ankles.\\nNeuro: Alert and oriented x3, cranial nerves [**1-11**] grossly\\nintact, 5/5 strength bilaterally in deltoids, triceps, biceps,\\ngrip, hip flexor, hip extensors, quadriceps, hamstrings,\\ndorsiflexion, plantarflexion.  Sensation symmetric to light\\ntouch bilaterally.\\n\\nPertinent Results:\\n12.4>28.6<147\\nN:97.5 L:0.9 Bands:0 Monos:1.1 Eos:0.2 Basos:0.1\\n.\\n[**Age over 90 **]|96|24/230\\n4.3|21|1.1\\\\\\nCa:8.2 Mg:1.7 P:2.9\\n.\\nPT:12.6 PTT:32.9 INR:1.1\\n.\\nLactate:2.4\\n.\\nIron:63 CaTIBC:114 Ferritin:>[**2171**] TRF:88\\nB12:755 Folate:3.9\\n.\\nSputum (induced) 4+ yeast with pseudohypae\\nBlood Culture ([**9-27**]) no growth\\nUrine Culture ([**9-27**]) no growth\\n.\\nUrinalysis:small blood, trace protein, trace ketones, 0-2 RBC,\\n0-2 WBC, few bacteria, [**2-1**] epithelial cells.\\n.\\nCXR: Multifocal new patchy opacities. While this might all\\nrepresent\\natelectasis, differential diagnosis includes aspiration and\\ninfiltrate.\\n.\\nCTA: No PE. Bibasilar dependent consolidation.  RUL dependent\\nconsolidation.\\n\\nBrief Hospital Course:\\n63 year-old male with recurrent follicular cell lymphoma with\\nrecent chemotherapy and radiation to L3 who was admitted for\\npneumonia and sepsis.\\n.\\n1. Pneumonia: On chest x-ray, he had evidence of pneumonia.\\nGiven that he has recently been hospitalized, he was initially\\ncovered for both pseudomonas and MRSA with ceftazidime and\\nvancomycin.  On hospital day 3, his oxygen requirement increased\\nand he spiked a temperature; therefore, his antibiotic coverage\\nwas broadened to include Flagyl, Caspofungin, and Bactrim.  He\\nimproved on that regimen and his oxygen requirement decreased.\\nAn induced sputum showed budding yeast and was negative for PCP.\\n [**Name10 (NameIs) **] that time, the Flagyl and the treatment dose Bactrim was\\nstopped.  His oxygen requirement decreased throughout his\\nhospital course.  On discharge, he had completed 11 days of\\nvancomycin and ceftazidime and 9 days of caspofungin.  He was\\ndischarged to complete 14 days of antibiotics with levofloxacin.\\n.\\n2. Sepsis: The source of his sepsis was likely the pneumonia.\\nHe was adequately volume resuscitated in the emergency\\ndepartment.  He was initially monitored in the intensive care\\nunit.  His lactate trended down with fluids and he remained\\nnormotensive.\\n.\\n3. Lymphoma: He recently underwent a cycle of [**Hospital1 **] chemotherapy\\n2 weeks prior to admission.  He has just completed a 10-day\\ncourse of radiation therapy for his L3 thecal sac compression.\\nHe was admitted on a prednisone taper from his recent admission.\\n When he was tapered from 40 to 20 mg of prednisone, he had\\nincreased pain and lower extremity weakness.  Until a cervical,\\nthoracic, and lumbar spine MRI was negative for compression, he\\nwas maintained on high dose dexamethasone.  He was then maintain\\non 40 mg prednisone daily.  He also has C-3 disease for which he\\nshould continue to wear his soft c-spine collar.   During this\\nadmission, he had an increase in size of his right neck mass.\\nHe will need his third cycle of [**Hospital1 **] chemotherapy once he has\\nrecovered from his pneumonia.  He was maintain on his\\nallopurinol and prophylactic Bactrim.\\n.\\n4. Anion gap acidosis: He initially had an anion gap acidosis\\nthat was likely secondary to lactate.  His anion gap acidosis\\nresolved with fluid resuscitation.\\n.\\n5. Acute renal failure: On admission, his BUN and creatinine\\nwere elevated.  This was attributed to a pre-renal etiology in\\nthe setting of decreased perfusion from sepsis.  His creatinine\\nreturned to baseline with fluid resuscitation.\\n.\\n6. Anemia: On admission, his hematocrit was near baseline of\\n27-30.  His iron studies were consistent with anemia of chronic\\ndisease and his B12 and folate were normal.  His hematocrit\\ndropped to 18 on hospital day 1, which was likely secondary to\\ndilution from fluid resuscitation.  He received 1 U packed red\\ncell transfusion with an appropriate increase in his hematocrit.\\n He hematocrit remained stable above 25 throughout the remainder\\nof the admission.\\n.\\n7. Hyperglycemia: He has no history of diabetes.  His elevated\\nglucose was likely secondary to steroids.  He was covered with\\nan insulin sliding scale.\\n.\\n8. FEN: He was maintained on a regular diet.  Initially, he\\nreceived IV fluid resuscitation for low blood pressure as above.\\n His electrolytes were repleted.\\n.\\n9. Prophylaxis: Subcutaneous heparin, PPI, bowel regimen.\\n.\\n10. Access: Left Port-a-cath and peripheral IV.\\n.\\n11. Code: DNR/DNI\\n.\\n12. Dispo: He was discharged to rehab once his respiratory\\nstatus had improved.  He will follow-up with his oncologist to\\ndiscuss when to start cycle 3 of [**Hospital1 **].\\n\\nMedications on Admission:\\nMedications on Admission:\\nPrednisone taper\\nSC Heparin\\nPantoprazole 40 mg Tablet PO Q24H\\nGabapentin 800 mg PO Q8H\\nOxycodone 5 mg 1-2 Tablets PO Q2-4HR prn\\nDocusate Sodium 100 mg [**Hospital1 **]\\nSenna 8.6 mg 1 Tablet PO BID\\nOxycodone 40 mg Tablet Sustained Release 12HR\\nTrimethoprim-Sulfamethoxazole 160-800 mg 1 Tablet PO 3X/WEEK\\n(MO,WE,FR)\\nAllopurinol 300 mg DAILY\\n\\n\\nDischarge Medications:\\n1. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One\\n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).\\n2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2\\ntimes a day).\\n3. Senna 8.6 mg Capsule Sig: One (1) Tablet PO BID (2 times a\\nday).\\n4. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1)\\nInjection TID (3 times a day).\\n5. Gabapentin 400 mg Capsule Sig: Two (2) Capsule PO Q8H (every\\n8 hours).\\n6. Allopurinol 100 mg Tablet Sig: Two (2) Tablet PO DAILY\\n(Daily).\\n7. Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID\\n(4 times a day) as needed for thrush.\\n8. Trimethoprim-Sulfamethoxazole 160-800 mg Tablet Sig: One (1)\\nTablet PO 3X/WEEK (MO,WE,FR).\\n9. Oxycodone 20 mg Tablet Sustained Release 12HR Sig: Three (3)\\nTablet Sustained Release 12HR PO Q12H (every 12 hours).\\n10. Oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q4-6H (every 4\\nto 6 hours) as needed.\\n11. Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY\\n(Daily).\\n12. Insulin Regular Human 300 unit/3 mL Insulin Pen Sig: sliding\\nscale  Subcutaneous four times a day: Check QID fingersticks and\\nuse sliding scale as follows:\\n150-199:2Units\\n200-249:4Units\\n250-299:6Units\\n300-349:8Units\\n350-300:10Units.\\n13. Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO once a day\\nfor 3 days.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\nArberJonice\\n\\nDischarge Diagnosis:\\nPneumonia\\nLymphoma\\nAcute renal failure\\nAnion gap metabolic acidosis\\n\\n\\nDischarge Condition:\\nStable.  His oxygen requirement has decreased.\\n\\n\\nDischarge Instructions:\\nPlease take all medications as prescribed.  You will finish a 14\\nday course of antibiotics with levofloxacin for your pneumonia.\\n\\n\\nFollowup Instructions:\\nYou have the following appointment with Dr. [**First Name (STitle) 1557**]:\\nProvider: [**First Name11 (Name Pattern1) 1730**] [**Last Name (NamePattern4) 6175**], MD Phone:[**Telephone/Fax (1) 3237**]\\nDate/Time:[**2177-10-9**] 2:30\\n\\n\\n\\nCompleted by:[**2177-10-6**]\",\n          \"Admission Date:  [**2155-3-26**]              Discharge Date:   [**2155-6-10**]\\n\\nDate of Birth:  [**2098-11-22**]             Sex:   M\\n\\nService: MEDICINE\\n\\nAllergies:\\nPenicillins\\n\\nAttending:[**Last Name (NamePattern4) 290**]\\nChief Complaint:\\nAutologous BMT\\n\\nMajor Surgical or Invasive Procedure:\\ncontinuous renal replacement therapy\\nhemodialysis\\nintubation and mechanical ventilation\\ntracheostomy\\nparacentesis\\n\\n\\nHistory of Present Illness:\\nMr. [**Known lastname **] is a 56-year-old male who was diagnosed with\\nfollicular lymphoma transitioning to a marginal zone lymphoma in\\n01/[**2154**]. He had a long preceding history of night sweats and dry\\ncough, followed by the development of right leg swelling and a\\nright inguinal mass.\\n\\nIn [**2154-1-31**] he developed swelling in his right lower\\nextremity and a mass in his inguinal area. CT scan of his\\nabdomen and pelvis on [**2154-2-18**] revealed generalized\\nlymphadenopathy beginning at the crural lymph nodes and\\nextending inferiorly into the periaortic, mesenteric, celiac,\\npararenal, common iliac, and external iliac chains. In the right\\ngroin, there was a large lymph node mass approximately 6 x 5 x\\n6.6 cm. There was also a rounded low-density area just medial to\\nthe femoral artery which was felt to represent thrombosed\\nfemoral and external iliac veins. Overall, the findings were\\nconcerning for lymphoma. He was referred for a CT of his chest\\non [**2154-2-19**] which showed prominent adenopathy, principally in\\nthe left supraclavicular and left axillary regions, with the\\nlargest mass measuring 2.6 cm in his left axilla. Based on that,\\nhe was referred for excisional biopsy of the right inguinal\\nadenopathy on [**2154-2-26**] which revealed follicular lymphoma with\\npartial marginal zone differentiation, grade I-II by large cell\\nquantitation. These cells were CD19 and CD20 positive and also\\nco-expressed CD5 and CD10. They were also kappa light chain\\nrestricted. There was no expression of CD-23 or cyclin D1. Ki67\\nwas 20-30%. His lymphoma was felt to represent a transitional\\nstate between follicular lymphoma and marginal zone B-cell\\nlymphoma. He was then started on R-CVP. He tolerated therapy\\nfairly well, but suffered from fatigue, hyperglycemia, flushing,\\nand hypertension. His prednisone dose during treatment was\\neventually lowered from 200 mg daily to 100 mg daily. He\\nreceived 2 days of neupogen after each cycle of chemotherapy.\\nAfter three cycles of R-CVP, the vincristine was discontinued\\ndue to neuropathy. He underwent a PET scan on [**2154-5-1**] after the\\nthird cycle and this continued to show extensive FDG avid\\ndisease. However, his night sweats and leg swelling had\\nimproved. He continued on R-CVP for two additional cycles, but\\nafter the fifth cycle, he noticed the recurrence of right\\ninguinal lymphadenopathy. He had also developed recurrent night\\nsweats and cough. The lymphadenopathy grew quite quickly and\\nbecame the size of a quarter over the span of 24 hours. He\\nunderwent a second PET scan on [**2154-6-12**] which showed little\\nsignificant change, with hyperactive adenopathy at the left\\naxilla and extensively below the diaphragm in the mesentery,\\npara-aortic and pelvic regions. He underwent a second excisional\\nbiopsy on [**2154-7-2**] which again showed follicular lymphoma, grade\\nI-II. The decision was made to hold on further R-CVP as his\\nlymphoma was no longer responding to the current therapy.\\n\\nCYTOGENETICS\\n\\nCD19 and CD20 positive, also co-expressed CD5 and CD10, and\\nkappa light chain restricted; no expression of CD-23 or cyclin\\nD1; Ki67 was 20-30%.\\n\\nCHEMOTHERAPY HISTORY\\n\\n[**Date range (1) 83066**]: He received cyclophosphamide, vincristine,\\nprednisolone plus rituximab (R-CVP) x 3 cycles; the vincristine\\nwas discontinued due to neuropathy. Night sweats and leg\\nswelling improved.\\n\\n[**2154-5-1**]: PET Scan showing extensive FDG avid disease\\n\\n[**Date range (1) 83067**]: continued on R-CVP for two additional cycles, but\\nafter the fifth cycle, he noticed the recurrence of right\\ninguinal lymphadenopathy. He had also developed recurrent night\\n\\nsweats and cough.\\n\\n[**2154-6-12**]: repeat PET - little interval change\\n\\n[**2154-7-2**]: repeat lesion biopsy - similar findings\\n\\n[**2154-8-5**]: transferred care to [**Hospital1 **], presented with bilateral\\ninguinal lymphadenopathy; received 4 cyclyes R-Bendamustine by\\nlocal oncologist at time of transfer; planned for two more\\ncycles of R-bendamustine\\n\\n[**2155-1-22**]: Mobilization HiDAC, final cumulative CD-34 yield of\\n5.19 x 10e CD-34 cells/kg over three days, discharged on Cipro,\\nNeupogen and Compazine. WBC at discharge 20.9. Two weeks later\\nWBC 0.7 and one week later 0.5 w/ANC 0, asymptomatic. Started on\\nMoxifloxacin and neupogen. Stem cell harvesting [**Date range (1) 83068**].\\n\\n[**2155-2-25**]: W1 Rituxan/Zevalin: WBC 7.3, Hct 34.9, Plt 244.\\n\\n[**2155-3-4**]: W1 Rituxan/Zevalin: WBC 5.4, ANC 4560, Hct 32.5, Plt\\n292.\\n\\nToday he presents for admission for his BEAM autologous BMT. No\\ncurrent complaints. Denies headache, nausea, vomiting, diarrhea,\\nabdominal pain, weakness, fevers, chills, recent night sweats,\\nblurry vision, shortness of breath. Reports only mild ongoing\\ncough significantly improved from prior and occasional fatigue\\nwhen his counts get low.\\n\\n\\nPast Medical History:\\nDiagnosed with follicular lymphoma transitioning to a marginal\\nzone lymphoma in [**1-/2154**] (These cells were CD19 and CD20\\npositive and also co-expressed CD5 and CD10. They were also\\nkappa light chain restricted. There was no expression of CD-23\\nor cyclin D1. Ki67 was 20-30%.)\\nRight thigh lymphedema (significantly improved, per patient)\\nRLE DVT from compression (was on coumadin until [**2154-11-25**])\\nMild diverticulitis\\ns/p vasectomy, tonsillectomy\\n\\n\\nSocial History:\\nWorks in a management position at a metal fabrication plant\\noverseeing production and quality control. He is married and has\\nfour children, ages [**8-17**]. He and his family live in Hooksett,\\n[**Location (un) 3844**]. He denies any current tobacco use. He previously\\nsmoked but quit 15 years ago after a 20-pack-year history. He\\ngenerally drinks several martinis a day but has decreased his\\ndrinking while on treatment.\\n\\nFamily History:\\nfather - died at 80, lung cancer, Charcot-[**Doctor Last Name **]-Tooth disease,\\npulmonary embolism\\nmother - alive at 80, diabetes and asthma\\nthree brothers - all in good health\\nno family history of leukemia or lymphoma\\nhas 2 children from previous marriage and 2 children from his\\ncurrent marriage\\n\\n\\nPhysical Exam:\\nON ADMISSION:\\nVS: 96.6 132/96 109 18 98/ra 195lbs 71\\\"\\nGENERAL: NAD\\nHEENT: Sclerae are anicteric. PERRLA. EOMI. O/P clear.\\nNeck: Supple.\\nLymph: No cervical, supraclavicular, or axillary\\nlymphadenopathy; some left supraclavicular fullness; possible\\nright inguinal lymphadenopathy although possibly just scar\\ntissue from biopsy\\nCARDIAC: RRR Normal S1/S2 No R/G/M\\nLUNGS: CTAB\\nABDOMEN: Soft, nontender, nondistended, normoactive bowel\\nsounds; no HSM\\nEXTREMITIES: no edema\\n.\\nON DISCHARGE: [**2155-6-10**]\\nTmax: 36.5 ??????C (97.7 ??????F)\\nTcurrent: 36.3 ??????C (97.3 ??????F)\\nHR: 117 (109 - 117) bpm\\nBP: 79/57(62) {64/40(48) - 93/59(68)} mmHg\\nRR: 30 (21 - 30) insp/min\\nSpO2: 95%\\nHeart rhythm: ST (Sinus Tachycardia)\\nWgt (current): 80.3 kg (admission): 98.2 kg\\nHeight: 72 Inch\\n                     24 HR:      SMN:\\nTotal In:          1,807 mL     722 mL\\nPO:\\nTF:                1,017 mL     602 mL\\nIVF:\\nBlood products:\\nTotal out:             0 mL       0 mL\\nUrine:                 0 mL       0 mL\\nNG:\\nStool:\\nDrains:\\nBalance:            1,807 mL    722 mL\\n\\nRespiratory support:\\nO2 Delivery Device:  Trach mask 50%\\nSpO2: 95%\\n\\nPhysical Examination:\\nGeneral Appearance: Well nourished, No acute distress, Thin,\\nEyes / Conjunctiva: PERRL\\nHead, Ears, Nose, Throat: Normocephalic, Tracheostomy in place,\\nNG tube in place\\nLymphatic: No Cervical or Supraclavicular adenopathy\\nCardiovascular: PMI Normal, S1: Normal, S2: Normal, No murmurs,\\nrubs, gallops.\\nChest: Expansion: Symmetric Excursion, No Dullness, CTAB.\\nAbdominal: Soft, Non-tender, Bowel sounds present, Distended, +\\nfluid wave. Non-tender.\\nExtremities: No edema, Cyanosis, Clubbing, 2+ Peripheral pulses.\\n\\nMusculoskeletal: Muscle wasting, Unable to stand,\\nSkin:  Warm, No Rash, No Jaundice\\nNeurologic: Attentive, Follows commands, Responds to verbal\\nstimuli, Oriented x3, Moving all extremeties equally, Strength\\n[**4-2**] in UE & LE bilat, Dizzy if not in supine position, Moving\\nall extremeties equally, sensation intact.\\n\\n\\n\\nPertinent Results:\\nLABS ON ADMISSION:\\n[**2155-3-26**] 10:15AM BLOOD WBC-3.9* RBC-4.62 Hgb-13.8* Hct-41.5#\\nMCV-90 MCH-29.9 MCHC-33.3 RDW-15.7* Plt Ct-144*#\\n[**2155-3-26**] 10:15AM BLOOD Neuts-88.5* Lymphs-4.0* Monos-6.4 Eos-0.7\\nBaso-0.3\\n[**2155-3-26**] 10:15AM BLOOD PT-11.2 PTT-21.2* INR(PT)-0.9\\n[**2155-3-28**] 12:00AM BLOOD Gran Ct-4380\\n[**2155-3-26**] 10:15AM BLOOD UreaN-14 Creat-0.8 Na-141 K-4.6 Cl-102\\nHCO3-32 AnGap-12\\n[**2155-3-26**] 10:15AM BLOOD ALT-35 AST-33 LD(LDH)-157 AlkPhos-102\\nTotBili-0.3 DirBili-0.1 IndBili-0.2\\n[**2155-3-26**] 10:15AM BLOOD TotProt-7.0 Albumin-4.5 Globuln-2.5\\nCalcium-10.0 Phos-3.8 Mg-2.0 UricAcd-8.3*\\n\\nLAB TRENDS DURING ADMISSION:\\nWBC: MAX 47.8 on [**2155-5-13**] --> 35.3 on [**2155-5-20**] -->  25.9 on\\n[**2155-5-28**] -->18.9 on [**2155-6-3**]  --> 15.5 on [**2155-6-10**]\\nHCT: stable at 28-33 for past 2 weeks\\nPLT: stable at 40-70 for past 2 weeks.\\nCOAGS: have been within normal limits.\\nCHEM7: Patient on HD Tues, Thurs, Sat\\nLFTS:\\nAST: 1341 & ALT: 2472*  MAX on [**2155-4-12**]  trended down to AST: 59*\\nALT: 40 by [**2155-4-23**] and AST & ALT have been normal since [**2155-5-28**].\\n\\nLDH: 1466 MAX on [**2155-4-12**] trended down to normal by [**2155-5-17**]\\nALK PHOS: 170 on [**2155-4-12**] trended up to MAX on 248 on [**2155-4-15**] and\\nthen down to 172 on [**2155-6-10**].\\nTBILI: 10.0 MAX on [**2155-4-12**] trended down to 2.9 on [**2155-6-10**]\\n\\nLIPID/CHOLESTEROL     Cholest   Triglyc   HDL   CHOL/HD\\nLDLcalc\\n[**2155-5-8**] 08:46AM      173      196*     11    15.7     123\\n\\nCORTISOL Stimulation Test:\\n[**2155-5-25**] 03:30PM    29.4*1\\n[**2155-5-25**] 02:37PM    17.91\\n\\nHEPATITIS              HBsAg     HBsAb     HBcAb     HAV Ab\\nIgM HAV\\n[**2155-4-10**] 03:46AM    NEGATIVE  POSITIVE  NEGATIVE  POSITIVE\\nNEGATIVE\\n\\nHEPARIN DEPENDENT ANTIBODIES:       Negative   [**2155-5-27**]\\n12:00PM\\nASPERGILLUS ANTIGEN:     0.1   <0.5 considered to be negative\\n[**2155-5-20**]\\nB-GLUCAN: 65  pg/mL    Negative       Less than 60 pg/mL\\n                       Indeterminate  60 - 79 pg/mL\\n                       Positive       Greater than or equal to\\n80 pg/mL\\n\\nLABS ON DISCHARGE:\\n[**2155-6-10**] 04:21AM BLOOD WBC-15.5* RBC-2.61* Hgb-10.0* Hct-31.1*\\nMCV-119* MCH-38.1* MCHC-32.0 RDW-19.6* Plt Ct-40*\\n[**2155-6-10**] 04:21AM BLOOD PT-12.8 PTT-25.9 INR(PT)-1.1\\n[**2155-6-10**] 04:21AM BLOOD Plt Ct-40*\\n[**2155-6-10**] 04:21AM BLOOD Glucose-140* UreaN-54* Creat-5.0* Na-139\\nK-5.5* Cl-103 HCO3-23 AnGap-19  ****PRIOR TO HD TODAY*****\\n[**2155-6-10**] 04:21AM BLOOD ALT-27 AST-34 AlkPhos-172* TotBili-2.9*\\n\\n\\nIMAGING:\\nRUQ ULTRASOUND  [**2155-4-8**].\\nIMPRESSION:\\n1. Apparent reversed flow in the main portal vein with normal\\nflow direction in the left and right portal veins. These\\nfindings are discrepant and do not appear to be artifactual in\\nnature. Given that the etiology of these findings is unclear,\\nwhether there is true portal vein reversal or possibly more\\nproximal thrombus, we would recommend focused MRI of the abdomen\\nincluding 2D time-of-flight sequences (with saturation bands to\\ndetermine directionality of\\nflow) through the portal vein to clarify this issue.\\n2. Cholelithiasis but no other evidence of acute cholecystitis.\\n3. Small amount of ascites.\\n\\nMRI Abdomen. [**2155-4-9**].\\nIMPRESSION:\\n1. Reversal of flow within the main portal vein, both on\\nbreath-hold imaging and free breathing.\\n2. Reversal of flow within the right anterior portal vein on\\nbreath-hold imaging.\\n3. Suggestion of reversed flow within the right posterior portal\\nvein during breath-hold, but antegrade flow during free\\nbreathing. This may reverse depending on phasicity of\\nrespiration.\\n4. Directionality of flow within the left portal vein is not\\nclearly\\ndemonstrated on this examination.\\n5. Interval increase in ascites since yesterday's examination.\\n6. No evidence of focal hepatic lesion or hepatic or portal vein\\nthrombus.\\n7. Suggestion of siderosis within the spleen. Possibility of\\niron deposition within the liver cannot be excluded without\\ndual-echo gradient-echo images (omitted in this abbreviated\\nexamination due to patient intolerance of examination).\\n8. Cholelithiasis. No biliary abnormalities noted.\\n\\nMR HEAD W/O CONTRAST Study Date of [**2155-5-2**] 12:31 PM\\nIMPRESSION:\\n1. Hyperintense subarachnoid material, involving the sulci of\\nboth cerebral\\nhemispheres, most likely representing subarachnoid hemorrhage,\\nless likely\\nproteinaceous material as seen in meningitis. Oxygen therapy can\\nalso have\\nthis appearance.\\n2. No evidence of masses, mass effect or infarction.\\n\\nECHO: [**2155-5-23**] at 3:47:46 PM   Conclusions:\\nThe left atrium and right atrium are normal in cavity size. Left\\nventricular wall thicknesses and cavity size are normal.\\nRegional left ventricular wall motion is normal. Left\\nventricular systolic function is hyperdynamic (EF>75%). Tissue\\nDoppler imaging suggests a normal left ventricular filling\\npressure (PCWP<12mmHg). Right ventricular chamber size and free\\nwall motion are normal. The aortic valve leaflets (3) appear\\nstructurally normal with good leaflet excursion and no aortic\\nregurgitation. No masses or vegetations are seen on the aortic\\nvalve. The mitral valve appears structurally normal with trivial\\nmitral regurgitation. No mass or vegetation is seen on the\\nmitral valve. The pulmonary artery systolic pressure could not\\nbe determined. There is no pericardial effusion.\\nCompared with the prior study (images reviewed) of [**2155-4-21**],\\nthe findings are similar.\\n\\nCT TORSO:  [**2155-5-23**] 1:53 PM\\nCHEST CT: Bilateral small pleural effusions, on the left\\nincreased as\\ncompared to the prior study and the right slightly increased as\\ncompared to the prior study. Linear atelectasis in the right\\nlower lobe and left lower lobe accompanied by small patchy\\nconsolidations in the left lower lobe. This is new as compared\\nto the previous study.\\nSmall amount of pericardial effusion is noted (series 2, image\\n34). Central line catheter is noted with its tip in the right\\natrium. Tracheostomy.  Nasogastric tube with its tip in the\\nstomach.\\nABDOMINAL CT: Small-to-moderate amount of ascites is\\ndemonstrated. Limited\\nevaluation of the liver due to lack of i.v. contrast and\\nartifacts. There is no evidence of intrahepatic or extrahepatic\\nbile duct dilatation. The\\npancreas is within normal limits. Gallbladder is nondistended.\\nAdrenals are unremarkable bilaterally. Spleen is of normal size\\nand attenuation on this non-contrast scan. Visualized small\\nbowel demonstrate diffuse mucosal\\nthickening without evidence of dilatation. The findings may\\ncaused by ascites or GVHD.\\nRetroperitoneal and mesenteric lymphadenopathy, small but\\nnumerous, measuring up to 1 cm in mesentery and 1.4 cm in the\\nretroperitoneum.\\nPELVIC CT: Moderate amount of fluid is seen in the pelvis.\\nUrinary bladder\\nis not distended. Rectal tube is seen in the rectum.\\nOSSEOUS STRUCTURES: Degenerative changes in the lumbar and\\nsacral vertebra.\\nIMPRESSION:\\n1. Bilateral small pleural effusions, slightly larger as\\ncompared to the\\nprior study.\\n2. Linear atelectasis in the right lower lobe and left lower\\nlobe and left\\nlower lobe patchy consolidation which is new as compared to the\\nprior study.\\n3. Moderate amount of ascites.\\n4. Limited evaluation of the liver due to artifacts.\\n\\nCXR: [**2155-6-6**]\\nFINDINGS: Indwelling support and monitoring devices are similar\\nin position, and cardiomediastinal contours are unchanged. There\\nis a suggestion of increasing layering effusions on this\\nsemi-upright projection. Persistent left retrocardiac opacity is\\nprobably due to atelectasis. Patchy opacities in right mid and\\nright lower lung could be due to either atelectasis or early\\nsites of pneumonia, and followup radiographs may be helpful in\\nthis regard.\\n\\n\\n\\nBrief Hospital Course:\\nThis is a 56 year old male with PMH of follicular lymphoma\\ntransitioning to a marginal zone lymphoma s/p R-CVP admitted for\\nBEAM auto-SCT (C1D1 ([**2155-3-26**]) and as per BMT protocol,\\ninitiated carmustine day -7, followed by etoposide/cytarabine on\\ndays -6 to -3, then melphalan on day -2 ([**2155-3-31**]).  He then\\nunderwent Autologus stem cell transplant on [**2155-4-2**].\\nPost-transplant course was complicated by mucositis, diarrhea,\\nfebrile neutropenia, and transient hyperuricemia that responded\\nto 1 dose of allopurinol.  On [**2155-4-11**], the patient was\\ntransferred to the ICU for respiratory distress, altered mental\\nstatus, renal failure, and transaminitis secondary to\\n[**Last Name (un) **]-occlusive disease.\\n\\n1. Respiratory distress - The patient was tachypneic to the 40s\\non admission to the ICU and had an increasing oxygen\\nrequirement, thought to represent attempted compensation for\\nmetabolic acidosis and low lung volumes with atelectasis.  The\\npatient failed a trial of bipap and was intubated and placed on\\nA/C mechanical ventilation.  He had no evidence of pneumonia but\\nwas noted to be >7L fluid positive on admission, with increasing\\nascites secondary to his hepatic complications.  Serial CXRs\\nover course of his ICU stay demonstrated reduced lung volumes\\nwith small amounts of atelectasis but no new consolidation,\\neffusion, or intravascular congestion.  Patient remained\\nintubated in the [**Hospital Unit Name 153**] for a) impaired mental status and b)\\nrestrictive physiology [**3-4**] increased intra-abdominal pressure.\\nThe patient remained on the ventilator for approximately three\\nweeks; his respiratory status remained relatively stable but his\\nmental status precluded extubation. He did experience an episode\\nof leukocytosis, detailed below, and was treated for a\\npseudomonas ventilator associated pneumonia with improvement in\\nhis leukocytosis. The patient eventually received a tracheostomy\\nand was subsequently weaned down to trach collar, which\\ncoincided with an improvement in his mental status.\\n\\n2. Hypotension - The etiology was initially thought to be a\\ncombination of a) intravascular volume depletion [**3-4**] decreased\\neffective circulating volume and splanchnic vasodilation from\\nliver failure, and b) sedation.  Sepsis thought to be a\\ncontributing factor as well, but he was maintained on\\nbroad-spectrum antimicrobial coverage, with no infectious source\\nidentified for the majority of his hospitalization.  CT imaging\\nwas unremarkable for an infectious source.  The patient was\\ninitiated on levophed [**4-12**] and had a prolonged ongoing pressor\\nrequirement without an obvious cause for hypotension.  Although\\ncortisol levels were normal, suggesting against adrenal\\ninsufficiency, the patient was trialed on a three day course of\\nsteroids, which temporarily improved his pressures and removed\\nhis pressor requirement.  Following the conclusion of the\\nsteroid trial, the patient again required vasopressor support to\\nmaintain his blood pressure.  A cortisol stimulation test was\\nperformed to better assess for impaired adrenal response, did\\nnot reveal any significant abnormal findings. Ultimately,\\nvasopressin was started and levophed was weaned. After his CVVH\\nwas stopped, the patient had an episode of symptomatic\\nhypotension, for which vasopressin was briefly restarted. For\\nthe rest of his ICU course, the patient was maintained off of\\npressors and perfusion was monitored by assessing mental status.\\nHe was initiated on HD, and tolerated this well without\\nultrafiltration. His hypotension may be related to his liver\\ndisease in addition to severe deconditioning.  He is\\npersistently orthostatic which has somewhat improved with\\nrestarting midodrine. He mentates well with a blood pressure of\\n60s systolic.  Please continue to encourage thigh high\\ncompression stockings to increase peripheral resistance.  Please\\nelevate head of bed as patient tolerates and continue passive\\nmotion in bed.  Autonomics was consulted prior to discharge and\\nfeels like hypotension is not likely related to dysautonomia\\ngiven his hypotension even while supine. Autonomics recommended\\ncontinuation of midodrine and a trial of florinef to be started\\nat rehabilitation. Florinef will be started at low dose (0.1 mg\\ndaily) and can be uptitrated based on patient response to a\\nmaximum of 0.4 mg daily. It is felt that the hypotension is\\nlikely related to deconditioning and aggressive PT should be\\npursued.\\n\\n3. Leukocytosis - Elevated WBC count beginning [**4-13**] with\\npersistent hypotension. Filgrastim discontinued [**4-12**]; therefore,\\nthis could not account for the persistent leukocytosis.  Patient\\nwas at high risk for nosocomial infection (critically ill,\\nascites, multiple tubes/lines) with difficult-to-interpret fever\\ncurve on CVVH.  He was empirically started on broad spectrum\\nantibiotics with a mild improvement in his leukocytosis but with\\nno obvious source on cultures.  Multiple paracenteses were\\nnegative for SBP.  Much later in the [**Hospital 228**] hospital course,\\na re-elevation in his white blood cell count corresponded with a\\nnew positive sputum culture for Pseudomonas.  The patient was\\ntreated with seven days of ceftazidime per infectious disease\\nrecommendations, after which his leukocytosis improved but still\\nremained dramatically elevated.  A large volume paracentesis was\\nperformed with fluid sent for cytology and flow cytometry, which\\nwas not revealing. Ultimately, only his CVVH catheter tip grew\\nout the same strain of pseudomonas on [**6-4**] that was in his sputum\\non [**5-12**].  It is felt that this was a colonizer only as\\nsurveillance blood cultures were negative. No other infectious\\nsources were identified. His antibiotics were ultimately all\\ndiscontinued and he did well.  He should no longer be on\\nprecautions as he has no active infections. His leukocytosis\\ncontinues to improve, but does remain elevated. A component of\\nthis elevation may be due to auto splenectomy that appears to\\nhave occurred during this hospitalization.\\n\\n4. Transaminitis/Hepatic Failure - Right upper quadrant\\nultrasound and abdominal MRI demonstrated reversal of flow\\nthrough portal vein, suggestive of cirrhosis.  On admission to\\nthe intensive care unit, he was noted to have new significant\\nascites.  Rising INR and worsening mental status were suggestive\\nof progression to hepatic failure.  Liver biopsy confirmed a\\ndiagnosis of [**Last Name (un) **]-occlusive disease.  Infectious workup of\\nhepatitis was negative.  Per Hepatology, patient would not be a\\ncandidate for liver transplant.  The patient was then started on\\na defibrotide treatment protocol on [**2155-4-9**] with close\\nmonitoring of coags, plts, hct, fibrinogen due to concern of\\nbleeding (goal INR < 1.5, plts > 30, Hct > 30, Fibrinogen >\\n150). LFTs peaked [**Date range (1) 14806**] with TBili 10, then trended down\\ngradually.  After 25 days of treatment for defibrotide, a head\\nMRI revealed a subarachnoid hemorrhage, which necessitated\\ndiscontinuation of the treatment.  The patient subsequently\\ncontinued to show gradual, mild improvement in functional\\nstatus, but continued to have large ascites on exam requiring\\nperiodic taps. Currently he is requiring paracentesis every\\n10-14 days and his ascites should continue to be monitored and\\ntapped PRN.  Through his ICU course, his LFTs gradually\\nimproved; however, his bilirubin did remain elevated at 2.9 on\\ndischarge.  He should have liver clinic follow-up with Dr. [**Last Name (STitle) 497**]\\nwithin one month after discharge.\\n\\n5. Depression: The patient appears to be extremely frustrated\\nand depressed about his current state. He was started on low\\ndose amphetamine salts at 5mg [**Hospital1 **] to increase his energy and\\nblood pressure.  His cardiac status should be monitored closely\\nas well as his mood on this new medication.  It can also be\\ntitrated up slowly in an attempt to increase his energy.\\n\\n6. Thrombocytopenia: His platelets have fallen dramatically\\nduring his hospitalization.  They have remained stable around\\n50. There was initial concern for HIT, but antibody returned\\nnegative on [**5-28**]. Platelets should be transfused only if the\\npatient is actively bleeding. Caution should be used with blood\\nthinners due to his low platelet level.\\n\\n7. Ileus - Attributed to critical illness with ascites and\\nopioid -based sedation.  Abdominal x-ray and CT scan were\\nnegative for obstruction. The patient was started on reglan and\\nan aggressive bowel regimen.  Following withdrawal of sedation\\nas patient's respiratory status improved, his ileus improved as\\nwell.  Lactulose was continued less frequently as prophylaxis\\nagainst hepatic encephalopathy and was eventually discontinued.\\nThe reglan was stopped. He developed loose stools/ diarrhea that\\nwas treated as below.\\n\\n8. Diarrhea - Patient has had continued loose stools ever since\\nhis ileus resolved. His stool frequency has improved after\\nstopping lactulose but have continued to remain loose. C diff.\\ntoxin has been checked multiple times and has remained negative.\\nIt is likely that the diarrhea is related to tube feeds and\\nbanana flakes have been added recently with subsequent\\nimprovement in diarrhea.\\n\\n9. Altered mental status - Attributed to hepatic encephalopathy\\nin addition to sedating meds for treatment of his abdominal\\npain.  Standing lactulose was started for therapy of hepatic\\nencephalopathy and was also given broad spectrum antibiotics for\\ntreatment of possible infections.  Patient had a protracted\\nhospital course with minimal improvement in mental status but\\nbegan to show dramatic improvement in mid [**Month (only) 547**], approximately\\none month after initiation of defibrotide.  His mental status\\ncontinued to improve throughout his ICU course and he is now\\nable to interact appropriately. His antibiotics and lactulose\\nwere ultimately discontinued.\\n\\n10. Renal failure - The patient was found to have new renal\\nfailure that began on [**2155-4-10**].  Per renal, the etiology was most\\nconsistent with ischemic ATN.  His initial hypotensive insult\\nwas likely secondary to hepatorenal syndrome.  The patient was\\nstarted on CVVH on [**2155-4-12**] for worsening metabolic acidosis.  He\\ncontinued to be severely oliguric throughout his admission with\\nno restoration in renal function.  The patient's severe volume\\noverload was corrected gradually via CVVH while he continued to\\nhave an ongoing pressor requirement.  Midodrine was started in\\nan effort to improve the patient's blood pressures so that he\\ncould be transitioned to HD. He was eventually transitioned to\\nHD without ultrafiltration, and has tolerated it well.\\n\\n11. EKG Changes:  The patient had subtle ST depressions at the\\nbeginning of [**Month (only) 116**] in the setting of decreased mentation and\\nhypotension. He was ruled out for an MI and these depressions\\nhave since resolved.  It was likely related to demand in setting\\nof hypotension.\\n\\n12. Neutropenic fevers - On admission, patient was kept on broad\\nspectrum antibiotics for neutropenic fevers\\n(vancomycin/cefepime/ganciclovir/micafungin). Infectious disease\\nwas consulted. Patient was culture negative and no source of\\ninfection was identified. Antibiotics were stopped [**4-12**]\\nfollowing recovery of his neutrophil counts. He was treated\\nlater in his hospital course for a pseudomonas pneumonia (see\\nabove).\\n\\n13. Hyperglycemia: Patient with blood sugars persistently\\nbetween 200-300. Regular insulin was added to the TPN, and the\\npatient was placed on a Regular Insulin SS. This may represent\\ndiabetes. He will need ongoing monitoring and upon discharge\\nfrom rehabilitation center follow-up with his primary care\\nprovider.\\n\\n14. Follicular Lymphoma: Patient is status post BEAM Auto SCT on\\n[**2155-4-2**]. Patient engrafted. Received IV solumedrol x1 for\\nanti-inflammatory effect. Received filgrastim until ANC>1000\\n(discontinued [**2155-4-12**]). He was continued on atovaquone\\nprophylaxis for PCP but there was concern that it was not being\\nabsorbed as it appeared to be present in his diarrhea.  He was\\ngiven one dose of inhaled pentamidine on [**2155-6-9**] and will be\\ncontinued on atovaquone.  If his diarrhea continues to improve,\\nhe can remain on atovaquone and will likely not need another\\ndose of inhaled pentamidine one month from [**2155-6-9**].  He also\\nremains on Acyclovir prophylaxis.\\n\\n15. Deep Vein Thombosis Prophylaxis: Patient not started on\\nheparin due to low platelets. Patient repeatedly offered\\npneumoboots, but usually declined to wear the pneumoboots.\\nEncourage aggressive physical therapy.\\n\\nMedications on Admission:\\nMultivitamin\\nNo other current medications\\n\\n\\nDischarge Medications:\\n1. White Petrolatum-Mineral Oil 42.5-56.8 % Ointment Sig: One\\n(1) Appl Ophthalmic PRN (as needed) as needed for dry eyes.\\n2. Midodrine 5 mg Tablet Sig: Three (3) Tablet PO TID (3 times a\\nday).\\n3. Acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q24H (every 24\\nhours): give every day, on dialysis days give daily dose after\\ndialysis.\\n4. Heparin Flush (10 units/ml) 2 mL IV PRN line flush\\nPICC, heparin dependent: Flush with 10mL Normal Saline followed\\nby Heparin as above daily and PRN per lumen.\\n5. Trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as\\nneeded for insomnia.\\n6. Ursodiol 300 mg Capsule Sig: One (1) Capsule PO QAM (once a\\nday (in the morning)).\\n7. Ursodiol 300 mg Capsule Sig: Two (2) Capsule PO QPM (once a\\nday (in the evening)).\\n8. Insulin Regular Human 100 unit/mL Solution Sig: per scale\\nInjection ASDIR (AS DIRECTED).\\n9. Atovaquone 750 mg/5 mL Suspension Sig: 1500 (1500) mg PO\\nDAILY (Daily).\\n10. Amphetamine-Dextroamphetamine 5 mg Tablet Sig: One (1)\\nTablet PO BID (2 times a day).\\n11. Fludrocortisone 0.1 mg Tablet Sig: One (1) Tablet PO DAILY\\n(Daily): uptitrate as tolerated.\\n\\n\\nDischarge Disposition:\\nExtended Care\\n\\nFacility:\\n[**Hospital3 105**] - [**Location (un) 1121**] - [**Location (un) 1456**]\\n\\nDischarge Diagnosis:\\nPrimary:\\n- Follicular Lymphoma\\n- Renal Failure, Acute tubular necrosis, now requiring\\nhemodialysis.\\n- Respiratory Failure\\n- Hepatic Failure Secondary to Venous Occlusive Disease\\n- Hypotension\\n- Multi-Drug Resistant Pseudomonal Pneumonia\\n\\n\\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Bedbound.\\nBlood pressure: SBPs 50-80s with good mentation. If concerned\\nabout blood pressure, monitor for change in mental status.\\nPatient tolerating very low blood pressures attributed to\\ndeconditioning.\\n\\n\\nDischarge Instructions:\\nYou were admitted for bone marrow transplant. You had a\\nprolonged hospital course that was complicated by liver failure,\\ninfection, persistent low blood pressure, kidney failure, and\\nrespiratory failure that ultimately required trach tube\\nplacement. Your clinical status ultimately improved. You are now\\nbeing discharged to a rehab facility for further care.\\n\\nYou were started on many different medications during your\\nhospital course. You should follow the medication list provided\\nat the time of discharge.\\n\\nIt was a pleasure taking part in your medical care.\\n\\nFollowup Instructions:\\nYou will need to see the following providers within the\\ntimeframe below.  We are working to schedule appointments for\\nyou, please call the following offices in [**2-1**] days time to get\\nthe appointment information:\\n\\nPROVIDER: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD\\nSPECIALTY: HEMATOLOGY/ONCOLOGY\\nTELEPHONE: ([**Telephone/Fax (1) 3936**]\\nTIMEFRAME: within 2-4 weeks\\n\\nPROVIDER: [**Name10 (NameIs) **] [**Name8 (MD) **], MD\\nSPECIALTY: LIVER\\nTELEPHONE: ([**Telephone/Fax (1) 1582**]\\nTIMEFRAME: within 2-4 weeks.\\n\\nYou will need to see you primary care doctor within 2 weeks\\nafter discharge from the rehab facilty.\\n\\n\\n                             [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Name8 (MD) **] MD [**MD Number(1) 292**]\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 11
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# filter lymphoma_summary_df for ICD9_CODE 20203\n",
        "\n",
        "# Filter for ICD9_CODE 20203 - Nodular Lymphoma for abdomen\n",
        "nod_lymph_abd_filtered_df = lymphoma_summary_df[lymphoma_summary_df['ICD9_CODE'] == 20203]\n",
        "print(nod_lymph_abd_filtered_df.head())\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ThdElvOrnlcq",
        "outputId": "7e2e32f8-673d-4a8d-81e9-add8dbf63cb3"
      },
      "execution_count": 12,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "   ICD9_CODE             SHORT_TITLE  SUBJECT_ID  HADM_ID  \\\n",
            "3      20203  Nodular lymphoma abdom       70754   116929   \n",
            "4      20203  Nodular lymphoma abdom       96779   132235   \n",
            "\n",
            "                                                TEXT  \n",
            "3  Admission Date:  [**2147-7-4**]              D...  \n",
            "4  Admission Date:  [**2163-6-1**]              D...  \n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# write a function to tokenize and clean the TEXT using SpaCy\n",
        "\n",
        "import re\n",
        "\n",
        "def tokenize_and_clean(text):\n",
        "    doc = nlp(text)\n",
        "    tokens = []\n",
        "    for token in doc:\n",
        "        # Remove punctuation and special characters\n",
        "        token_text = re.sub(r'[^\\w\\s]', '', token.text)\n",
        "        # Convert to lowercase\n",
        "        token_text = token_text.lower()\n",
        "        # Remove stop words and numbers\n",
        "        if token_text and not token.is_stop and not token.is_punct and not token.like_num:\n",
        "            tokens.append(token_text)\n",
        "    return tokens\n"
      ],
      "metadata": {
        "id": "FKOaM3Dcof7e"
      },
      "execution_count": 13,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# write a function to extract entities from text using SpaCy\n",
        "\n",
        "def extract_entities(text):\n",
        "    doc = nlp(text)\n",
        "    entities = []\n",
        "    for ent in doc.ents:\n",
        "        entities.append((ent.text, ent.label_))\n",
        "        print(ent.text, ent.start_char, ent.end_char, ent.label_)\n",
        "    print(\"*********************************************************\")\n",
        "    return doc\n",
        "\n"
      ],
      "metadata": {
        "id": "xHccmIvgo2qW"
      },
      "execution_count": 14,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#apply tokenization to nod_lymph_abd_filtered_df column\n",
        "\n",
        "nod_lymph_abd_filtered_df['tokens'] = nod_lymph_abd_filtered_df['TEXT'].apply(tokenize_and_clean)\n",
        "nod_lymph_abd_filtered_df"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 229
        },
        "id": "NRxRt9N-pXru",
        "outputId": "4e127e09-a78e-4e5e-8868-7ca3f9208b48"
      },
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-15-65c774e674fe>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  nod_lymph_abd_filtered_df['tokens'] = nod_lymph_abd_filtered_df['TEXT'].apply(tokenize_and_clean)\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "   ICD9_CODE             SHORT_TITLE  SUBJECT_ID  HADM_ID  \\\n",
              "3      20203  Nodular lymphoma abdom       70754   116929   \n",
              "4      20203  Nodular lymphoma abdom       96779   132235   \n",
              "\n",
              "                                                TEXT  \\\n",
              "3  Admission Date:  [**2147-7-4**]              D...   \n",
              "4  Admission Date:  [**2163-6-1**]              D...   \n",
              "\n",
              "                                              tokens  \n",
              "3  [admission, date,  ,              , discharge,...  \n",
              "4  [admission, date,  ,              , discharge,...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-cfa15394-d826-4f5e-9060-c86745cc1316\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>ICD9_CODE</th>\n",
              "      <th>SHORT_TITLE</th>\n",
              "      <th>SUBJECT_ID</th>\n",
              "      <th>HADM_ID</th>\n",
              "      <th>TEXT</th>\n",
              "      <th>tokens</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>20203</td>\n",
              "      <td>Nodular lymphoma abdom</td>\n",
              "      <td>70754</td>\n",
              "      <td>116929</td>\n",
              "      <td>Admission Date:  [**2147-7-4**]              D...</td>\n",
              "      <td>[admission, date,  ,              , discharge,...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>20203</td>\n",
              "      <td>Nodular lymphoma abdom</td>\n",
              "      <td>96779</td>\n",
              "      <td>132235</td>\n",
              "      <td>Admission Date:  [**2163-6-1**]              D...</td>\n",
              "      <td>[admission, date,  ,              , discharge,...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-cfa15394-d826-4f5e-9060-c86745cc1316')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-cfa15394-d826-4f5e-9060-c86745cc1316 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-cfa15394-d826-4f5e-9060-c86745cc1316');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-d5cd2adb-ca09-4e70-8f5e-0dd03b34d263\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-d5cd2adb-ca09-4e70-8f5e-0dd03b34d263')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-d5cd2adb-ca09-4e70-8f5e-0dd03b34d263 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_7d5b1e54-670e-43ef-afab-a3a3452ca689\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('nod_lymph_abd_filtered_df')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_7d5b1e54-670e-43ef-afab-a3a3452ca689 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('nod_lymph_abd_filtered_df');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "nod_lymph_abd_filtered_df",
              "summary": "{\n  \"name\": \"nod_lymph_abd_filtered_df\",\n  \"rows\": 2,\n  \"fields\": [\n    {\n      \"column\": \"ICD9_CODE\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 0,\n        \"min\": 20203,\n        \"max\": 20203,\n        \"num_unique_values\": 1,\n        \"samples\": [\n          20203\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"SHORT_TITLE\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"Nodular lymphoma abdom\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"SUBJECT_ID\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 18402,\n        \"min\": 70754,\n        \"max\": 96779,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          96779\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"HADM_ID\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 10822,\n        \"min\": 116929,\n        \"max\": 132235,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          132235\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"TEXT\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"Admission Date:  [**2163-6-1**]              Discharge Date:   [**2163-6-2**]\\n\\nDate of Birth:  [**2101-7-20**]             Sex:   F\\n\\nService: MEDICINE\\n\\nAllergies:\\nPenicillins / Percocet\\n\\nAttending:[**First Name3 (LF) 338**]\\nChief Complaint:\\ndifficult extubation after endoscopy\\n\\nMajor Surgical or Invasive Procedure:\\nendoscopy\\n\\nHistory of Present Illness:\\nPt is a 61yo f w/folicular lymnphoma, HTN, obesity and asthma,\\nwent for repeat endoscopy today and desatted on MAC when GI\\nprobe was put down due to laryngospasm. Probe was removed and pt\\nwas intubated w/out difficulty. Procedure was successfully\\ncompleted but no cuff leak post op. WAs given 10mg IV decadron\\nbut concern regarding extubation in PACU given ? pulm edema on\\nCXR. VSS throughout.\\n.\\nPer EGD report pt was incidentally found to have a follicular\\nlymphoma in the 2nd part of the duodenum adjacent to, but not\\ndirectly involving, the ampulla during an EGD [**2163-2-8**]. Pt had\\ninitially presented w/unresolving symptoms of reflux Work-up for\\nmetastatic disease was negative (CT, PET, bone marrow bx). Pt\\nunderwent last EGD with Dr. [**Last Name (STitle) 64304**] [**2163-3-11**]-he re-biopsied an\\narea of white granular mucosal nodularity, which was negative\\nfor lymphoma, as were biopsies of 3rd portion of duodenum beyond\\nthe lymphoma.\\n.\\nOn the transfer, initial vs were: T 95 P 90 BP 161/83 R 21 O2\\nsat 96% and pt intubated. When arrived, pt had cuff leak and was\\nable to be extubated. Throat feels scratchy but otherwise\\nfeeling ok.\\n.\\nReview of sytems:\\n(+) Per HPI\\n(-) Denies fever, chills, night sweats, recent weight loss or\\ngain. Denies headache, sinus tenderness, rhinorrhea or\\ncongestion. Denied cough, shortness of breath. Denied chest pain\\nor tightness, palpitations. Denied nausea, vomiting, diarrhea,\\nconstipation or abdominal pain. No recent change in bowel or\\nbladder habits. No dysuria. Denied arthralgias or myalgias.\\n\\n\\nPast Medical History:\\nfollicular lymphoma [**2-/2163**]\\nHTN\\nAsthma\\nKidney stone\\nD&C\\nsinusitis\\nchronic allergies\\n\\nSocial History:\\nlive w/husband in [**Name (NI) **],MA. Retired.\\n\\nFamily History:\\nNC\\n\\nPhysical Exam:\\nAdmission Physical Exam:\\nVitals: T 95 P 90 BP 161/83 R 21 O2 sat 96%\\nGeneral: Alert, oriented, no acute distress after extubation\\nHEENT: Sclera anicteric, MMM, oropharynx clear\\nNeck: supple, JVP not elevated, no LAD\\nLungs: Clear to auscultation bilaterally, no wheezes, rales,\\nrhonchi\\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,\\ngallops\\nAbdomen: soft, non-tender, non-distended, bowel sounds present,\\nno rebound tenderness or guarding, no organomegaly\\nGU: no foley\\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or\\nedema\\n\\n\\nPertinent Results:\\nEGD\\nFindings: Esophagus: Normal esophagus.\\nStomach: Normal stomach.\\nDuodenum:\\n Mucosa: Localized discontinuous white, granular, nodularity in\\na patchy distribution was noted in the area of the papilla.\\nThree endoclips were successfully applied to the papilla major\\nfor the purpose of radiation therapy mapping. An small patch of\\nwhite, granular tissue was noted in the mid-jejunum. Cold\\nforceps biopsies were performed for histology at the\\nmid-jejunum.\\nImpression: Granularity, nodularity, and white patchy in the\\narea of the papilla consistent with previous biospy results that\\nindicated lymphoma.\\n A very tiny, 1mm, white, granular patch in the mid-jejunum;\\nbiopsy of this area was performed.\\nThree [**Company 2267**] resolution clips were placed around the\\narea of nodularity at the level of the entrum.  One clip was\\nplace proximal, one distal and another in between to triangulate\\nthe area.\\nOtherwise normal enteroscopy to third part of the duodenum.\\n\\nRecommendations: Follow up with your [**Company 5564**] and radiation\\n[**Company 5564**] for planned therapy.\\nPlan discussed with Dr. [**Last Name (STitle) 64304**] prior to procedure. He will\\nnotify radiation [**Last Name (STitle) 5564**] that clipping has been performed.\\nPlease page the on call ERCP fellow at [**Telephone/Fax (1) 2756**], pager [**Numeric Identifier **]\\nwith any immediate concerns such as bleeding, fever, abdominal\\npain, or other problems.\\nPlease call Dr.[**Name (NI) 2798**] office at [**Telephone/Fax (1) 2799**] with any\\nquestions or concerns.\\n\\nAdditional notes: Patient will remain intubated and transferred\\nto PACU for observation and later extubation.  Husband was\\ncalled an informed of the need to intubate for the exam and the\\nabove findings were explained to him.\\n\\nFINAL DIAGNOSES are listed in the impression section above.\\nEstimated blood loss = zero. Specimens were taken for pathology\\nas listed above.\\n\\n\\n\\nBrief Hospital Course:\\nPt is a 61yo f w/folicular lymnphoma, HTN, obesity and asthma,\\nwent for repeat endoscopy today and desatted on MAC when GI\\nprobe was put down due to laryngospasm. Probe was removed and pt\\nwas intubated w/out difficulty. Procedure was successfully\\ncompleted but no cuff leak post op. WAs given 10mg IV decadron\\nbut concern regarding extubation in PACU given ? pulm edema on\\nCXR. VSS throughout.\\n.\\n# Larygnospasm: now resolved and extubated essentially on\\narrival to ICU. Monitored airway, nebs prn, home flovent\\ncontinued, cepacol lozenges. Went home in AM. Recommend\\nconsideration of possible sleep study if signs of sleep apnea\\novernight\\n.\\n# Follicular lymphoma: plan per outpt onco. Clips placed for rad\\ntherapy for localization of lymphoma, otherwise normal EGD.\\nContinued omperazole.\\n.\\n# Asthma: stable. Continued flovent, nebs prn and fenofexadine\\n(zyrtec at home) for allergy\\n.\\n#HTN: stable, continued home lisinopril\\n.\\n# Anxiety:  stable, continued home dose lorazepam\\n\\n\\nMedications on Admission:\\nALBUTEROL SULFATE - (Prescribed by Other Provider) - Dosage\\nuncertain\\nFLUTICASONE [FLOVENT HFA] - (Prescribed by Other Provider) - 44\\nmcg Aerosol - 2 (Two) puffs by mouth once a day\\nLISINOPRIL - (Prescribed by Other Provider) - 10 mg Tablet - 1\\n(One) Tablet(s) by mouth once a day\\nLORAZEPAM - (Prescribed by Other Provider) - 0.5 mg Tablet - 1\\n(One) Tablet(s) by mouth as needed as needed for anxiety\\nOMEPRAZOLE - (Prescribed by Other Provider) - 20 mg Capsule,\\nDelayed Release(E.C.) - 1 (One) Capsule(s) by mouth once a day\\nTRIAMCINOLONE ACETONIDE - (Prescribed by Other Provider) -\\nDosage uncertain\\n\\nMedications - OTC\\nCALCIUM - (Prescribed by Other Provider) - Dosage uncertain\\nCALCIUM CITRATE-VITAMIN D3 [CITRACAL + D] - (Prescribed by Other\\nProvider) - 315 mg-200 unit Tablet - 2 (Two) Tablet(s) by mouth\\nonce a day\\nCETIRIZINE [ZYRTEC] - (Prescribed by Other Provider) - 10 mg\\nCapsule - 1 (One) Capsule(s) by mouth once a day\\nGLUCOSAMINE-CHONDROITIN - (Prescribed by Other Provider) -\\nDosage uncertain\\nSODIUM BICARB-SODIUM CHLORIDE [NEILMED SINUS RINSE COMPLETE] -\\n(Prescribed by Other Provider) - Dosage uncertain\\n\\n\\nDischarge Medications:\\n1. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig:\\nOne (1)  Inhalation prn as needed for shortness of breath or\\nwheezing.\\n2. Flovent HFA 44 mcg/Actuation Aerosol Sig: Two (2) puffs\\nInhalation once a day.\\n3. lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day.\\n4. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO once a day as\\nneeded for anxiety.\\n5. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1)\\nCapsule, Delayed Release(E.C.) PO once a day.\\n6. triamcinolone acetonide  Topical\\n7. Citracal + D 315-200 mg-unit Tablet Sig: One (1) Tablet PO\\nonce a day.\\n8. calcium  Oral\\n9. Zyrtec 10 mg Tablet Sig: One (1) Tablet PO once a day.\\n10. glucosamine-chondroitin  Oral\\n11. Neilmed Sinus Rinse Complete     Packet Sig: One (1)  Nasal\\nthree times a day as needed for allergy symptoms.\\n\\n\\nDischarge Disposition:\\nHome\\n\\nDischarge Diagnosis:\\nFollicular lymphoma\\nLaryngiospasm on intubation for endoscopy\\n\\nDischarge Condition:\\nMental Status: Clear and coherent.\\nLevel of Consciousness: Alert and interactive.\\nActivity Status: Ambulatory - Independent.\\n\\nDischarge Instructions:\\nYou came to the hospital because you were scheduled to have an\\nendoscopy for further evaluation of your cancer. During the\\nprocedure, you needed to be intubated to better protect your\\nairway and help you breath to ensure the oxygen levels in your\\nblood stayed at appropriate levels. You experienced spasm of the\\nmuscles in you windpipe which required a dose of steroids to\\nhelp relieve them and you required slightly longer recovery time\\nprior to extubation. However, you were able to be successfully\\nextubated shortly after coming to the ICU for close monitoring.\\nYou did well and were able to be discharged home with outpatient\\nfollow-up planned with your primary care doctor [**First Name (Titles) **] [**Last Name (Titles) 5564**].\\n\\nNo changes were made to your medications.\\n- Please continue to take all of your other home medications as\\nprescribed\\n\\nPlease be sure to keep all follow-up appointments with your\\nprimary care doctor, [**Last Name (Titles) 5564**] and other health care providers.\\n\\nIt was a pleasure taking care of you and we wish you a speedy\\nrecovery\\n\\nFollowup Instructions:\\nPlease be sure to keep all follow-up appointments with your\\nprimary care doctor, [**Last Name (Titles) 5564**] and other health care providers.\\n\\n\\nCompleted by:[**2163-6-4**]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"tokens\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 15
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#Extract entities from TEXT column\n",
        "\n",
        "extract_entities(nod_lymph_abd_filtered_df.iloc[0]['TEXT'])\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9d4NCxL6p74L",
        "outputId": "edb095f4-6ae7-4757-d954-04776ce118d4"
      },
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "2147-7-4 20 28 DATE\n",
            "2147-8-23 66 75 DATE\n",
            "2103-7-19 99 108 DATE\n",
            "4377 247 251 DATE\n",
            "Surgical or Invasive Procedure 303 333 ORG\n",
            "1st 465 468 CARDINAL\n",
            "50% 488 491 PERCENT\n",
            "2nd 521 524 ORDINAL\n",
            "L 555 556 ORG\n",
            "43 643 645 CARDINAL\n",
            "2147-6-9 718 726 DATE\n",
            "today 772 777 DATE\n",
            "417 945 948 CARDINAL\n",
            "2147-6-9 969 977 DATE\n",
            "2147-6-13 987 996 DATE\n",
            "0.9 1141 1144 CARDINAL\n",
            "1501 1219 1223 DATE\n",
            "Today 1297 1302 DATE\n",
            "1501 1324 1328 DATE\n",
            "7.8 1387 1390 CARDINAL\n",
            "9.9 1411 1414 CARDINAL\n",
            "ED 1562 1564 ORG\n",
            "VS 1574 1576 PRODUCT\n",
            "98.9 1584 1588 CARDINAL\n",
            "18 95% 1599 1605 PERCENT\n",
            "RA 1606 1608 ORG\n",
            "8.6 1630 1633 CARDINAL\n",
            "10.6 1657 1661 CARDINAL\n",
            "10U 1677 1680 CARDINAL\n",
            "1 1704 1705 CARDINAL\n",
            "10.1 1915 1919 CARDINAL\n",
            "6.7 1939 1942 CARDINAL\n",
            "Nephrology 1945 1955 ORG\n",
            "6.3 2111 2114 CARDINAL\n",
            "MICU 2228 2232 ORG\n",
            "VS 2244 2246 PRODUCT\n",
            "97.4 79 2252 2259 CARDINAL\n",
            "118/82 2260 2266 DATE\n",
            "15 98% 2267 2273 PERCENT\n",
            "RA\n",
            "\n",
            "\n",
            "Past Medical History 2277 2302 ORG\n",
            "Anxiety\n",
            "Depression 2329 2347 ORG\n",
            "Irritable 2402 2411 ORG\n",
            "Hemorrhoids\n",
            "Heroin 2427 2445 ORG\n",
            "IVDA 2501 2505 ORG\n",
            "quit years ago 2507 2521 DATE\n",
            "Family History 2714 2728 PERSON\n",
            "HEENT 2803 2808 ORG\n",
            "Sclera 2810 2816 ORG\n",
            "JVP 2870 2873 ORG\n",
            "3-20 2985 2989 CARDINAL\n",
            "GU 3268 3270 ORG\n",
            "Ext: Warm 3288 3297 ORG\n",
            "2 3314 3315 CARDINAL\n",
            "LE 3347 3349 GPE\n",
            "Neuro 3356 3361 ORG\n",
            "x3 3380 3382 ORG\n",
            "4 3395 3396 CARDINAL\n",
            "DISCHARGE 3458 3467 ORG\n",
            "HEENT 3508 3513 ORG\n",
            "Sclera 3515 3521 ORG\n",
            "JVP 3575 3578 ORG\n",
            "MRG 3640 3643 ORG\n",
            "GU 3782 3784 ORG\n",
            "Ext: Warm 3808 3817 ORG\n",
            "2 3834 3835 CARDINAL\n",
            "1 3845 3846 CARDINAL\n",
            "LE 3858 3860 GPE\n",
            "Neuro 3867 3872 ORG\n",
            "II 3900 3902 CARDINAL\n",
            "2147-7-4 4002 4010 DATE\n",
            "2147-7-4 4116 4124 DATE\n",
            "09:25PM 4128 4135 CARDINAL\n",
            "2147-7-4 4195 4203 DATE\n",
            "2147-7-5 4253 4261 DATE\n",
            "03:02AM BLOOD Ret Aut-1.2 4265 4290 PRODUCT\n",
            "2147-7-4 4294 4302 DATE\n",
            "HCO3-22 4373 4380 PRODUCT\n",
            "2147-7-4 4394 4402 DATE\n",
            "2147-7-4 4435 4443 DATE\n",
            "2147-7-5 4508 4516 DATE\n",
            "07:01AM 4520 4527 CARDINAL\n",
            "2147-7-5 4583 4591 DATE\n",
            "03:02AM 4595 4602 CARDINAL\n",
            "2147-7-5 4624 4632 DATE\n",
            "03:02AM 4636 4643 CARDINAL\n",
            "2147-7-4 4665 4673 DATE\n",
            "09:25PM 4677 4684 CARDINAL\n",
            "2147-7-4 4750 4758 DATE\n",
            "2147-7-5 4799 4807 DATE\n",
            "12:25AM 4811 4818 CARDINAL\n",
            "URINE Color-Straw Appear-Clear Sp 4819 4852 ORG\n",
            "2147-7-5 4884 4892 DATE\n",
            "12:25AM 4896 4903 CARDINAL\n",
            "2147-7-5 5010 5018 DATE\n",
            "12:25AM 5022 5029 CARDINAL\n",
            "Bacteri-FEW Yeast-NONE 5048 5070 ORG\n",
            "2147-7-5 5090 5098 DATE\n",
            "12:25AM 5102 5109 CARDINAL\n",
            "NEG 5160 5163 ORG\n",
            "2147-7-4 5201 5209 DATE\n",
            "2147-7-4 5281 5289 DATE\n",
            "1 5298 5299 CARDINAL\n",
            "Retrocardiac 5302 5314 NORP\n",
            "2 5364 5365 CARDINAL\n",
            "2147-7-5 5522 5530 DATE\n",
            "1 5539 5540 CARDINAL\n",
            "SVC 5571 5574 ORG\n",
            "2 5576 5577 CARDINAL\n",
            "2147-7-6 5606 5614 DATE\n",
            "3:26 PM # 5618 5627 TIME\n",
            "Telephone/Fax 5631 5644 ORG\n",
            "103896 5649 5655 DATE\n",
            "ABD & PELVIS W/O 5671 5687 ORG\n",
            "1 5692 5693 CARDINAL\n",
            "IVC 5786 5789 ORG\n",
            "2 6024 6025 CARDINAL\n",
            "3 6233 6234 CARDINAL\n",
            "2147-7-12 6366 6375 DATE\n",
            "12:20 PM # 6379 6389 TIME\n",
            "1 6439 6440 CARDINAL\n",
            "8 6493 6494 CARDINAL\n",
            "French 6495 6501 NORP\n",
            "2 6531 6532 CARDINAL\n",
            "8 6575 6576 CARDINAL\n",
            "French 6577 6583 NORP\n",
            "3 6622 6623 CARDINAL\n",
            "3-17 6661 6665 CARDINAL\n",
            "weeks 6669 6674 DATE\n",
            "2147-7-18 6888 6897 DATE\n",
            "11:23 AM # 6901 6911 TIME\n",
            "Telephone/Fax 6915 6928 ORG\n",
            "103898 6933 6939 DATE\n",
            "U.S. 6951 6955 GPE\n",
            "2147-7-19 7114 7123 DATE\n",
            "Doppler 7254 7261 PERSON\n",
            "55% 7364 7367 PERCENT\n",
            "3 7536 7537 CARDINAL\n",
            "1+ 7679 7681 DATE\n",
            "2142 8256 8260 DATE\n",
            "AHA 8264 8267 ORG\n",
            "2147-7-19 8483 8492 DATE\n",
            "1 8530 8531 CARDINAL\n",
            "3.6-cm 8533 8539 QUANTITY\n",
            "1.8-cm 8697 8703 QUANTITY\n",
            "2 8823 8824 CARDINAL\n",
            "3 8960 8961 CARDINAL\n",
            "4. 9113 9115 CARDINAL\n",
            "2147-7-21 9167 9176 DATE\n",
            "Radiology US UPPER EXTREMITY 9180 9208 ORG\n",
            "FNAed 9417 9422 ORG\n",
            "2147-7-24 9460 9469 DATE\n",
            "1 9507 9508 CARDINAL\n",
            "one week ago 9582 9594 DATE\n",
            "2 9666 9667 CARDINAL\n",
            "myositis 9960 9968 GPE\n",
            "3 9970 9971 CARDINAL\n",
            "2147-7-25 10163 10172 DATE\n",
            "Pathology Tissue 10176 10192 ORG\n",
            "Hematoma 10212 10220 GPE\n",
            "2147-7-27 10275 10284 DATE\n",
            "2147-8-12 10427 10436 DATE\n",
            "Pelvis 10452 10458 PERSON\n",
            "1 10471 10472 CARDINAL\n",
            "2 10579 10580 CARDINAL\n",
            "2147-8-21 10719 10728 DATE\n",
            "Antegradge 10732 10742 ORG\n",
            "IMPRESSION 10754 10764 ORG\n",
            "1 10766 10767 CARDINAL\n",
            "Mildly 10889 10895 GPE\n",
            "UPJ 10987 10990 ORG\n",
            "2 11032 11033 CARDINAL\n",
            "2147-7-5 11234 11242 DATE\n",
            "23,720,478 11280 11290 CARDINAL\n",
            "2147-7-8 11301 11309 DATE\n",
            "2147-7-12 11392 11401 DATE\n",
            "2147-7-19 11472 11481 DATE\n",
            "9:46 am 11485 11492 TIME\n",
            "2147-7-21 11589 11598 DATE\n",
            "2147-7-19 11655 11664 DATE\n",
            "2147-7-21 11828 11837 DATE\n",
            "SHIGELLA FOUND 11909 11923 PERSON\n",
            "2147-7-21 11961 11970 DATE\n",
            "FOUND 11996 12001 ORG\n",
            "Cryptosporidium/Giardia 12007 12030 ORG\n",
            "2147-7-21 12047 12056 DATE\n",
            "5/22,26,27 12124 12134 CARDINAL\n",
            "6/4,5,6,7,8,9,13 12149 12165 CARDINAL\n",
            "ECG 12185 12188 ORG\n",
            "2147-7-31 12194 12203 DATE\n",
            "2147-7-28 12311 12320 DATE\n",
            "QRS QT 12471 12477 PERSON\n",
            "82 144 86 12490 12499 CARDINAL\n",
            "Telephone/Fax 12503 12516 ORG\n",
            "35 12531 12533 CARDINAL\n",
            "Brief Hospital Course 12545 12566 ORG\n",
            "C, HTN 12594 12600 ORG\n",
            "IV 12602 12604 GPE\n",
            "L 12750 12751 ORG\n",
            "1 12958 12959 CARDINAL\n",
            "3 12963 12964 CARDINAL\n",
            "2147-7-25 13163 13172 DATE\n",
            "D1-5 13370 13374 DATE\n",
            "50% 13392 13395 PERCENT\n",
            "2 13417 13418 CARDINAL\n",
            "2147-8-12 13469 13478 DATE\n",
            "Oncologist\n",
            "Dr 13691 13704 WORK_OF_ART\n",
            "21628 13727 13732 DATE\n",
            "Telephone/Fax 13780 13793 ORG\n",
            "103900 13843 13849 DATE\n",
            "1474 13867 13871 DATE\n",
            "9-11 13888 13892 DATE\n",
            "Healthcare 13900 13910 ORG\n",
            "CXR 13980 13983 ORG\n",
            "7-10 14049 14053 CARDINAL\n",
            "Acute 14162 14167 ORG\n",
            "Cr 10.6 14260 14267 ORG\n",
            "8.6 14282 14285 CARDINAL\n",
            "ICU 14315 14318 ORG\n",
            "BMT 14382 14385 ORG\n",
            "L 14471 14472 ORG\n",
            "IR 14505 14507 ORG\n",
            "2147-7-12 14514 14523 DATE\n",
            "L 14560 14561 ORG\n",
            "16 14597 14599 CARDINAL\n",
            "~2.4L 14652 14657 FAC\n",
            "16 14663 14665 CARDINAL\n",
            "IR 14711 14713 ORG\n",
            "2147-7-13 14720 14729 DATE\n",
            "Cr 14761 14763 GPE\n",
            "2.5 14773 14776 CARDINAL\n",
            "2147-7-13 14783 14792 DATE\n",
            "morning 14796 14803 TIME\n",
            "2.0 14842 14845 CARDINAL\n",
            "2147-7-14 14852 14861 DATE\n",
            "Cr 14914 14916 PERSON\n",
            "1.1 14941 14944 CARDINAL\n",
            "2147-7-24 14951 14960 DATE\n",
            "L 15051 15052 NORP\n",
            "2147-7-27 15151 15160 DATE\n",
            "2147-8-21 15171 15180 DATE\n",
            "IR 15192 15194 ORG\n",
            "UOP 15375 15378 ORG\n",
            "1.1 15397 15400 CARDINAL\n",
            "UTI 15425 15428 ORG\n",
            "UA 15452 15454 ORG\n",
            "100 15497 15500 CARDINAL\n",
            "2147-9-7 15551 15559 DATE\n",
            "# Hyperkalemia - Secondary 15563 15589 MONEY\n",
            "Kayexalate 15631 15641 ORG\n",
            "5.5 15762 15765 CARDINAL\n",
            "IV 16265 16267 GPE\n",
            "PO 16269 16271 ORG\n",
            "gabapentin 16288 16298 GPE\n",
            "10 16351 16353 CARDINAL\n",
            "4 16381 16382 CARDINAL\n",
            "daily 16571 16576 DATE\n",
            "half 16622 16626 CARDINAL\n",
            "8 16650 16651 CARDINAL\n",
            "4 16657 16658 CARDINAL\n",
            "every 4 hours 16661 16674 TIME\n",
            "250 16855 16858 CARDINAL\n",
            "PO BID 16862 16868 ORG\n",
            "5 16881 16882 CARDINAL\n",
            "1 16928 16929 CARDINAL\n",
            "PO TID 16933 16939 ORG\n",
            "1 16966 16967 CARDINAL\n",
            "# Normocytic Anemia 17101 17120 MONEY\n",
            "Nadir 17176 17181 PERSON\n",
            "21.1 17185 17189 CARDINAL\n",
            "2147-7-10 17196 17205 DATE\n",
            "23 million 17418 17428 CARDINAL\n",
            "HBV 17457 17460 ORG\n",
            "LFT 17467 17470 ORG\n",
            "C.\n",
            "\n",
            "# Drug 17556 17566 ORG\n",
            "IV 17596 17598 GPE\n",
            "10246 17870 17875 DATE\n",
            "18 17941 17943 CARDINAL\n",
            "10246 18105 18110 DATE\n",
            "MA 18310 18312 PERSON\n",
            "103901 18420 18426 DATE\n",
            "Telephone/Fax 18438 18451 ORG\n",
            "fax:[**Telephone 18465 18481 ORG\n",
            "103902 18490 18496 DATE\n",
            "Main 18511 18515 PERSON\n",
            "un 18529 18531 ORG\n",
            "103903 18533 18539 DATE\n",
            "Mass)on 18543 18550 ORG\n",
            "2147-8-28 18554 18563 DATE\n",
            "12967 18654 18659 DATE\n",
            "Oncologist Dr 18703 18716 LOC\n",
            "21628 18739 18744 DATE\n",
            "1474 18764 18768 DATE\n",
            "9-11 18778 18782 DATE\n",
            "2147 18790 18794 DATE\n",
            "2 19104 19105 CARDINAL\n",
            "PO q3h 19110 19116 LOC\n",
            "1 19140 19141 CARDINAL\n",
            "100 19164 19167 CARDINAL\n",
            "daily 19170 19175 DATE\n",
            "250 19185 19188 CARDINAL\n",
            "0.5 19215 19218 CARDINAL\n",
            "30 19253 19255 CARDINAL\n",
            "PO 19258 19260 ORG\n",
            "7 19272 19273 CARDINAL\n",
            "1 19288 19289 CARDINAL\n",
            "100 19303 19306 CARDINAL\n",
            "100 19338 19341 CARDINAL\n",
            "1 19373 19374 CARDINAL\n",
            "Scalp Prosthesis\n",
            "Dispense 19393 19418 ORG\n",
            "1 19420 19421 CARDINAL\n",
            "100 19441 19444 CARDINAL\n",
            "One 19461 19464 CARDINAL\n",
            "1 19466 19467 CARDINAL\n",
            "PO BID 19477 19483 ORG\n",
            "2 19485 19486 CARDINAL\n",
            "3 19501 19502 CARDINAL\n",
            "8.6 19510 19513 CARDINAL\n",
            "1 19529 19530 CARDINAL\n",
            "2 19549 19550 CARDINAL\n",
            "4 19592 19593 CARDINAL\n",
            "1 19606 19607 CARDINAL\n",
            "One 19623 19626 CARDINAL\n",
            "1 19628 19629 CARDINAL\n",
            "PO TID 19638 19644 ORG\n",
            "3 19646 19647 CARDINAL\n",
            "5 19703 19704 CARDINAL\n",
            "250 19717 19720 CARDINAL\n",
            "DR/EC) Sig: 19748 19759 ORG\n",
            "One 19760 19763 CARDINAL\n",
            "1 19765 19766 CARDINAL\n",
            "DR/EC 19792 19797 ORG\n",
            "PO BID 19799 19805 ORG\n",
            "2 19807 19808 CARDINAL\n",
            "DR/EC)(s 19856 19864 ORG\n",
            "6 19879 19880 CARDINAL\n",
            "200 19894 19897 CARDINAL\n",
            "One 19913 19916 CARDINAL\n",
            "1 19918 19919 CARDINAL\n",
            "PO Q24H 19928 19935 ORG\n",
            "24 hours 19943 19951 TIME\n",
            "7 19986 19987 CARDINAL\n",
            "hydroxyzine 19989 20000 ORG\n",
            "25 20005 20007 CARDINAL\n",
            "Four 20023 20027 CARDINAL\n",
            "PO 20039 20041 ORG\n",
            "8 20109 20110 CARDINAL\n",
            "acyclovir 400 20112 20125 CARDINAL\n",
            "One 20141 20144 CARDINAL\n",
            "1 20146 20147 CARDINAL\n",
            "PO 20156 20158 ORG\n",
            "8\n",
            "hours 20170 20177 TIME\n",
            "9 20212 20213 CARDINAL\n",
            "400-80 20245 20251 CARDINAL\n",
            "One 20267 20270 CARDINAL\n",
            "1 20272 20273 CARDINAL\n",
            "Tablet PO DAILY 20275 20290 ORG\n",
            "Tablet(s 20309 20317 GPE\n",
            "10 20332 20334 CARDINAL\n",
            "5 20347 20348 CARDINAL\n",
            "One 20364 20367 CARDINAL\n",
            "1 20369 20370 CARDINAL\n",
            "PO TID 20379 20385 ORG\n",
            "3 20387 20388 CARDINAL\n",
            "11 20435 20437 CARDINAL\n",
            "0.5 20449 20452 CARDINAL\n",
            "One 20468 20471 CARDINAL\n",
            "1 20473 20474 CARDINAL\n",
            "PO 20483 20485 ORG\n",
            "Disp:*8 tablet(s 20521 20537 PERSON\n",
            "12 20552 20554 CARDINAL\n",
            "nitrofurantoin monohyd 20556 20578 ORG\n",
            "100 20587 20590 CARDINAL\n",
            "One 20607 20610 CARDINAL\n",
            "1 20612 20613 CARDINAL\n",
            "PO Q12H 20623 20630 ORG\n",
            "every 12 hours 20632 20646 TIME\n",
            "2147-9-7 20661 20669 DATE\n",
            "13 20707 20709 CARDINAL\n",
            "4 20725 20726 CARDINAL\n",
            "One 20742 20745 CARDINAL\n",
            "1 20747 20748 CARDINAL\n",
            "PO 20757 20759 ORG\n",
            "5-19 20769 20773 CARDINAL\n",
            "14 20835 20837 CARDINAL\n",
            "300 20850 20853 CARDINAL\n",
            "One 20870 20873 CARDINAL\n",
            "1 20875 20876 CARDINAL\n",
            "PO TID 20886 20892 ORG\n",
            "3 20894 20895 CARDINAL\n",
            "15 20943 20945 CARDINAL\n",
            "100 20959 20962 CARDINAL\n",
            "Two 20978 20981 CARDINAL\n",
            "PO DAILY 20993 21001 ORG\n",
            "Daily 21003 21008 ORG\n",
            "16 21043 21045 CARDINAL\n",
            "14 mg/24 21056 21064 QUANTITY\n",
            "One 21085 21088 CARDINAL\n",
            "4 21261 21262 CARDINAL\n",
            "Discharge Disposition 21278 21299 ORG\n",
            "Discharge Condition 21489 21508 ORG\n",
            "Ambulatory - Independent 21609 21633 ORG\n",
            "Discharge Instructions 21637 21659 ORG\n",
            "two 22438 22441 CARDINAL\n",
            "4 22882 22883 CARDINAL\n",
            "4-6 hours 22893 22902 TIME\n",
            "Methadone 22917 22926 ORG\n",
            "methadone clinic 22948 22964 ORG\n",
            "three 22983 22988 CARDINAL\n",
            "Nicotine 23296 23304 NORP\n",
            "14 23311 23313 CARDINAL\n",
            "daily 23331 23336 DATE\n",
            "200 23498 23501 CARDINAL\n",
            "acyclovir 400 23511 23524 CARDINAL\n",
            "every 8 hours 23528 23541 TIME\n",
            "daily 23573 23578 DATE\n",
            "100 23628 23631 CARDINAL\n",
            "2147-9-7 23673 23681 DATE\n",
            "5 23729 23730 CARDINAL\n",
            "three 23734 23739 CARDINAL\n",
            "1 23833 23834 CARDINAL\n",
            "7 23860 23861 CARDINAL\n",
            "1826 23884 23888 DATE\n",
            "Outpatient Clinic 23892 23909 ORG\n",
            "18 23924 23926 CARDINAL\n",
            "Time 23930 23934 ORG\n",
            "12\n",
            "pm 23936 23941 TIME\n",
            "noon 23943 23947 TIME\n",
            "tomorrow 23949 23957 DATE\n",
            "8 23961 23962 CARDINAL\n",
            "2 23969 23970 CARDINAL\n",
            "Monday 24009 24015 DATE\n",
            "8 24019 24020 CARDINAL\n",
            "2:00 pm 24027 24034 TIME\n",
            "1474 24048 24052 DATE\n",
            "Neighborhood Health 24056 24075 ORG\n",
            "1474 24110 24114 DATE\n",
            "MA\n",
            "3 24119 24123 ORG\n",
            "103904 24187 24193 DATE\n",
            "1474 24241 24245 DATE\n",
            "Neighborhood Health 24249 24268 ORG\n",
            "4 24269 24270 CARDINAL\n",
            "21628 24338 24343 DATE\n",
            "9-11 24364 24368 DATE\n",
            "1474 24385 24389 DATE\n",
            "Neighborhood Health 24393 24412 ORG\n",
            "*********************************************************\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Admission Date:  [**2147-7-4**]              Discharge Date:   [**2147-8-23**]\n",
              "\n",
              "Date of Birth:  [**2103-7-19**]             Sex:   F\n",
              "\n",
              "Service: MEDICINE\n",
              "\n",
              "Allergies:\n",
              "No Known Allergies / Adverse Drug Reactions\n",
              "\n",
              "Attending:[**Last Name (NamePattern1) 4377**]\n",
              "Chief Complaint:\n",
              "Left lower leg swelling\n",
              "\n",
              "Major Surgical or Invasive Procedure:\n",
              "hemodialysis\n",
              "left internal jugular hemodialysis catheter placement and\n",
              "removal\n",
              "right upper extremity PICC placement\n",
              "chemotherapy: 1st cycle fludarabine (50% dose due to renal\n",
              "function), 2nd cycle CHOP\n",
              "R Nephrosotomy and L renal stent placement\n",
              "R Nephrostomy and  L stent removal\n",
              "\n",
              "History of Present Illness:\n",
              "43 y.o women with a history of hepatitis C, recent lymph node\n",
              "biopsy on [**2147-6-9**] at [**Hospital3 **] hospital who presents today\n",
              "with left lower extremity redness and pain, who was then found\n",
              "to have severe hyperkalemia and acute renal failure.\n",
              "\n",
              "The patient recently was admitted to [**Hospital3 417**] hospital\n",
              "from [**2147-6-9**] to [**2147-6-13**] for an elective excisional biopsy of\n",
              "diffuse lymphadenopathy, most prominent in her left groin.\n",
              "Based on limited records, her creatinine was 0.9 at that time.\n",
              "She was then discharged from the hospital to a [**Hospital1 1501**] due to\n",
              "inability to ambulate, where she has been residing ever since.\n",
              "Today, at the [**Hospital1 1501**] her labs were checked and she was found to\n",
              "have a K of 7.8 and a creatinine of 9.9.  The patient herself\n",
              "reports that she feels that her urine output has been decreasing\n",
              "lately along with some increased generalized edema.\n",
              "\n",
              "In the ED, initial VS were:  98.9 92 146/90 18 95% RA.  On labs,\n",
              "her K was 8.6 and her creatinine was 10.6. She was given 10U of\n",
              "regular insulin and 1 amp of D50W for her hyperkalemia.  She was\n",
              "also given a dose of vancomycin for a possible cellulitis.  A\n",
              "left lower extremity ultrasound was negative for clot.  Other\n",
              "notable labs include a uric acid level of 10.1 and a phosphate\n",
              "of 6.7.  Nephrology was consulted and recommended that she be\n",
              "admitted to the MICU for medical management of her hyperkalemia.\n",
              " Her K after the above interventions dropped to 6.3, and given\n",
              "an EKG that did not show evidence of cardiac toxicity, dialysis\n",
              "was not initiated.\n",
              "\n",
              "On arrival to the MICU, patient's VS were 97.4 79 118/82 15 98%\n",
              "on RA\n",
              "\n",
              "\n",
              "Past Medical History:\n",
              "Hepatitis C\n",
              "hypertension\n",
              "Anxiety\n",
              "Depression\n",
              "myocardial infarction\n",
              "Bilateral lower extremity edema\n",
              "Irritable bowel syndrome\n",
              "Hemorrhoids\n",
              "Heroin abuse\n",
              "Borderline personality disorder\n",
              "\n",
              "Social History:\n",
              "IVDA, quit years ago according to patient, during a search of\n",
              "her belongings a significant amount of drug paraphenelia was\n",
              "found including a spoon, wrapping papers, and syringes.  Current\n",
              "1ppd smoker.  No EtOH.\n",
              "\n",
              "\n",
              "Family History:\n",
              "NC\n",
              "\n",
              "Physical Exam:\n",
              "ADMISSION EXAM:\n",
              "General: somlenent, no acute distress\n",
              "HEENT: Sclera anicteric, dry mucous membranes, PERRL\n",
              "Neck: supple, JVP not elevated, mild left anterior cervical\n",
              "lymphadenoapthy\n",
              "CV: Regular rate and rhythm, normal S1 + S2, mild [**3-20**] mid\n",
              "systolic murmur best heard at RUSB.\n",
              "Lungs: Bibasilar crackles, R>L\n",
              "Abdomen: soft, non-distended, bowel sounds present, no\n",
              "organomegaly, no tenderness to palpation, no rebound or\n",
              "guarding.  Dressing at inguinal site c/d/i.  Significant\n",
              "bilateral inguinal lymphadenopathy.\n",
              "GU: foley  in place\n",
              "Ext: Warm, well perfused, 2+ pulses, significant bilateral LE\n",
              "edema Neuro: GCS 14, oriented x3, moving all 4 extremities,\n",
              "otherwise unable to cooperate with neuro exam.\n",
              "\n",
              "DISCHARGE EXAM:\n",
              "General: alert, no acute distress\n",
              "HEENT: Sclera anicteric, dry mucous membranes, PERRL\n",
              "Neck: supple, JVP not elevated\n",
              "CV: Regular rate and rhythm, normal S1 + S2, no MRG\n",
              "Lungs: CTAB\n",
              "Abdomen: soft, slightly distended, bowel sounds present, no\n",
              "organomegaly, no tenderness to palpation, no rebound or\n",
              "guarding.\n",
              "GU: nephrostomy stent and\n",
              "Ext: Warm, well perfused, 2+ pulses, 1+ bilateral LE edema\n",
              "Neuro: alert and oriented x3, CN II-XII grossly intact, normal\n",
              "gait, normal muscle tone and buk\n",
              "\n",
              "Pertinent Results:\n",
              "ADMISSION LABS:\n",
              "[**2147-7-4**] 09:25PM BLOOD WBC-3.9* RBC-3.50* Hgb-9.4* Hct-30.2*\n",
              "MCV-86 MCH-26.9* MCHC-31.2 RDW-13.0 Plt Ct-266\n",
              "[**2147-7-4**] 09:25PM BLOOD Neuts-66.6 Lymphs-23.2 Monos-8.5 Eos-1.5\n",
              "Baso-0.1\n",
              "[**2147-7-4**] 09:25PM BLOOD PT-10.0 PTT-30.9 INR(PT)-0.9\n",
              "[**2147-7-5**] 03:02AM BLOOD Ret Aut-1.2\n",
              "[**2147-7-4**] 09:25PM BLOOD Glucose-80 UreaN-70* Creat-10.6* Na-135\n",
              "K-8.6* Cl-98 HCO3-22 AnGap-24*\n",
              "[**2147-7-4**] 09:25PM BLOOD CK(CPK)-169\n",
              "[**2147-7-4**] 09:25PM BLOOD Calcium-9.0 Phos-6.7* Mg-3.2*\n",
              "UricAcd-10.1*\n",
              "[**2147-7-5**] 07:01AM BLOOD calTIBC-247* VitB12-578 Ferritn-200*\n",
              "TRF-190*\n",
              "[**2147-7-5**] 03:02AM BLOOD Osmolal-305\n",
              "[**2147-7-5**] 03:02AM BLOOD Valproa-47*\n",
              "[**2147-7-4**] 09:25PM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG\n",
              "Barbitr-NEG Tricycl-NEG\n",
              "[**2147-7-4**] 09:49PM BLOOD Lactate-1.2\n",
              "\n",
              "URINE:\n",
              "[**2147-7-5**] 12:25AM URINE Color-Straw Appear-Clear Sp [**Last Name (un) **]-1.004\n",
              "[**2147-7-5**] 12:25AM URINE Blood-NEG Nitrite-NEG Protein-TR\n",
              "Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-MOD\n",
              "[**2147-7-5**] 12:25AM URINE RBC-1 WBC-2 Bacteri-FEW Yeast-NONE Epi-1\n",
              "TransE-<1\n",
              "[**2147-7-5**] 12:25AM URINE bnzodzp-NEG barbitr-NEG opiates-POS\n",
              "cocaine-NEG amphetm-NEG mthdone-NEG\n",
              "\n",
              "STUDIES:\n",
              "[**2147-7-4**] Lower extremity ultrasound:\n",
              "No DVT of the left lower extremity.\n",
              "\n",
              "[**2147-7-4**] CXR:\n",
              "1.  Retrocardiac opacity compatible with pneumonia or\n",
              "atelectasis\n",
              "2.  Prominence of the right hilus may be secondary to low lung\n",
              "volumes or\n",
              "hilar opacity.  Suggest follow up radiographs, ideally with\n",
              "better\n",
              "inspiration.\n",
              "\n",
              "[**2147-7-5**] CXR:\n",
              "1.  Left IJ catheter in the mid SVC.\n",
              "2.  Mild pulmonary edema.\n",
              "\n",
              "[**2147-7-6**] 3:26 PM # [**Telephone/Fax (1) 103896**]   CT CHEST, ABD & PELVIS W/O CON\n",
              "1. Infiltrative soft tissue mass surrounding the retroperitoneal\n",
              "region, including the aorta, IVC, and presumably the ureters.\n",
              "This is likely secondary to lymphoma and would be expected to be\n",
              "the cause of the patient's bilateral renal obstruction. However,\n",
              "given the cortical thinning on the left, this is likely a\n",
              "chronic process. 2. Ground-glass opacities seen within the right\n",
              "upper lobe and right middle lobe suggestive of atypical\n",
              "infection. The typical consolidations seen with bacterial\n",
              "pneumonia are not evident on this examination. 3. Bilateral\n",
              "pleural effusions are moderate in size, slightly greater on the\n",
              "right and on the left, with associated atelectasis.\n",
              "\n",
              "[**2147-7-12**] 12:20 PM # [**Numeric Identifier 103897**] INTRO CATH RENAL\n",
              "1. Successful uncomplicated placement of a left-sided 8 French\n",
              "x22 cm nephroureteral stent. 2. Successful uncomplicated\n",
              "placement of an 8 French nephrostomy tube in the right kidney.\n",
              "3. A future study is recommended in [**3-17**] weeks to try to attempt\n",
              "reconversion of the right-sided nephrostomy tube to a\n",
              "nephroureteral stent and to try to further characterize the\n",
              "filling defect seen in the right renal pelvis, which could be an\n",
              "air bubble.\n",
              "\n",
              "[**2147-7-18**] 11:23 AM # [**Telephone/Fax (1) 103898**]   RENAL U.S.\n",
              "IMPRESSION: Complete resolution of left hydronephrosis.\n",
              "Near-complete resolution of right hydronephrosis with only\n",
              "minimal residual hydronephrosis noted.\n",
              "\n",
              "[**2147-7-19**] Cardiovascular ECHO\n",
              "The left atrium and right atrium are normal in cavity size. No\n",
              "atrial septal defect is seen by 2D or color Doppler. Left\n",
              "ventricular wall thickness, cavity size and regional/global\n",
              "systolic function are normal (LVEF >55%). Right ventricular\n",
              "chamber size and free wall motion are normal. The diameters of\n",
              "aorta at the sinus, ascending and arch levels are normal. The\n",
              "aortic valve leaflets (3) appear structurally normal with good\n",
              "leaflet excursion and no aortic stenosis. No masses or\n",
              "vegetations are seen on the aortic valve. Mild (1+) aortic\n",
              "regurgitation is seen. The mitral valve appears structurally\n",
              "normal with trivial mitral regurgitation. There is no mitral\n",
              "valve prolapse. The estimated pulmonary artery systolic pressure\n",
              "is high normal. There is no pericardial effusion. IMPRESSION:\n",
              "Mild aortic regurgitation with normal valve morphology. Normal\n",
              "biventricular cavity sizes with preserved global and regional\n",
              "biventricular systolic function. If clinically indicated, a\n",
              "transesophageal echocardiographic examination is recommended to\n",
              "assess aortic valve morphology.  CLINICAL IMPLICATIONS: Based on\n",
              "[**2142**] AHA endocarditis prophylaxis recommendations, the echo\n",
              "findings indicate prophylaxis is NOT recommended. Clinical\n",
              "decisions regarding the need for prophylaxis should be based on\n",
              "clinical and echocardiographic data.\n",
              "\n",
              "[**2147-7-19**] Radiology MRI PELVIS W/O & W/CONT\n",
              "1. 3.6-cm lymph node in the left external iliac chain has\n",
              "features concerning for a necrotic lymph node with probable\n",
              "secondary infection (suppurative lymph node). An 1.8-cm lymph in\n",
              "the left common iliac chain has similar characteristics, and\n",
              "also is concerning for a suppurative lymph node. 2. Edema and\n",
              "swelling of the left iliacus and obturator internus muscles is\n",
              "suggesting of an ongoing inflammatory or infectious process. 3.\n",
              "Compression of the left external iliac artery and vein due to\n",
              "the enlarged external iliac chain lymph node without evidence of\n",
              "thrombus or occlusion. 4. Extensive pelvic and inguinal\n",
              "lymphadenopathy.\n",
              "\n",
              "[**2147-7-21**] Radiology US UPPER EXTREMITY, SOFT TISSUE NODULE\n",
              "IMPRESSION: Multiple subcutaneous soft tissue nodules in the\n",
              "right and left upper extremity, suggestive of lymphomatous\n",
              "deposits/ lymph nodes in the soft tissues. If desired, these can\n",
              "be FNAed/biopsied under imaging guidance.\n",
              "\n",
              "[**2147-7-24**] Radiology MR THIGH W&W/O CONTRAST\n",
              "1. Left inguinal lymphadenopathy, slightly progressed since the\n",
              "recent MRI one week ago. No new lesion identified, and no distal\n",
              "lymphadenopathy in the thigh. 2. Diffuse subcutaneous soft\n",
              "tissue swelling and edema is nonspecific but may represent\n",
              "lymphedema or cellulitis. Fluid tracks along the superficial\n",
              "fascia, but this is unlikely to represent fasciitis given the\n",
              "lack of fascial enhancement. Mild inter- and intramuscular edema\n",
              "representing mild myositis. 3. Diffuse patchy bone marrow signal\n",
              "abnormality likely represents red marrow, but osseous\n",
              "lymphomatous involvement is not excluded especially in the\n",
              "intertrochanteric regions bilaterally.\n",
              "\n",
              "[**2147-7-25**] Pathology Tissue: RIGHT ARM NODULE.\n",
              "Hematoma with early organization. No evidence of lymphoma.\n",
              "\n",
              "[**2147-7-27**] Radiology CT CHEST W/O CONTRAST\n",
              "IMPRESSION:  No findings to suggest pulmonary infection with\n",
              "unchanged prominent lymph nodes as above.\n",
              "\n",
              "[**2147-8-12**] Abdomen and Pelvis\n",
              "IMPRESSION:\n",
              "1.  Decreased size of left retroperitoneal lymph node\n",
              "conglomerates and\n",
              "bilateral inguinal lymphadenopathy.\n",
              "2.  Right nephrostomy tube and left nephroureteral stent\n",
              "appropriately\n",
              "positioned with interval resolution of bilateral hydronephrosis.\n",
              "\n",
              "[**2147-8-21**] Antegradge nephrogram\n",
              "IMPRESSION:\n",
              "1.  Left antegrade nephrostogram demonstrated brisk passage of\n",
              "contrast\n",
              "through the left ureter into the urinary bladder.  Mildly\n",
              "dilated left\n",
              "interpolar to lower pole calices, likely as a result of\n",
              "caliectasis.  No left\n",
              "UPJ obstruction.  Left NU stent was removed.\n",
              "2.  Right antegrade nephrostogram did not demonstrate\n",
              "hydroureteronephrosis.\n",
              "Brisk passage of contrast through the reter into the bladder.\n",
              "Right\n",
              "nephrostomy catheter was removed.\n",
              "\n",
              "\n",
              "----------\n",
              "MICRO:\n",
              "[**2147-7-5**] IMMUNOLOGY HCV VIRAL LOAD-FINAL -\n",
              "23,720,478 IU/mL.\n",
              "[**2147-7-8**] IMMUNOLOGY HIV-1 Viral\n",
              "Load/Ultrasensitive-FINAL HIV-1 RNA is not detected.\n",
              "[**2147-7-12**] STOOL C. difficile DNA amplification\n",
              "assay-FINAL -NEGATIVE\n",
              "----\n",
              "[**2147-7-19**] 9:46 am STOOL     CONSISTENCY: SOFT      Source: Stool.\n",
              "\n",
              "\n",
              "                            **FINAL REPORT [**2147-7-21**]**\n",
              "\n",
              "   C. difficile DNA amplification assay (Final [**2147-7-19**]):\n",
              "      Negative for toxigenic C. difficile by the Illumigene DNA\n",
              "      amplification assay.\n",
              "           (Reference Range-Negative).\n",
              "\n",
              "   FECAL CULTURE (Final [**2147-7-21**]):\n",
              "      NO ENTERIC GRAM NEGATIVE RODS FOUND.\n",
              "      NO SALMONELLA OR SHIGELLA FOUND.\n",
              "\n",
              "   CAMPYLOBACTER CULTURE (Final [**2147-7-21**]):    NO CAMPYLOBACTER\n",
              "FOUND.\n",
              "\n",
              "   Cryptosporidium/Giardia (DFA) (Final [**2147-7-21**]):\n",
              "      NO CRYPTOSPORIDIUM OR GIARDIA SEEN.\n",
              "---\n",
              "BLOOD CULTURES: 5/22,26,27 all negative. 6/4,5,6,7,8,9,13 all\n",
              "negative\n",
              "-----\n",
              "ECG - [**2147-7-31**]\n",
              "Sinus rhythm.  Precordial T wave inversions of uncertain\n",
              "significance. Since the previous tracing of [**2147-7-28**] ventricular\n",
              "premature beat is not seen, the  lateral T waves are improved,\n",
              "early precordial T wave abnormalities persist.\n",
              "  Intervals Axes\n",
              "Rate PR QRS QT/QTc P QRS T\n",
              "82 144 86 [**Telephone/Fax (2) 103899**] 35\n",
              "\n",
              "-------\n",
              "\n",
              "\n",
              "Brief Hospital Course:\n",
              "43 yoF with h/o hepatitis C, HTN, IV drug use, and recent\n",
              "diagnosis of follicular lymphoma who initially presented with\n",
              "acute obstructive renal failure (s/p HD and R nephrostomy and L\n",
              "nephroureteral stent) with course complicated by fevers and left\n",
              "necrotic iliac lymph nodes.\n",
              "\n",
              "# Follicular Lymphoma: Final pathology showed follicular\n",
              "lymphoma, follicular growth pattern, cytological grade 1 of 3.\n",
              "New subcutaneous nodules were concerning for lymphomatous\n",
              "transformation, supported by increasing LDH. Pt had an\n",
              "excisional biopsy of R upper extremity subcutaneous nodule by\n",
              "general surgery on [**2147-7-25**], but these only showed organizing\n",
              "hematoma, perhaps from prior drug use. Choices for treatment\n",
              "were initially limited by Pt's profound obstructive renal\n",
              "failure. Pt was treated with fludarabine D1-5, dose-reduced to\n",
              "50% normal and completed 2 cycles of R-CHOP when renal function\n",
              "resolved. [**2147-8-12**] CT abdomen showed interval improvement in\n",
              "retroperitoneal masses and improvement of bilateral\n",
              "hydronephrosis. Pt was discharged with acyclovir, fluconazole,\n",
              "and bactrim ss for ppx. She has an appointment with Oncologist\n",
              "Dr [**Last Name (STitle) 21628**] (ph:1-[**Telephone/Fax (1) 71494**] fax: [**Telephone/Fax (1) 83170**] address [**Last Name (NamePattern1) 103900**]. [**Hospital1 1474**], Mass) on [**9-11**].\n",
              "\n",
              "# Healthcare associated pneumonia: Patient presented with fever\n",
              "and infiltrate on CXR. Pt was treated with vancomycin and\n",
              "pip/tazo 4.5g iv q6h d1 = [**7-10**] for full 8 day course with\n",
              "complete resolution of symptoms and radiographic resolution on\n",
              "repeat CXR.\n",
              "\n",
              "# Acute renal failure/obstructive uropathy: Pt presented in\n",
              "profound obstructive renal failure with Cr 10.6 and potassium\n",
              "8.6. Pt was initally admitted to ICU, initially medically\n",
              "managed, then dialyzed and transferred to BMT service for\n",
              "further managment. Pt had uneventful placement of R nephrostomy\n",
              "tube and L nephro-ureteral stent placed by IR on [**2147-7-12**]. Pt had\n",
              "little urine output from L nephro-ureteral stent (~250mL over 16\n",
              "hrs) but plentiful urine output from R nephrostomy (~2.4L over\n",
              "16 hrs). L nephro-ureteral stent was capped per IR on [**2147-7-13**].\n",
              "Given rapid improvement in Cr, down to 2.5 on [**2147-7-13**] morning\n",
              "w/out dialysis, further decreasing to 2.0 on [**2147-7-14**], Pt's HD\n",
              "line was discontinued w/out issue. Pt's Cr continues to improve\n",
              "to 1.1 on [**2147-7-24**] and ultimately down to baseline. Repeat renal\n",
              "ultrasound showed complete resolution of L hydronephrosis and\n",
              "almost complete resolution of R hydronephrosis. R nephrostomy\n",
              "was capped on [**2147-7-27**], On [**2147-8-21**], pt had IR evaluate the\n",
              "nephrostomy tubes via nephrostogram which showed no obstruction\n",
              "of R or L ureter, the nephrostomy tube and stents were removed\n",
              "without complication.\n",
              "Patient with good UOP and creatinine of 1.1 at time of discharge\n",
              "\n",
              "# UTI. Patient with positive UA. Ucx + E.Coli. Patient placed on\n",
              "macrobid 100 mg twice per day with instruction to take thru\n",
              "[**2147-9-7**]\n",
              "# Hyperkalemia - Secondary to the acute renal failure, treated\n",
              "with Kayexalate, insulin, and calcium gluconate prior to\n",
              "initiation of HD. No e/o EKG changes. Resolved with HD. K at\n",
              "time of discharge 5.5\n",
              "\n",
              "# Altered mental status. Noted on admission. Differential\n",
              "diagnosis: uremia, hypoglycemia (although she was quite sleepy\n",
              "prior to getting insulin in the emergency room), accumulation of\n",
              "drugs including klonopin and dilaudid that she had been\n",
              "receiving due to her renal failure. Resolved with HD and\n",
              "mentating at baseline.\n",
              "\n",
              "# Chronic back pain / abdominal pain with possible\n",
              "radiculopathy. Pt is an active cocaine and heroin user.With\n",
              "initial pain consult evaluation, Pt was placed on hydromorphone\n",
              "IV, PO, and methadone, gabapentin, and lidocaine patch.  Pt was\n",
              "titrated to methadone 10mg po tid, hydromorphone to 4mg po q4hrs\n",
              "prn. QTc monitored and within normal limits. Pt was strongly\n",
              "opposed any effort to taper her pain medications but after pt\n",
              "was rejected by facilities for having a much too high daily\n",
              "dilaudid requirement, patient was willing to half her Dilaudid\n",
              "dose from 8mg to 4mg every 4 hours. Will need outpatient pain\n",
              "medication taper.\n",
              "\n",
              "# Anxiety / agitation: Very labile behavior with hypothesized\n",
              "underlying personality disorder per psych. Pt was started on\n",
              "divalproex 250 mg PO BID, olanzapine 5mg po tid standing per\n",
              "psychiatry; clonazepam 1 mg PO TID for anxiety and lorazepam 1mg\n",
              "po tid prn. These medications should be tapered as an\n",
              "outpatient. She will follow up with her primary care doctor\n",
              "after discharge.\n",
              "# Normocytic Anemia: Hct initially downtrending, hemolysis labs\n",
              "negative.  Nadir of 21.1 on [**2147-7-10**]. Likely related to\n",
              "underproduction in setting of underlying lymphoma/renal failure.\n",
              "Iron studies suggestive of anemia of chronic disease. No\n",
              "evidence of bleeding. HCT 26.8 on discharge.\n",
              "\n",
              "# HCV: HCV viral load 23 million. Pt has not been exposed to\n",
              "HBV. Pt's LFT have been normal. She will need outpatient\n",
              "hepatology follow up for active hepatitis C.\n",
              "\n",
              "# Drug abuse - Patient with current IV drug use. Pt was also\n",
              "using drugs in while hospitalized. Social work was consulted.\n",
              "Will need outpatient support program.  Patient will follow up\n",
              "with PCP and pain specialist.\n",
              "\n",
              "# Disposition issues: Pt was homeless prior to admission. Her\n",
              "husband is also at [**Name (NI) 10246**], and they had a significant\n",
              "altercation while at [**Hospital1 18**]. Patient has been barred from several\n",
              "shelters/rehabs due to issues with continued heroin abuse and\n",
              "altercations w/ other residents. Rejected by [**Hospital1 10246**], [**Hospital **]\n",
              "hospital, [**Doctor Last Name **] house. As patient did not meet inpatient\n",
              "criteria after lengthy discussion patient was discharged to live\n",
              "with a friend in [**Name (NI) 5110**], MA per her request.\n",
              "\n",
              "# Follow-up\n",
              "The patient will follow up with her PCP, [**Name10 (NameIs) **] [**Name (NI) 103901**] (ph:\n",
              "[**Telephone/Fax (1) 10216**] fax:[**Telephone/Fax (1) 103902**] address:64 Main [**Location (un) 103903**] Mass)on\n",
              "[**2147-8-28**].\n",
              "She will also meet with [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 12967**] for pain management.\n",
              "She will meet with Oncologist Dr [**Last Name (STitle) 21628**] in [**Hospital1 1474**] on [**9-11**], [**2147**].\n",
              "\n",
              "TRANSITIONAL ISSUES:\n",
              "-needs continued chemotherapy for treatment of lymphoma\n",
              "-will need outpatient hepatology follow up for active hepatitis\n",
              "C\n",
              "-will need referral to drug abuse cessation program\n",
              "-taper pain medications\n",
              "-taper sedatives including lorazepam, clonazepam\n",
              "\n",
              "Medications on Admission:\n",
              "Dilaudid 2-4mg PO q3h prn pain.\n",
              "multivitamin 1 tab daily\n",
              "fluconazole 100mg daily\n",
              "depakote 250mg [**Hospital1 **]\n",
              "ativan 0.5mg [**Hospital1 **] prn\n",
              "kayexalate 30mg PO once on [**7-4**]\n",
              "klonopin 1mg tid\n",
              "colace 100mg [**Hospital1 **]\n",
              "hydroxyzine 100mg qhs\n",
              "\n",
              "\n",
              "Discharge Medications:\n",
              "1. Scalp prosthesis\n",
              "Scalp Prosthesis\n",
              "Dispense: 1\n",
              "2. docusate sodium 100 mg capsule Sig: One (1) capsule PO BID (2\n",
              "times a day).\n",
              "3. senna 8.6 mg tablet Sig: 1-2 Tablets PO BID (2 times a day)\n",
              "as needed for constipation.\n",
              "4. clonazepam 1 mg tablet Sig: One (1) tablet PO TID (3 times a\n",
              "day): anxiety.\n",
              "Disp:*12 tablet(s)* Refills:*0*\n",
              "5. divalproex 250 mg tablet,delayed release (DR/EC) Sig: One (1)\n",
              "tablet,delayed release (DR/EC) PO BID (2 times a day).\n",
              "Disp:*30 tablet,delayed release (DR/EC)(s)* Refills:*0*\n",
              "6. fluconazole 200 mg tablet Sig: One (1) tablet PO Q24H (every\n",
              "24 hours).\n",
              "Disp:*30 tablet(s)* Refills:*0*\n",
              "7. hydroxyzine HCl 25 mg tablet Sig: Four (4) tablet PO at\n",
              "bedtime as needed for pruritis.\n",
              "Disp:*30 tablet(s)* Refills:*0*\n",
              "8. acyclovir 400 mg tablet Sig: One (1) tablet PO Q8H (every 8\n",
              "hours).\n",
              "Disp:*30 tablet(s)* Refills:*0*\n",
              "9. sulfamethoxazole-trimethoprim 400-80 mg tablet Sig: One (1)\n",
              "Tablet PO DAILY (Daily).\n",
              "Disp:*30 Tablet(s)* Refills:*0*\n",
              "10. olanzapine 5 mg tablet Sig: One (1) tablet PO TID (3 times a\n",
              "day).\n",
              "Disp:*15 tablet(s)* Refills:*0*\n",
              "11. lorazepam 0.5 mg tablet Sig: One (1) tablet PO twice a day\n",
              "as needed for anxiety.\n",
              "Disp:*8 tablet(s)* Refills:*0*\n",
              "12. nitrofurantoin monohyd/m-cryst 100 mg capsule Sig: One (1)\n",
              "capsule PO Q12H (every 12 hours): End date [**2147-9-7**].\n",
              "Disp:*30 capsule(s)* Refills:*0*\n",
              "13. hydromorphone 4 mg tablet Sig: One (1) tablet PO every [**5-19**]\n",
              "hours as needed for pain.\n",
              "Disp:*16 tablet(s)* Refills:*0*\n",
              "14. gabapentin 300 mg capsule Sig: One (1) capsule PO TID (3\n",
              "times a day).\n",
              "Disp:*30 capsule(s)* Refills:*0*\n",
              "15. allopurinol 100 mg tablet Sig: Two (2) tablet PO DAILY\n",
              "(Daily).\n",
              "Disp:*30 tablet(s)* Refills:*0*\n",
              "16. nicotine 14 mg/24 hr Patch 24 hr Sig: One (1)  Transdermal\n",
              "once a day: Do not use with tobacco.  If you are going to smoke,\n",
              "you must remove this patch due to risk of cardiovascular\n",
              "complications and death.\n",
              "Disp:*4 4* Refills:*2*\n",
              "\n",
              "\n",
              "Discharge Disposition:\n",
              "Home\n",
              "\n",
              "Discharge Diagnosis:\n",
              "Primary:\n",
              "pneumonia\n",
              "hyperkalemia, now resolved\n",
              "obstructive renal failure, now resolved\n",
              "follicular lymphoma\n",
              "\n",
              "Secondary:\n",
              "hepatitis C\n",
              "heroin use\n",
              "chronic back pain\n",
              "\n",
              "\n",
              "Discharge Condition:\n",
              "Mental Status: Clear and coherent.\n",
              "Level of Consciousness: Alert and interactive.\n",
              "Activity Status: Ambulatory - Independent.\n",
              "\n",
              "\n",
              "Discharge Instructions:\n",
              "Ms. [**Known lastname **],\n",
              "\n",
              "You were admitted to the hospital because you had leg swelling\n",
              "and shortness of breath. You were found to have a large mass in\n",
              "your abdomen, later discovered to be follicular lymphoma, a type\n",
              "of cancer. This mass compressed both of your ureters and caused\n",
              "your kidneys to fail. When you arrived, you had dangerous high\n",
              "levels of potassium in your blood. You were treated with\n",
              "hemodialysis, and your condition stabilized. You then received a\n",
              "urinary stent in your left kidney and a nephrostomy in your\n",
              "right kidney. Your left kidney did not show much improvement in\n",
              "function, likely due to the chronic nature of the urinary\n",
              "obstruction. Your right kidney recovered very well. You were\n",
              "treated with chemotherapy, and you responded well to the initial\n",
              "two cycles. You were also treated for a pneumonia and had a full\n",
              "recovery. Your left leg and abdomen remain swollen, likely due\n",
              "to blockage of lymphatic drainage systems by your cancer. This\n",
              "should improve as your cancer responds to the chemotherapy.  The\n",
              "kidney stent and kidney drain (nephrostomy) were removed and\n",
              "your kidney function has improved.\n",
              "\n",
              "Changes to your medications:\n",
              "To treat your pain, the following changes were made:\n",
              "Dilaudid 4 mg every 4-6 hours to treat pain\n",
              "Methadone will be dispensed at methadone clinic\n",
              "Gabapentin 300 mg three times per day\n",
              "**Do not take these medications while driving or drinking\n",
              "alcohol or using recreational drugs as these will cause sedation\n",
              "and possible death if used in combination\n",
              "**Please take stool softeners while taking narcotics because\n",
              "this can cause constipation**\n",
              "\n",
              "For smoking cessation, please take:\n",
              "Nicotine patch 14 mg, replace once daily\n",
              "** Do not take nicotine patch with cigarettes due to\n",
              "cardiovascular risk and possible death.\n",
              "\n",
              "To prevent infection, the following changes were made:\n",
              "fluconazole 200 mg daily\n",
              "acyclovir 400 mg every 8 hours\n",
              "bactrim single strength tablet daily\n",
              "\n",
              "To treat your urinary tract infection,\n",
              "macrobid 100 mg twice per day, please take through [**2147-9-7**]\n",
              "\n",
              "To treat your mood,\n",
              "continue on olanzapine 5 mg three times per day\n",
              "\n",
              "Please take all your other medications as prescribed.\n",
              "\n",
              "Followup Instructions:\n",
              "1) [**Hospital **] Clinic: 7 [**Hospital Ward Name 1826**] Outpatient Clinic @[**Hospital1 18**] Time: 12\n",
              "pm (noon) tomorrow [**8-24**]\n",
              "2) Dr. [**Last Name (STitle) **] (PCP): Monday [**8-28**] 2:00 pm\n",
              "[**Hospital1 1474**] Neighborhood Health\n",
              "[**Location (un) **] [**Hospital1 1474**], MA\n",
              "3) [**First Name5 (NamePattern1) **] [**Last Name (NamePattern1) 103904**] (pain management): will see at [**Hospital1 1474**]\n",
              "Neighborhood Health\n",
              "4) Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 21628**] (oncologist): [**9-11**]\n",
              "[**Hospital1 1474**] Neighborhood Health\n",
              "phone [**Telephone/Fax (1) 71494**]\n",
              "\n",
              "\n"
            ]
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# use displacy to visualize entities from TEXT\n",
        "\n",
        "from spacy import displacy\n",
        "\n",
        "displacy.render(nlp(nod_lymph_abd_filtered_df.iloc[0]['TEXT']), style=\"ent\", jupyter='True')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "70SgeELstrLQ",
        "outputId": "da3bb1bb-b527-40e4-e562-f266b72ed42c"
      },
      "execution_count": 17,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Admission Date:  [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]              Discharge Date:   [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-8-23\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br></br>Date of Birth:  [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2103-7-19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]             Sex:   F</br></br>Service: MEDICINE</br></br>Allergies:</br>No Known Allergies / Adverse Drug Reactions</br></br>Attending:[**Last Name (NamePattern1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4377\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br>Chief Complaint:</br>Left lower leg swelling</br></br>Major \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Surgical or Invasive Procedure\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>hemodialysis</br>left internal jugular hemodialysis catheter placement and</br>removal</br>right upper extremity PICC placement</br>chemotherapy: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1st\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " cycle fludarabine (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    50%\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
              "</mark>\n",
              " dose due to renal</br>function), \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2nd\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
              "</mark>\n",
              " cycle CHOP</br>R Nephrosotomy and \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    L\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " renal stent placement</br>R Nephrostomy and  L stent removal</br></br>History of Present Illness:</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    43\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " y.o women with a history of hepatitis C, recent lymph node</br>biopsy on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-6-9\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] at [**Hospital3 **] hospital who presents \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    today\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "</br>with left lower extremity redness and pain, who was then found</br>to have severe hyperkalemia and acute renal failure.</br></br>The patient recently was admitted to [**Hospital3 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    417\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**] hospital</br>from [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-6-9\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] to [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-6-13\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] for an elective excisional biopsy of</br>diffuse lymphadenopathy, most prominent in her left groin.</br>Based on limited records, her creatinine was \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    0.9\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " at that time.</br>She was then discharged from the hospital to a [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1501\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] due to</br>inability to ambulate, where she has been residing ever since.</br>\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Today\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              ", at the [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1501\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] her labs were checked and she was found to</br>have a K of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7.8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " and a creatinine of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9.9\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  The patient herself</br>reports that she feels that her urine output has been decreasing</br>lately along with some increased generalized edema.</br></br>In the \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ED\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", initial \n",
              "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    VS\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
              "</mark>\n",
              " were:  \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    98.9\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " 92 146/90 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    18 95%\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ".  On labs,</br>her K was \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8.6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " and her creatinine was \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10.6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". She was given \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10U\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " of</br>regular insulin and \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " amp of D50W for her hyperkalemia.  She was</br>also given a dose of vancomycin for a possible cellulitis.  A</br>left lower extremity ultrasound was negative for clot.  Other</br>notable labs include a uric acid level of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10.1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " and a phosphate</br>of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    6.7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Nephrology\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " was consulted and recommended that she be</br>admitted to the MICU for medical management of her hyperkalemia.</br> Her K after the above interventions dropped to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    6.3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ", and given</br>an EKG that did not show evidence of cardiac toxicity, dialysis</br>was not initiated.</br></br>On arrival to the \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MICU\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", patient's \n",
              "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    VS\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
              "</mark>\n",
              " were \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    97.4 79\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    118/82\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    15 98%\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
              "</mark>\n",
              "</br>on \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RA\n",
              "\n",
              "\n",
              "Past Medical History\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>Hepatitis C</br>hypertension</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Anxiety\n",
              "Depression\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>myocardial infarction</br>Bilateral lower extremity edema</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Irritable\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " bowel syndrome</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Hemorrhoids\n",
              "Heroin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " abuse</br>Borderline personality disorder</br></br>Social History:</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IVDA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    quit years ago\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " according to patient, during a search of</br>her belongings a significant amount of drug paraphenelia was</br>found including a spoon, wrapping papers, and syringes.  Current</br>1ppd smoker.  No EtOH.</br></br></br>\n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Family History\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              ":</br>NC</br></br>Physical Exam:</br>ADMISSION EXAM:</br>General: somlenent, no acute distress</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    HEENT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Sclera\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " anicteric, dry mucous membranes, PERRL</br>Neck: supple, \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    JVP\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " not elevated, mild left anterior cervical</br>lymphadenoapthy</br>CV: Regular rate and rhythm, normal S1 + S2, mild [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3-20\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**] mid</br>systolic murmur best heard at RUSB.</br>Lungs: Bibasilar crackles, R&gt;L</br>Abdomen: soft, non-distended, bowel sounds present, no</br>organomegaly, no tenderness to palpation, no rebound or</br>guarding.  Dressing at inguinal site c/d/i.  Significant</br>bilateral inguinal lymphadenopathy.</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    GU\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": foley  in place</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Ext: Warm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", well perfused, \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "+ pulses, significant bilateral \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    LE\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              "</br>edema \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Neuro\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": GCS 14, oriented \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    x3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", moving all \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " extremities,</br>otherwise unable to cooperate with neuro exam.</br></br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    DISCHARGE\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " EXAM:</br>General: alert, no acute distress</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    HEENT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Sclera\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " anicteric, dry mucous membranes, PERRL</br>Neck: supple, \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    JVP\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " not elevated</br>CV: Regular rate and rhythm, normal S1 + S2, no \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MRG\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>Lungs: CTAB</br>Abdomen: soft, slightly distended, bowel sounds present, no</br>organomegaly, no tenderness to palpation, no rebound or</br>guarding.</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    GU\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": nephrostomy stent and</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Ext: Warm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", well perfused, \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "+ pulses, \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "+ bilateral \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    LE\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " edema</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Neuro\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": alert and oriented x3, CN \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    II\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "-XII grossly intact, normal</br>gait, normal muscle tone and buk</br></br>Pertinent Results:</br>ADMISSION LABS:</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] 09:25PM BLOOD WBC-3.9* RBC-3.50* Hgb-9.4* Hct-30.2*</br>MCV-86 MCH-26.9* MCHC-31.2 RDW-13.0 Plt Ct-266</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    09:25PM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " BLOOD Neuts-66.6 Lymphs-23.2 Monos-8.5 Eos-1.5</br>Baso-0.1</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] 09:25PM BLOOD PT-10.0 PTT-30.9 INR(PT)-0.9</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    03:02AM BLOOD Ret Aut-1.2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
              "</mark>\n",
              "</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] 09:25PM BLOOD Glucose-80 UreaN-70* Creat-10.6* Na-135</br>K-8.6* Cl-98 \n",
              "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    HCO3-22\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
              "</mark>\n",
              " AnGap-24*</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] 09:25PM BLOOD CK(CPK)-169</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] 09:25PM BLOOD Calcium-9.0 Phos-6.7* Mg-3.2*</br>UricAcd-10.1*</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    07:01AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " BLOOD calTIBC-247* VitB12-578 Ferritn-200*</br>TRF-190*</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    03:02AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " BLOOD Osmolal-305</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    03:02AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " BLOOD Valproa-47*</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    09:25PM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG</br>Barbitr-NEG Tricycl-NEG</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] 09:49PM BLOOD Lactate-1.2</br></br>URINE:</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12:25AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    URINE Color-Straw Appear-Clear Sp\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " [**Last Name (un) **]-1.004</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12:25AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " URINE Blood-NEG Nitrite-NEG Protein-TR</br>Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-MOD</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12:25AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " URINE RBC-1 WBC-2 \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Bacteri-FEW Yeast-NONE\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " Epi-1</br>TransE-&lt;1</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12:25AM\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " URINE bnzodzp-NEG barbitr-NEG opiates-POS</br>cocaine-\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    NEG\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " amphetm-NEG mthdone-NEG</br></br>STUDIES:</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] Lower extremity ultrasound:</br>No DVT of the left lower extremity.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] CXR:</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Retrocardiac\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " opacity compatible with pneumonia or</br>atelectasis</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Prominence of the right hilus may be secondary to low lung</br>volumes or</br>hilar opacity.  Suggest follow up radiographs, ideally with</br>better</br>inspiration.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] CXR:</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Left IJ catheter in the mid \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    SVC\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ".</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Mild pulmonary edema.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3:26 PM #\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " [**\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Telephone/Fax\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103896\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]   CT CHEST, \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ABD &amp; PELVIS W/O\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " CON</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Infiltrative soft tissue mass surrounding the retroperitoneal</br>region, including the aorta, \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IVC\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", and presumably the ureters.</br>This is likely secondary to lymphoma and would be expected to be</br>the cause of the patient's bilateral renal obstruction. However,</br>given the cortical thinning on the left, this is likely a</br>chronic process. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Ground-glass opacities seen within the right</br>upper lobe and right middle lobe suggestive of atypical</br>infection. The typical consolidations seen with bacterial</br>pneumonia are not evident on this examination. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Bilateral</br>pleural effusions are moderate in size, slightly greater on the</br>right and on the left, with associated atelectasis.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12:20 PM #\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " [**Numeric Identifier 103897**] INTRO CATH RENAL</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Successful uncomplicated placement of a left-sided \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    French\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              "</br>x22 cm nephroureteral stent. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Successful uncomplicated</br>placement of an \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    French\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " nephrostomy tube in the right kidney.</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". A future study is recommended in [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3-17\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    weeks\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " to try to attempt</br>reconversion of the right-sided nephrostomy tube to a</br>nephroureteral stent and to try to further characterize the</br>filling defect seen in the right renal pelvis, which could be an</br>air bubble.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-18\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    11:23 AM #\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " [**\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Telephone/Fax\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103898\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]   RENAL \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    U.S.\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              "</br>IMPRESSION: Complete resolution of left hydronephrosis.</br>Near-complete resolution of right hydronephrosis with only</br>minimal residual hydronephrosis noted.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] Cardiovascular ECHO</br>The left atrium and right atrium are normal in cavity size. No</br>atrial septal defect is seen by 2D or color \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Doppler\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              ". Left</br>ventricular wall thickness, cavity size and regional/global</br>systolic function are normal (LVEF &gt;\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    55%\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
              "</mark>\n",
              "). Right ventricular</br>chamber size and free wall motion are normal. The diameters of</br>aorta at the sinus, ascending and arch levels are normal. The</br>aortic valve leaflets (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") appear structurally normal with good</br>leaflet excursion and no aortic stenosis. No masses or</br>vegetations are seen on the aortic valve. Mild (\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1+\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              ") aortic</br>regurgitation is seen. The mitral valve appears structurally</br>normal with trivial mitral regurgitation. There is no mitral</br>valve prolapse. The estimated pulmonary artery systolic pressure</br>is high normal. There is no pericardial effusion. IMPRESSION:</br>Mild aortic regurgitation with normal valve morphology. Normal</br>biventricular cavity sizes with preserved global and regional</br>biventricular systolic function. If clinically indicated, a</br>transesophageal echocardiographic examination is recommended to</br>assess aortic valve morphology.  CLINICAL IMPLICATIONS: Based on</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2142\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    AHA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " endocarditis prophylaxis recommendations, the echo</br>findings indicate prophylaxis is NOT recommended. Clinical</br>decisions regarding the need for prophylaxis should be based on</br>clinical and echocardiographic data.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] Radiology MRI PELVIS W/O &amp; W/CONT</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3.6-cm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " lymph node in the left external iliac chain has</br>features concerning for a necrotic lymph node with probable</br>secondary infection (suppurative lymph node). An \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1.8-cm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " lymph in</br>the left common iliac chain has similar characteristics, and</br>also is concerning for a suppurative lymph node. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Edema and</br>swelling of the left iliacus and obturator internus muscles is</br>suggesting of an ongoing inflammatory or infectious process. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".</br>Compression of the left external iliac artery and vein due to</br>the enlarged external iliac chain lymph node without evidence of</br>thrombus or occlusion. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4.\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " Extensive pelvic and inguinal</br>lymphadenopathy.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Radiology US UPPER EXTREMITY\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", SOFT TISSUE NODULE</br>IMPRESSION: Multiple subcutaneous soft tissue nodules in the</br>right and left upper extremity, suggestive of lymphomatous</br>deposits/ lymph nodes in the soft tissues. If desired, these can</br>be \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    FNAed\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "/biopsied under imaging guidance.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-24\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] Radiology MR THIGH W&amp;W/O CONTRAST</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Left inguinal lymphadenopathy, slightly progressed since the</br>recent MRI \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    one week ago\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              ". No new lesion identified, and no distal</br>lymphadenopathy in the thigh. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Diffuse subcutaneous soft</br>tissue swelling and edema is nonspecific but may represent</br>lymphedema or cellulitis. Fluid tracks along the superficial</br>fascia, but this is unlikely to represent fasciitis given the</br>lack of fascial enhancement. Mild inter- and intramuscular edema</br>representing mild \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    myositis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Diffuse patchy bone marrow signal</br>abnormality likely represents red marrow, but osseous</br>lymphomatous involvement is not excluded especially in the</br>intertrochanteric regions bilaterally.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-25\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Pathology Tissue\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": RIGHT ARM NODULE.</br>\n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Hematoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " with early organization. No evidence of lymphoma.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-27\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] Radiology CT CHEST W/O CONTRAST</br>IMPRESSION:  No findings to suggest pulmonary infection with</br>unchanged prominent lymph nodes as above.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-8-12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] Abdomen and \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Pelvis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              "</br>IMPRESSION:</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Decreased size of left retroperitoneal lymph node</br>conglomerates and</br>bilateral inguinal lymphadenopathy.</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Right nephrostomy tube and left nephroureteral stent</br>appropriately</br>positioned with interval resolution of bilateral hydronephrosis.</br></br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-8-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Antegradge\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " nephrogram</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IMPRESSION\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Left antegrade nephrostogram demonstrated brisk passage of</br>contrast</br>through the left ureter into the urinary bladder.  \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Mildly\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              "</br>dilated left</br>interpolar to lower pole calices, likely as a result of</br>caliectasis.  No left</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    UPJ\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " obstruction.  Left NU stent was removed.</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".  Right antegrade nephrostogram did not demonstrate</br>hydroureteronephrosis.</br>Brisk passage of contrast through the reter into the bladder.</br>Right</br>nephrostomy catheter was removed.</br></br></br>----------</br>MICRO:</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] IMMUNOLOGY HCV VIRAL LOAD-FINAL -</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    23,720,478\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " IU/mL.</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] IMMUNOLOGY HIV-1 Viral</br>Load/Ultrasensitive-FINAL HIV-1 RNA is not detected.</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] STOOL C. difficile DNA amplification</br>assay-FINAL -NEGATIVE</br>----</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9:46 am\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " STOOL     CONSISTENCY: SOFT      Source: Stool.</br></br></br>                            **FINAL REPORT [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]**</br></br>   C. difficile DNA amplification assay (Final [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]):</br>      Negative for toxigenic C. difficile by the Illumigene DNA</br>      amplification assay.</br>           (Reference Range-Negative).</br></br>   FECAL CULTURE (Final [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]):</br>      NO ENTERIC GRAM NEGATIVE RODS FOUND.</br>      NO SALMONELLA OR \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    SHIGELLA FOUND\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              ".</br></br>   CAMPYLOBACTER CULTURE (Final [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]):    NO CAMPYLOBACTER</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    FOUND\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ".</br></br>   \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Cryptosporidium/Giardia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (DFA) (Final [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]):</br>      NO CRYPTOSPORIDIUM OR GIARDIA SEEN.</br>---</br>BLOOD CULTURES: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5/22,26,27\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " all negative. \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    6/4,5,6,7,8,9,13\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " all</br>negative</br>-----</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ECG\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " - [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-31\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br>Sinus rhythm.  Precordial T wave inversions of uncertain</br>significance. Since the previous tracing of [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-28\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] ventricular</br>premature beat is not seen, the  lateral T waves are improved,</br>early precordial T wave abnormalities persist.</br>  Intervals Axes</br>Rate PR \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    QRS QT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              "/QTc P QRS T</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    82 144 86\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " [**\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Telephone/Fax\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (2) 103899**] \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    35\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "</br></br>-------</br></br></br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Brief Hospital Course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>43 yoF with h/o hepatitis \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    C, HTN\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IV\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " drug use, and recent</br>diagnosis of follicular lymphoma who initially presented with</br>acute obstructive renal failure (s/p HD and R nephrostomy and \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    L\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>nephroureteral stent) with course complicated by fevers and left</br>necrotic iliac lymph nodes.</br></br># Follicular Lymphoma: Final pathology showed follicular</br>lymphoma, follicular growth pattern, cytological grade \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ".</br>New subcutaneous nodules were concerning for lymphomatous</br>transformation, supported by increasing LDH. Pt had an</br>excisional biopsy of R upper extremity subcutaneous nodule by</br>general surgery on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-25\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], but these only showed organizing</br>hematoma, perhaps from prior drug use. Choices for treatment</br>were initially limited by Pt's profound obstructive renal</br>failure. Pt was treated with fludarabine \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    D1-5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              ", dose-reduced to</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    50%\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
              "</mark>\n",
              " normal and completed \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " cycles of R-CHOP when renal function</br>resolved. [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-8-12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] CT abdomen showed interval improvement in</br>retroperitoneal masses and improvement of bilateral</br>hydronephrosis. Pt was discharged with acyclovir, fluconazole,</br>and bactrim ss for ppx. She has an appointment with \n",
              "<mark class=\"entity\" style=\"background: #f0d0ff; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Oncologist\n",
              "Dr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">WORK_OF_ART</span>\n",
              "</mark>\n",
              " [**Last Name (STitle) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    21628\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] (ph:1-[**Telephone/Fax (1) 71494**] fax: [**\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Telephone/Fax\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (1) 83170**] address [**Last Name (NamePattern1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103900\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]. [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1474\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], Mass) on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9-11\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**].</br></br># \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Healthcare\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " associated pneumonia: Patient presented with fever</br>and infiltrate on \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    CXR\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ". Pt was treated with vancomycin and</br>pip/tazo 4.5g iv q6h d1 = [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7-10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**] for full 8 day course with</br>complete resolution of symptoms and radiographic resolution on</br>repeat CXR.</br></br># \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Acute\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " renal failure/obstructive uropathy: Pt presented in</br>profound obstructive renal failure with \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Cr 10.6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " and potassium</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8.6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Pt was initally admitted to \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ICU\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", initially medically</br>managed, then dialyzed and transferred to \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    BMT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " service for</br>further managment. Pt had uneventful placement of R nephrostomy</br>tube and \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    L\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " nephro-ureteral stent placed by \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IR\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]. Pt had</br>little urine output from \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    L\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " nephro-ureteral stent (~250mL over \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    16\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "</br>hrs) but plentiful urine output from R nephrostomy (\n",
              "<mark class=\"entity\" style=\"background: #9cc9cc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ~2.4L\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">FAC</span>\n",
              "</mark>\n",
              " over</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    16\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " hrs). L nephro-ureteral stent was capped per \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IR\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-13\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**].</br>Given rapid improvement in \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Cr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              ", down to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2.5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-13\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    morning\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              "</br>w/out dialysis, further decreasing to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2.0\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-14\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], Pt's HD</br>line was discontinued w/out issue. Pt's \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Cr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " continues to improve</br>to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1.1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-24\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] and ultimately down to baseline. Repeat renal</br>ultrasound showed complete resolution of \n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    L\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " hydronephrosis and</br>almost complete resolution of R hydronephrosis. R nephrostomy</br>was capped on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-27\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], On [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-8-21\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], pt had \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IR\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " evaluate the</br>nephrostomy tubes via nephrostogram which showed no obstruction</br>of R or L ureter, the nephrostomy tube and stents were removed</br>without complication.</br>Patient with good \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    UOP\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " and creatinine of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1.1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " at time of discharge</br></br># \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    UTI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ". Patient with positive \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    UA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ". Ucx + E.Coli. Patient placed on</br>macrobid \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg twice per day with instruction to take thru</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-9-7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    # Hyperkalemia - Secondary\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">MONEY</span>\n",
              "</mark>\n",
              " to the acute renal failure, treated</br>with \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Kayexalate\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", insulin, and calcium gluconate prior to</br>initiation of HD. No e/o EKG changes. Resolved with HD. K at</br>time of discharge \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5.5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "</br></br># Altered mental status. Noted on admission. Differential</br>diagnosis: uremia, hypoglycemia (although she was quite sleepy</br>prior to getting insulin in the emergency room), accumulation of</br>drugs including klonopin and dilaudid that she had been</br>receiving due to her renal failure. Resolved with HD and</br>mentating at baseline.</br></br># Chronic back pain / abdominal pain with possible</br>radiculopathy. Pt is an active cocaine and heroin user.With</br>initial pain consult evaluation, Pt was placed on hydromorphone</br>\n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IV\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", and methadone, \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    gabapentin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              ", and lidocaine patch.  Pt was</br>titrated to methadone \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg po tid, hydromorphone to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg po q4hrs</br>prn. QTc monitored and within normal limits. Pt was strongly</br>opposed any effort to taper her pain medications but after pt</br>was rejected by facilities for having a much too high \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "</br>dilaudid requirement, patient was willing to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    half\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " her Dilaudid</br>dose from \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg to \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    every 4 hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              ". Will need outpatient pain</br>medication taper.</br></br># Anxiety / agitation: Very labile behavior with hypothesized</br>underlying personality disorder per psych. Pt was started on</br>divalproex \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    250\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO BID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ", olanzapine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg po tid standing per</br>psychiatry; clonazepam \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO TID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " for anxiety and lorazepam \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg</br>po tid prn. These medications should be tapered as an</br>outpatient. She will follow up with her primary care doctor</br>after discharge.</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    # Normocytic Anemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">MONEY</span>\n",
              "</mark>\n",
              ": Hct initially downtrending, hemolysis labs</br>negative.  \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Nadir\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    21.1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-7-10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]. Likely related to</br>underproduction in setting of underlying lymphoma/renal failure.</br>Iron studies suggestive of anemia of chronic disease. No</br>evidence of bleeding. HCT 26.8 on discharge.</br></br># HCV: HCV viral load \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    23 million\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Pt has not been exposed to</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    HBV\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ". Pt's \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    LFT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " have been normal. She will need outpatient</br>hepatology follow up for active hepatitis \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    C.\n",
              "\n",
              "# Drug\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " abuse - Patient with current \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IV\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              " drug use. Pt was also</br>using drugs in while hospitalized. Social work was consulted.</br>Will need outpatient support program.  Patient will follow up</br>with PCP and pain specialist.</br></br># Disposition issues: Pt was homeless prior to admission. Her</br>husband is also at [**Name (NI) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10246\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], and they had a significant</br>altercation while at [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    18\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**]. Patient has been barred from several</br>shelters/rehabs due to issues with continued heroin abuse and</br>altercations w/ other residents. Rejected by [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10246\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], [**Hospital **]</br>hospital, [**Doctor Last Name **] house. As patient did not meet inpatient</br>criteria after lengthy discussion patient was discharged to live</br>with a friend in [**Name (NI) 5110**], \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " per her request.</br></br># Follow-up</br>The patient will follow up with her PCP, [**Name10 (NameIs) **] [**Name (NI) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103901\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] (ph:</br>[**\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Telephone/Fax\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (1) 10216**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    fax:[**Telephone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "/Fax (1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103902\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] address:64 \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Main\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " [**Location (\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    un\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ") \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103903\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Mass)on\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>[**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-8-28\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**].</br>She will also meet with [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12967\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] for pain management.</br>She will meet with \n",
              "<mark class=\"entity\" style=\"background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Oncologist Dr\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LOC</span>\n",
              "</mark>\n",
              " [**Last Name (STitle) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    21628\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] in [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1474\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] on [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9-11\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**].</br></br>TRANSITIONAL ISSUES:</br>-needs continued chemotherapy for treatment of lymphoma</br>-will need outpatient hepatology follow up for active hepatitis</br>C</br>-will need referral to drug abuse cessation program</br>-taper pain medications</br>-taper sedatives including lorazepam, clonazepam</br></br>Medications on Admission:</br>Dilaudid \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "-4mg \n",
              "<mark class=\"entity\" style=\"background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO q3h\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LOC</span>\n",
              "</mark>\n",
              " prn pain.</br>multivitamin \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " tab daily</br>fluconazole \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "</br>depakote \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    250\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg [**Hospital1 **]</br>ativan \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    0.5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg [**Hospital1 **] prn</br>kayexalate \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    30\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " once on [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "-4**]</br>klonopin \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg tid</br>colace \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg [**Hospital1 **]</br>hydroxyzine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "mg qhs</br></br></br>Discharge Medications:</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". Scalp prosthesis</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Scalp Prosthesis\n",
              "Dispense\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "</br>2. docusate sodium \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg capsule Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") capsule \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO BID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "</br>times a day).</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". senna \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8.6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "-2 Tablets PO BID (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " times a day)</br>as needed for constipation.</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". clonazepam \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO TID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " times a</br>day): anxiety.</br>Disp:*12 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". divalproex \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    250\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet,delayed release (\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    DR/EC) Sig:\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ")</br>tablet,delayed release (\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    DR/EC\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ") \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO BID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " times a day).</br>Disp:*30 tablet,delayed release (\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    DR/EC)(s\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ")* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    6\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". fluconazole \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    200\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO Q24H\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (every</br>\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    24 hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              ").</br>Disp:*30 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hydroxyzine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " HCl \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    25\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Four\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (4) tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " at</br>bedtime as needed for pruritis.</br>Disp:*30 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    acyclovir 400\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " Q8H (every \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              ").</br>Disp:*30 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". sulfamethoxazole-trimethoprim \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    400-80\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ")</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet PO DAILY\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (Daily).</br>Disp:*30 \n",
              "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet(s\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
              "</mark>\n",
              ")* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    10\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". olanzapine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO TID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " times a</br>day).</br>Disp:*15 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    11\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". lorazepam \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    0.5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " twice a day</br>as needed for anxiety.</br>\n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Disp:*8 tablet(s\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              ")* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    nitrofurantoin monohyd\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "/m-cryst \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg capsule Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ")</br>capsule \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO Q12H\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    every 12 hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              "): End date [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-9-7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**].</br>Disp:*30 capsule(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    13\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". hydromorphone \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " every [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5-19\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**]</br>hours as needed for pain.</br>Disp:*16 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    14\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". gabapentin \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    300\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg capsule Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") capsule \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO TID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "</br>times a day).</br>Disp:*30 capsule(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    15\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". allopurinol \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg tablet Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Two\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (2) tablet \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO DAILY\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>(\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ").</br>Disp:*30 tablet(s)* Refills:*0*</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    16\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ". nicotine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    14 mg/24\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">QUANTITY</span>\n",
              "</mark>\n",
              " hr Patch 24 hr Sig: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    One\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " (1)  Transdermal</br>once a day: Do not use with tobacco.  If you are going to smoke,</br>you must remove this patch due to risk of cardiovascular</br>complications and death.</br>Disp:*4 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "* Refills:*2*</br></br></br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Discharge Disposition\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>Home</br></br>Discharge Diagnosis:</br>Primary:</br>pneumonia</br>hyperkalemia, now resolved</br>obstructive renal failure, now resolved</br>follicular lymphoma</br></br>Secondary:</br>hepatitis C</br>heroin use</br>chronic back pain</br></br></br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Discharge Condition\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>Mental Status: Clear and coherent.</br>Level of Consciousness: Alert and interactive.</br>Activity Status: \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Ambulatory - Independent\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ".</br></br></br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Discharge Instructions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ":</br>Ms. [**Known lastname **],</br></br>You were admitted to the hospital because you had leg swelling</br>and shortness of breath. You were found to have a large mass in</br>your abdomen, later discovered to be follicular lymphoma, a type</br>of cancer. This mass compressed both of your ureters and caused</br>your kidneys to fail. When you arrived, you had dangerous high</br>levels of potassium in your blood. You were treated with</br>hemodialysis, and your condition stabilized. You then received a</br>urinary stent in your left kidney and a nephrostomy in your</br>right kidney. Your left kidney did not show much improvement in</br>function, likely due to the chronic nature of the urinary</br>obstruction. Your right kidney recovered very well. You were</br>treated with chemotherapy, and you responded well to the initial</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    two\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " cycles. You were also treated for a pneumonia and had a full</br>recovery. Your left leg and abdomen remain swollen, likely due</br>to blockage of lymphatic drainage systems by your cancer. This</br>should improve as your cancer responds to the chemotherapy.  The</br>kidney stent and kidney drain (nephrostomy) were removed and</br>your kidney function has improved.</br></br>Changes to your medications:</br>To treat your pain, the following changes were made:</br>Dilaudid \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg every \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4-6 hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " to treat pain</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Methadone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " will be dispensed at \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    methadone clinic\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>Gabapentin 300 mg \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    three\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " times per day</br>**Do not take these medications while driving or drinking</br>alcohol or using recreational drugs as these will cause sedation</br>and possible death if used in combination</br>**Please take stool softeners while taking narcotics because</br>this can cause constipation**</br></br>For smoking cessation, please take:</br>\n",
              "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Nicotine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
              "</mark>\n",
              " patch \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    14\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg, replace once \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "</br>** Do not take nicotine patch with cigarettes due to</br>cardiovascular risk and possible death.</br></br>To prevent infection, the following changes were made:</br>fluconazole \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    200\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg daily</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    acyclovir 400\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    every 8 hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              "</br>bactrim single strength tablet \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "</br></br>To treat your urinary tract infection,</br>macrobid \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    100\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg twice per day, please take through [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2147-9-7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br></br>To treat your mood,</br>continue on olanzapine \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " mg \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    three\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " times per day</br></br>Please take all your other medications as prescribed.</br></br>Followup Instructions:</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") [**Hospital **] Clinic: \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              " [**Hospital Ward Name \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1826\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Outpatient Clinic\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " @[**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    18\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Time\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    12\n",
              "pm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    noon\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              ") \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tomorrow\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "-24**]</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") Dr. [**Last Name (STitle) **] (PCP): \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Monday\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              " [**\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              "-28**] \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2:00 pm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
              "</mark>\n",
              "</br>[**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1474\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Neighborhood Health\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>[**Location (un) **] [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1474\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**], \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MA\n",
              "3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              ") [**First Name5 (NamePattern1) **] [**Last Name (NamePattern1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    103904\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] (pain management): will see at [**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1474\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br>\n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Neighborhood Health\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>\n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
              "</mark>\n",
              ") Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    21628\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] (oncologist): [**\n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    9-11\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**]</br>[**Hospital1 \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    1474\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "**] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Neighborhood Health\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              "</br>phone [**Telephone/Fax (1) 71494**]</br></br></br></br></div></span>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Load SciSpacy NLP with en_core_sci_md\n",
        "\n",
        "#!pip install scispacy\n",
        "#!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.5.1/en_core_sci_md-0.5.1.tar.gz\n",
        "\n",
        "import scispacy\n",
        "import spacy\n",
        "\n",
        "nlp = spacy.load(\"en_core_sci_md\")\n"
      ],
      "metadata": {
        "id": "9tiiQGT-vBAV"
      },
      "execution_count": 26,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Filter lymphoma_summary_df by ICD9_code = 20206\n",
        "\n",
        "# Filter for ICD9_CODE 20206\n",
        "nod_lymph_pelvic_filtered_df = lymphoma_summary_df[lymphoma_summary_df['ICD9_CODE'] == 20206]\n",
        "print(nod_lymph_pelvic_filtered_df.head())\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "gx4gCHzGzX7r",
        "outputId": "0836c17a-4129-4868-c72e-4cb93d9bf75d"
      },
      "execution_count": 29,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "   ICD9_CODE              SHORT_TITLE  SUBJECT_ID  HADM_ID  \\\n",
            "6      20206  Nodular lymphoma pelvic       73693   177173   \n",
            "\n",
            "                                                TEXT  \n",
            "6  Admission Date:  [**2195-10-14**]             ...  \n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# create functions to extract tokens and entities using SciSpacy library\n",
        "\n",
        "def extract_entities_scispacy(text):\n",
        "    doc = nlp(text)\n",
        "    entities = []\n",
        "    for ent in doc.ents:\n",
        "        entities.append((ent.text, ent.label_))\n",
        "        print(ent.text, ent.start_char, ent.end_char, ent.label_)\n",
        "    print(\"*********************************************************\")\n",
        "    return doc\n",
        "\n",
        "def extract_tokens_scispacy(text):\n",
        "    doc = nlp(text)\n",
        "    tokens = []\n",
        "    for token in doc:\n",
        "        # Remove punctuation and special characters\n",
        "        token_text = re.sub(r'[^\\w\\s]', '', token.text)\n",
        "        # Convert to lowercase\n",
        "        token_text = token_text.lower()\n",
        "        # Remove stop words and numbers\n",
        "        if token_text and not token.is_stop and not token.is_punct and not token.like_num:\n",
        "            tokens.append(token_text)\n",
        "    return tokens\n"
      ],
      "metadata": {
        "id": "ShMmtKda0Qdy"
      },
      "execution_count": 30,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#apply tokenization to nod_lymph_pelvic_filtered_df column\n",
        "\n",
        "nod_lymph_pelvic_filtered_df['tokens'] = nod_lymph_pelvic_filtered_df['TEXT'].apply(extract_tokens_scispacy)\n",
        "print(nod_lymph_pelvic_filtered_df.head())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_MubD3Nv0hDx",
        "outputId": "555f6f18-af95-451f-ad8a-52d762aae7a1"
      },
      "execution_count": 35,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "   ICD9_CODE              SHORT_TITLE  SUBJECT_ID  HADM_ID  \\\n",
            "6      20206  Nodular lymphoma pelvic       73693   177173   \n",
            "\n",
            "                                                TEXT  \\\n",
            "6  Admission Date:  [**2195-10-14**]             ...   \n",
            "\n",
            "                                              tokens  \n",
            "6  [admission, date,  ,              , discharge,...  \n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-35-1f308a7510f4>:3: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  nod_lymph_pelvic_filtered_df['tokens'] = nod_lymph_pelvic_filtered_df['TEXT'].apply(extract_tokens_scispacy)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "extract_entities_scispacy(nod_lymph_pelvic_filtered_df.iloc[0]['TEXT'])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "GmRO0C2W1k1C",
        "outputId": "83d52f20-372b-4f60-b4a0-e1d653f82657"
      },
      "execution_count": 37,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Admission 0 9 ENTITY\n",
            "Sex 127 130 ENTITY\n",
            "Allergies 176 185 ENTITY\n",
            "Adverse 188 195 ENTITY\n",
            "Drug Reactions 196 210 ENTITY\n",
            "Name3 231 236 ENTITY\n",
            "LF 238 240 ENTITY\n",
            "Surgical 282 290 ENTITY\n",
            "Invasive Procedure:\n",
            "Left parietal mass 294 332 ENTITY\n",
            "History 342 349 ENTITY\n",
            "Patient 370 377 ENTITY\n",
            "year 386 390 ENTITY\n",
            "woman 395 400 ENTITY\n",
            "**Hospital1 18**] 418 435 ENTITY\n",
            "evaluation 440 450 ENTITY\n",
            "minute 468 474 ENTITY\n",
            "post-ictal 529 539 ENTITY\n",
            "EMS 545 548 ENTITY\n",
            "arrival 549 556 ENTITY\n",
            "reponding 569 578 ENTITY\n",
            "commands 586 594 ENTITY\n",
            "airway 618 624 ENTITY\n",
            "**Hospital1 18**] 650 667 ENTITY\n",
            "ER 696 698 ENTITY\n",
            "evaluated 711 720 ENTITY\n",
            "seizure 737 744 ENTITY\n",
            "CT 756 758 ENTITY\n",
            "head 766 770 ENTITY\n",
            "left parietal brain lesion 785 811 ENTITY\n",
            "neurosurgery 816 828 ENTITY\n",
            "consulted 833 842 ENTITY\n",
            "consult 865 872 ENTITY\n",
            "patient 880 887 ENTITY\n",
            "intubated 896 905 ENTITY\n",
            "sedated 910 917 ENTITY\n",
            "airway 922 928 ENTITY\n",
            "protection 929 939 ENTITY\n",
            "patients 982 990 ENTITY\n",
            "intubation 998 1008 ENTITY\n",
            "Nodular Lymphoma 1089 1105 ENTITY\n",
            "pelvis 1123 1129 ENTITY\n",
            "XRT 1135 1138 ENTITY\n",
            "remission\n",
            "Hypertension\n",
            "Hyperlipidemia\n",
            "CKD 1143 1184 ENTITY\n",
            "baseline 1186 1194 ENTITY\n",
            "creat 1195 1200 ENTITY\n",
            "Anemia 1209 1215 ENTITY\n",
            "unclear 1217 1224 ENTITY\n",
            "etiology 1225 1233 ENTITY\n",
            "labs 1254 1258 ENTITY\n",
            "BMB 1260 1263 ENTITY\n",
            "GI 1265 1267 ENTITY\n",
            "neg 1272 1275 ENTITY\n",
            "pelvic mass/metrorrhagia '[**85**]\n",
            "Thyroiditis\n",
            "\n",
            " 1316 1364 ENTITY\n",
            "Social History:\n",
            " 1364 1380 ENTITY\n",
            "patient 1384 1391 ENTITY\n",
            "**Location 669**] 1402 1419 ENTITY\n",
            "Husband 1429 1436 ENTITY\n",
            "son 1441 1444 ENTITY\n",
            "Cafeteria 1469 1478 ENTITY\n",
            "[**Location 1486 1497 ENTITY\n",
            "daily 1555 1560 ENTITY\n",
            "years 1566 1571 ENTITY\n",
            "Mother 1590 1596 ENTITY\n",
            "Died 1599 1603 ENTITY\n",
            "age 1604 1607 ENTITY\n",
            "CAD 1616 1619 ENTITY\n",
            "Father 1620 1626 ENTITY\n",
            "Died 1629 1633 ENTITY\n",
            "no 1664 1666 ENTITY\n",
            "family history 1667 1681 ENTITY\n",
            "Gastrointestinal disease 1685 1709 ENTITY\n",
            "intubated 1746 1755 ENTITY\n",
            "sedated\n",
            "HEENT 1757 1770 ENTITY\n",
            "Pupils 1772 1778 ENTITY\n",
            "EOMs 1788 1792 ENTITY\n",
            "Lungs 1824 1829 ENTITY\n",
            "CTA 1831 1834 ENTITY\n",
            "bilaterally 1835 1846 ENTITY\n",
            "RRR 1857 1860 ENTITY\n",
            "NT 1880 1882 ENTITY\n",
            "BS+\n",
            "Extrem 1884 1894 ENTITY\n",
            "Warm 1896 1900 ENTITY\n",
            "well-perfused 1905 1918 ENTITY\n",
            "intuabted 1942 1951 ENTITY\n",
            "sedated 1953 1960 ENTITY\n",
            "Orientation 1974 1985 ENTITY\n",
            "assess 2024 2030 ENTITY\n",
            "Cranial Nerves 2032 2046 ENTITY\n",
            "Pupils 2066 2072 ENTITY\n",
            "round 2081 2086 ENTITY\n",
            "reactive to light 2091 2108 ENTITY\n",
            "bilaterally 2121 2132 ENTITY\n",
            "IV 2139 2141 ENTITY\n",
            "VI 2143 2145 ENTITY\n",
            "assess 2157 2163 ENTITY\n",
            "assess 2182 2188 ENTITY\n",
            "assess 2205 2211 ENTITY\n",
            "assess 2229 2235 ENTITY\n",
            "assess 2274 2280 ENTITY\n",
            "assess 2296 2302 ENTITY\n",
            "MAE\n",
            "\n",
            " 2311 2316 ENTITY\n",
            "Sensation 2316 2325 ENTITY\n",
            "assess 2337 2343 ENTITY\n",
            "bilaterally\n",
            "\n",
            "Coordination 2360 2385 ENTITY\n",
            "assess 2397 2403 ENTITY\n",
            "rounded 2462 2469 ENTITY\n",
            "hypodensity 2470 2481 ENTITY\n",
            "left\n",
            "parietooccipital region 2489 2517 ENTITY\n",
            "intra-axial\n",
            "mass with 2544 2565 ENTITY\n",
            "edema 2566 2571 ENTITY\n",
            "MRI 2585 2588 ENTITY\n",
            "cystic mass 2627 2638 ENTITY\n",
            "mural nodule\n",
            "\n",
            "[**10-15**] CT Torso 2663 2697 ENTITY\n",
            "Scattered 2725 2734 ENTITY\n",
            "enlarged 2735 2743 ENTITY\n",
            "head 2786 2790 ENTITY\n",
            "Hypoattenuating left parietal lesion 2792 2828 ENTITY\n",
            "neoplasm 2863 2871 ENTITY\n",
            "Narrowing 2873 2882 ENTITY\n",
            "left supraclinoid 2886 2903 ENTITY\n",
            "Postop 2922 2928 ENTITY\n",
            "Post-surgical 2941 2954 ENTITY\n",
            "left parietal\n",
            "craniotomy 2968 2992 ENTITY\n",
            "mild frontoparietal pneumocephalus 3003 3037 ENTITY\n",
            "hemorrhage 3054 3064 ENTITY\n",
            "subcutaneous air 3069 3085 ENTITY\n",
            "No sign 3121 3128 ENTITY\n",
            "transtentorial 3132 3146 ENTITY\n",
            "tonsillar\n",
            "herniation 3150 3170 ENTITY\n",
            "hemorrhage 3178 3188 ENTITY\n",
            "surgical bed 3204 3216 ENTITY\n",
            "evidence 3220 3228 ENTITY\n",
            "acute large territorial infarction 3232 3266 ENTITY\n",
            "Postop MRI 3281 3291 ENTITY\n",
            "foci 3332 3336 ENTITY\n",
            "inferior margin 3371 3386 ENTITY\n",
            "left\n",
            "occipitoparietal surgical cavity 3394 3431 ENTITY\n",
            "Recommend 3433 3442 ENTITY\n",
            "follow-up 3453 3462 ENTITY\n",
            "enhancing 3479 3488 ENTITY\n",
            "lesion 3489 3495 ENTITY\n",
            "left precentral cortex 3503 3525 ENTITY\n",
            "slow diffusion 3531 3545 ENTITY\n",
            "signal 3565 3571 ENTITY\n",
            "characteristics 3572 3587 ENTITY\n",
            "resected 3595 3603 ENTITY\n",
            "mass 3611 3615 ENTITY\n",
            "RBC-3.04* Hgb-9.2* Hct-27.3* MCV-90 3667 3702 ENTITY\n",
            "Ct-184\n",
            "Glucose-88 3707 3724 ENTITY\n",
            "UreaN-20 3725 3733 ENTITY\n",
            "Na-138 3744 3750 ENTITY\n",
            "K-3.8 3751 3756 ENTITY\n",
            "**] 3824 3827 ENTITY\n",
            "**Known lastname 3829 3845 ENTITY\n",
            "intubated 3860 3869 ENTITY\n",
            "emergency department 3877 3897 ENTITY\n",
            "control 3910 3917 ENTITY\n",
            "admitted 3922 3930 ENTITY\n",
            "Neurosurgery service 3938 3958 ENTITY\n",
            "Q1\n",
            "hour 3963 3970 ENTITY\n",
            "neuro checks 3971 3983 ENTITY\n",
            "Dilantin 4007 4015 ENTITY\n",
            "seizures 4020 4028 ENTITY\n",
            "MRI 4030 4033 ENTITY\n",
            "left posterior temporal lobe 4120 4148 ENTITY\n",
            "metastatic 4174 4184 ENTITY\n",
            "multiple 4206 4214 ENTITY\n",
            "enlarged 4215 4223 ENTITY\n",
            "scattered 4224 4233 ENTITY\n",
            "necrotic lymph nodes 4238 4258 ENTITY\n",
            "intubated 4288 4297 ENTITY\n",
            "OR 4334 4336 ENTITY\n",
            "resection\n",
            "of her 4341 4357 ENTITY\n",
            "lesion 4358 4364 ENTITY\n",
            "MRI 4377 4380 ENTITY\n",
            "CTA 4396 4399 ENTITY\n",
            "operative\n",
            "planning 4404 4422 ENTITY\n",
            "operating room 4444 4458 ENTITY\n",
            "resection 4463 4472 ENTITY\n",
            "afternoon 4480 4489 ENTITY\n",
            "transferred\n",
            "intubated 4531 4552 ENTITY\n",
            "ICU 4560 4563 ENTITY\n",
            "post 4570 4574 ENTITY\n",
            "operative course 4575 4591 ENTITY\n",
            "agitation 4608 4617 ENTITY\n",
            "controlled 4619 4629 ENTITY\n",
            "propofol 4635 4643 ENTITY\n",
            "extubation 4654 4664 ENTITY\n",
            "mild 4686 4690 ENTITY\n",
            "post\n",
            "extubation 4691 4706 ENTITY\n",
            "confusion 4707 4716 ENTITY\n",
            "hyponatremia 4732 4744 ENTITY\n",
            "PO 4765 4767 ENTITY\n",
            "fluid 4768 4773 ENTITY\n",
            "intake 4774 4780 ENTITY\n",
            "general\n",
            "medicine service 4814 4838 ENTITY\n",
            "seizures 4859 4867 ENTITY\n",
            "hospital stay 4900 4913 ENTITY\n",
            "patient's 4920 4929 ENTITY\n",
            "biopsy 4930 4936 ENTITY\n",
            "results 4937 4944 ENTITY\n",
            "consistent with 4950 4965 ENTITY\n",
            "metastatic\n",
            "carcinoma 4966 4986 ENTITY\n",
            "lung origin 4998 5009 ENTITY\n",
            "lymphoma 5079 5087 ENTITY\n",
            "anemia 5096 5102 ENTITY\n",
            "evaluation 5136 5146 ENTITY\n",
            "treatment 5151 5160 ENTITY\n",
            "Dr.[**Last Name (STitle) **] 5193 5221 ENTITY\n",
            "week 5226 5230 ENTITY\n",
            "discharge 5237 5246 ENTITY\n",
            "phenytoin 5322 5331 ENTITY\n",
            "level 5332 5337 ENTITY\n",
            "appointment 5360 5371 ENTITY\n",
            "CD 5405 5407 ENTITY\n",
            "imaging 5424 5431 ENTITY\n",
            "[**Location 5447 5458 ENTITY\n",
            "follow-up 5535 5544 ENTITY\n",
            "appointments 5545 5557 ENTITY\n",
            "arrangements 5559 5571 ENTITY\n",
            "pathology slides 5590 5606 ENTITY\n",
            "Phenytoin 5684 5693 ENTITY\n",
            "Decadron\n",
            "for 5698 5710 ENTITY\n",
            "seizure 5711 5718 ENTITY\n",
            "prophylaxis 5719 5730 ENTITY\n",
            "return to\n",
            "work 5762 5776 ENTITY\n",
            "Dr.[**Last Name (STitle) **] 5791 5819 ENTITY\n",
            "patient 5826 5833 ENTITY\n",
            "thyroid nodule 5863 5877 ENTITY\n",
            "followed-up 5900 5911 ENTITY\n",
            "outpatient 5918 5928 ENTITY\n",
            "home dose 5964 5973 ENTITY\n",
            "Atenolol 5977 5985 ENTITY\n",
            "Lisinopril 5994 6004 ENTITY\n",
            "blood pressures 6035 6050 ENTITY\n",
            "regimen 6059 6066 ENTITY\n",
            "follow-up 6089 6098 ENTITY\n",
            "PCP 6108 6111 ENTITY\n",
            "repeat blood\n",
            "pressure checks 6116 6144 ENTITY\n",
            "Medications 6148 6159 ENTITY\n",
            "Admission:\n",
            "Lisinopril 20 mg 6163 6190 ENTITY\n",
            "daily 6194 6199 ENTITY\n",
            "daily 6220 6225 ENTITY\n",
            "Atenolol 6226 6234 ENTITY\n",
            "Levothyroxine 6249 6262 ENTITY\n",
            "daily 6273 6278 ENTITY\n",
            "acetaminophen 6335 6348 ENTITY\n",
            "Tablets 6372 6379 ENTITY\n",
            "PO 6380 6382 ENTITY\n",
            "Q6H 6383 6386 ENTITY\n",
            "phenytoin 6432 6441 ENTITY\n",
            "Tablet 6448 6454 ENTITY\n",
            "Chewable 6456 6464 ENTITY\n",
            "Tablet 6478 6484 ENTITY\n",
            "PO 6495 6497 ENTITY\n",
            "TID 6498 6501 ENTITY\n",
            "day 6513 6516 ENTITY\n",
            "phenytoin 6533 6542 ENTITY\n",
            "level 6543 6548 ENTITY\n",
            "visit 6565 6570 ENTITY\n",
            "Dr.[**Last Name (STitle) 724**] 6576 6607 ENTITY\n",
            "Disp:*180 6609 6618 ENTITY\n",
            "Tablet 6619 6625 ENTITY\n",
            "Chewable(s)* Refills:*0*\n",
            "3 6627 6653 ENTITY\n",
            "atenolol 6655 6663 ENTITY\n",
            "Tablet PO 6690 6699 ENTITY\n",
            "BID 6700 6703 ENTITY\n",
            "day 6715 6718 ENTITY\n",
            "lower dose 6731 6741 ENTITY\n",
            "Refills:*2*\n",
            "4 6795 6808 ENTITY\n",
            "omeprazole 6810 6820 ENTITY\n",
            "Capsule 6827 6834 ENTITY\n",
            "Delayed Release(E.C. 6836 6856 ENTITY\n",
            "Capsule 6871 6878 ENTITY\n",
            "Delayed Release(E.C. 6880 6900 ENTITY\n",
            "PO 6902 6904 ENTITY\n",
            "Daily 6912 6917 ENTITY\n",
            "medication whie 6934 6949 ENTITY\n",
            "Decadron 6965 6973 ENTITY\n",
            "steroid 6980 6987 ENTITY\n",
            "Capsule 6999 7006 ENTITY\n",
            "Delayed 7008 7015 ENTITY\n",
            "Release(E.C.)(s 7016 7031 ENTITY\n",
            "Refills:*2*\n",
            "5 7034 7047 ENTITY\n",
            "levothyroxine 7049 7062 ENTITY\n",
            "Tablet 7070 7076 ENTITY\n",
            "Tablet PO 7090 7099 ENTITY\n",
            "Daily 7107 7112 ENTITY\n",
            "dexamethasone 7118 7131 ENTITY\n",
            "Tablet 7137 7143 ENTITY\n",
            "Tablet PO Q12H 7157 7171 ENTITY\n",
            "hours 7182 7187 ENTITY\n",
            "Refills:*2*\n",
            "7 7210 7223 ENTITY\n",
            "Outpatient Lab Work\n",
            "Please 7225 7251 ENTITY\n",
            "dilantin 7259 7267 ENTITY\n",
            "level 7268 7273 ENTITY\n",
            "Tuesday 7285 7292 ENTITY\n",
            "visit 7320 7325 ENTITY\n",
            "Dr.[**Last Name (STitle) **] 7331 7359 ENTITY\n",
            "Service\n",
            "\n",
            "Facility:\n",
            "[**Location 7396 7426 ENTITY\n",
            "VNA\n",
            "\n",
            "Discharge Diagnosis 7438 7462 ENTITY\n",
            "Left Parietal Tumor\n",
            "Metastatic Carcinoma\n",
            "\n",
            "Discharge Condition 7464 7525 ENTITY\n",
            "Clear 7542 7547 ENTITY\n",
            "coherent 7552 7560 ENTITY\n",
            "Alert 7586 7591 ENTITY\n",
            "interactive 7596 7607 ENTITY\n",
            "Ambulatory 7626 7636 ENTITY\n",
            "requires 7639 7647 ENTITY\n",
            "assistance 7648 7658 ENTITY\n",
            "walker\n",
            "or 7667 7676 ENTITY\n",
            "cane 7677 7681 ENTITY\n",
            "admitted 7718 7726 ENTITY\n",
            "hospital 7734 7742 ENTITY\n",
            "seizures 7748 7756 ENTITY\n",
            "brain mass 7782 7792 ENTITY\n",
            "metastatic\n",
            "carcinoma 7817 7837 ENTITY\n",
            "lung 7871 7875 ENTITY\n",
            "mass 7908 7912 ENTITY\n",
            "medications 7941 7952 ENTITY\n",
            "Dilantin 7954 7962 ENTITY\n",
            "Decadron 7967 7975 ENTITY\n",
            "seizures 7996 8004 ENTITY\n",
            "follow-up 8023 8032 ENTITY\n",
            "neuro-oncologist 8040 8056 ENTITY\n",
            "management 8092 8102 ENTITY\n",
            "medications 8112 8123 ENTITY\n",
            "underlying\n",
            "cancer 8133 8150 ENTITY\n",
            "instructions 8167 8179 ENTITY\n",
            "recent surgery 8200 8214 ENTITY\n",
            "Exercise 8217 8225 ENTITY\n",
            "walking 8247 8254 ENTITY\n",
            "straining 8268 8277 ENTITY\n",
            "excessive 8282 8291 ENTITY\n",
            "bending 8292 8299 ENTITY\n",
            "prescribed 8316 8326 ENTITY\n",
            "Dilantin 8327 8335 ENTITY\n",
            "Phenytoin 8337 8346 ENTITY\n",
            "anti-seizure\n",
            "medicine 8352 8373 ENTITY\n",
            "prescribed 8393 8403 ENTITY\n",
            "up with 8415 8422 ENTITY\n",
            "laboratory blood drawing 8423 8447 ENTITY\n",
            "week 8455 8459 ENTITY\n",
            "office 8512 8518 ENTITY\n",
            "[**Location 8535 8546 ENTITY\n",
            "[**Hospital3 328**]\n",
            "Yawkey Building 8563 8598 ENTITY\n",
            "home 8620 8624 ENTITY\n",
            "steroid 8630 8637 ENTITY\n",
            "medication 8638 8648 ENTITY\n",
            "medications 8656 8667 ENTITY\n",
            "stomach irritation 8678 8696 ENTITY\n",
            "steroid 8722 8729 ENTITY\n",
            "medication 8730 8740 ENTITY\n",
            "meals 8746 8751 ENTITY\n",
            "glass 8758 8763 ENTITY\n",
            "milk 8767 8771 ENTITY\n",
            "Clearance 8774 8783 ENTITY\n",
            "return to work 8797 8811 ENTITY\n",
            "neuro-oncologist 8861 8877 ENTITY\n",
            "SURGEON 8890 8897 ENTITY\n",
            "THE\n",
            "FOLLOWING\n",
            "?? 8935 8951 ENTITY\n",
            "tremors 8969 8976 ENTITY\n",
            "seizures 8980 8988 ENTITY\n",
            "confusion 9001 9010 ENTITY\n",
            "mental status 9024 9037 ENTITY\n",
            "tingling 9060 9068 ENTITY\n",
            "weakness 9070 9078 ENTITY\n",
            "your extremities 9082 9098 ENTITY\n",
            "headache 9115 9123 ENTITY\n",
            "increasing 9144 9154 ENTITY\n",
            "pain medication 9175 9190 ENTITY\n",
            "infection 9212 9221 ENTITY\n",
            "wound site 9229 9239 ENTITY\n",
            "increasing 9241 9251 ENTITY\n",
            "redness 9252 9259 ENTITY\n",
            "increased 9261 9270 ENTITY\n",
            "swelling 9271 9279 ENTITY\n",
            "increased 9281 9290 ENTITY\n",
            "tenderness 9291 9301 ENTITY\n",
            "drainage 9306 9314 ENTITY\n",
            "F.\n",
            "\n",
            "Followup Instructions:\n",
            "Please 9364 9397 ENTITY\n",
            "follow-up 9398 9407 ENTITY\n",
            "neuro-oncologist 9422 9438 ENTITY\n",
            "Dr.[**Last Name (STitle) 53939**]\n",
            "[**Name (STitle) **] 9440 9494 ENTITY\n",
            "[**Hospital3 328**] 9503 9522 ENTITY\n",
            "Thursday 9526 9534 ENTITY\n",
            "Dilantin 9577 9585 ENTITY\n",
            "level 9586 9591 ENTITY\n",
            "minutes 9603 9610 ENTITY\n",
            "visit 9623 9628 ENTITY\n",
            "appointment 9676 9687 ENTITY\n",
            "primary care 9698 9710 ENTITY\n",
            "**First Name8 9727 9740 ENTITY\n",
            "**Last Name (NamePattern1) **] 9761 9791 ENTITY\n",
            "**Last Name (NamePattern1) **] 9793 9823 ENTITY\n",
            "MD\n",
            "Specialty: Internal Medicine\n",
            "When: Wednesday [**10-28**] 9825 9884 ENTITY\n",
            "Location 9895 9903 ENTITY\n",
            "**Hospital6 9657**] PHYSICIAN 9906 9935 ENTITY\n",
            "**Location 9952 9962 ENTITY\n",
            "**Apartment Address(1) 25389**] 9973 10004 ENTITY\n",
            "**Location 10007 10017 ENTITY\n",
            "**Telephone/Fax 10065 10080 ENTITY\n",
            "*********************************************************\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "Admission Date:  [**2195-10-14**]              Discharge Date:   [**2195-10-23**]\n",
              "\n",
              "Date of Birth:  [**2133-8-29**]             Sex:   F\n",
              "\n",
              "Service: MEDICINE\n",
              "\n",
              "Allergies:\n",
              "No Known Allergies / Adverse Drug Reactions\n",
              "\n",
              "Attending:[**First Name3 (LF) 2195**]\n",
              "Chief Complaint:\n",
              "Seizure\n",
              "\n",
              "Major Surgical or Invasive Procedure:\n",
              "Left parietal mass removal\n",
              "\n",
              "History of Present Illness:\n",
              "Patient is a 62 year old woman who presents to [**Hospital1 18**] for\n",
              "evaluation after having a 2 minute witnessed tonic clonic\n",
              "seizure\n",
              "while at work. She was post-ictal upon EMS arrival and was not\n",
              "reponding to any commands but was protecting her airway. She was\n",
              "trasnferred to [**Hospital1 18**] for further care and in the ER while being\n",
              "evaluated she had another seizure. She had a CT of the head that\n",
              "showed a left parietal brain lesion and neurosurgery was\n",
              "consulted. Prior to arriving to consult on the patient she was\n",
              "intubated and sedated for airway protection. Unable to obtain\n",
              "review of systems given patients recent intubation and no family\n",
              "available to dicuss.\n",
              "\n",
              "Past Medical History:\n",
              "Poorly differentiated Nodular Lymphoma, >20years ago in pelvis,\n",
              "s/p XRT, in remission\n",
              "Hypertension\n",
              "Hyperlipidemia\n",
              "CKD, baseline creat 1.2-.14\n",
              "Anemia, unclear etiology (extensive w/u with labs, BMB, GI w/u\n",
              "neg, may be [**3-11**] CKD)\n",
              "s/p TAH/BSO for pelvic mass/metrorrhagia '[**85**]\n",
              "Thyroiditis\n",
              "\n",
              "Social History:\n",
              "The patient lives in [**Location 669**] with her Husband and son. She is\n",
              "employed in the Cafeteria of the [**Location (un) 86**] Public School.\n",
              "Tobacco: [**6-12**] cigarettes daily x 20 years\n",
              "\n",
              "\n",
              "Family History:\n",
              "Mother - Died age 86 from CAD\n",
              "Father - Died in 80s from \"poisoned ETOH\"\n",
              "- no family history of Gastrointestinal disease\n",
              "\n",
              "Physical Exam:\n",
              "PHYSICAL EXAM:\n",
              "Gen: intubated, sedated\n",
              "HEENT: Pupils:  PERRL  EOMs unable to obtain\n",
              "Neck: Supple.\n",
              "Lungs: CTA bilaterally.\n",
              "Cardiac: RRR. S1/S2.\n",
              "Abd: Soft, NT, BS+\n",
              "Extrem: Warm and well-perfused.\n",
              "Neuro:\n",
              "Mental status: intuabted, sedated, no commands\n",
              "Orientation: unable to obtain\n",
              "Language: unable to assess\n",
              "\n",
              "Cranial Nerves:\n",
              "I: Not tested\n",
              "II: Pupils equally round and reactive to light, 3mm to\n",
              "2mm bilaterally.\n",
              "III, IV, VI: unable to assess\n",
              "V, VII: unable to assess\n",
              "VIII: unable to assess\n",
              "IX, X: unable to assess\n",
              "[**Doctor First Name 81**]: unable to assess\n",
              "XII: unable to assess\n",
              "\n",
              "Motor: MAE\n",
              "\n",
              "Sensation: unable to assess\n",
              "\n",
              "Toes downgoing bilaterally\n",
              "\n",
              "Coordination: unable to assess\n",
              "\n",
              "Pertinent Results:\n",
              "[**10-14**] CT head noncontrast: 2-cm rounded hypodensity in the left\n",
              "parietooccipital region concerning for underlying intra-axial\n",
              "mass with edema\n",
              "\n",
              "[**10-14**] MRI with and without contrast: 3 x 2.8 cm cystic mass with\n",
              "internal enhancing mural nodule\n",
              "\n",
              "[**10-15**] CT Torso with and without contrast: Scattered enlarged and\n",
              "necrotic lymph nodes\n",
              "\n",
              "[**10-15**] CTA head: Hypoattenuating left parietal lesion is\n",
              "redemonstrated,\n",
              "suspicious for neoplasm. Narrowing of left supraclinoid ICA.\n",
              "\n",
              "[**10-16**] Postop CT head: 1. Post-surgical changes from left parietal\n",
              "craniotomy including mild frontoparietal pneumocephalus,\n",
              "post-operative hemorrhage and subcutaneous air. 2. Minimal\n",
              "subfalcine herniation. No sign of transtentorial or tonsillar\n",
              "herniation. 3. No hemorrhage outside of the surgical bed or\n",
              "evidence of acute large territorial infarction.\n",
              "\n",
              "[**10-17**] Postop MRI with and without contrast: 1. Two small foci of\n",
              "contrast enhancement along the inferior margin of the left\n",
              "occipitoparietal surgical cavity. Recommend continued follow-up.\n",
              "2. Stable 4-mm enhancing lesion in the left precentral cortex\n",
              "with slow diffusion, which has similar signal characteristics to\n",
              "the resected larger mass.\n",
              "\n",
              "Discharge Labs: [**2195-10-21**] 06:00AM\n",
              "WBC-9.5 RBC-3.04* Hgb-9.2* Hct-27.3* MCV-90 Plt Ct-184\n",
              "Glucose-88 UreaN-20 Creat-0.9 Na-138 K-3.8 Cl-105 HCO3-24\n",
              "AnGap-13\n",
              "\n",
              "Brief Hospital Course:\n",
              "[**Known firstname **] [**Known lastname 104205**] was intubated in the emergency department for\n",
              "seizure control and admitted to the Neurosurgery service for Q1\n",
              "hour neuro checks.  She was continued on Dilantin for seizures.\n",
              "MRI with and without contrast was performed and demonstrated a\n",
              "large cystic lesion in the left posterior temporal lobe.  CT\n",
              "torso performed for metastatic work up demonstrated multiple\n",
              "enlarged scattered and necrotic lymph nodes. On [**10-16**] she remained\n",
              "intubated and was prepared to be taken to the OR for resection\n",
              "of her lesion. She had an MRI WAND study and CTA for operative\n",
              "planning and was taken to the operating room for resection on\n",
              "the afternoon of [**10-16**]. Post-operatively she was transferred\n",
              "intubated to the ICU.\n",
              "\n",
              "Her post operative course was notable for agitation, controlled\n",
              "with propofol, and then extubation on [**10-18**], with mild post\n",
              "extubation confusion. She developed hyponatremia which resolved\n",
              "with PO fluid intake. She was then transferred to the general\n",
              "medicine service. She had no further seizures throughout the\n",
              "remainder of her hospital stay.\n",
              "\n",
              "The patient's biopsy results were consistent with metastatic\n",
              "carcinoma, likely of lung origin. Given she was already seen at\n",
              "the [**Hospital3 328**] for her prior lymphoma and her anemia, she\n",
              "preferred to pursue further evaluation and treatment there. She\n",
              "was scheduled to see Dr.[**Last Name (STitle) **] one week after discharge at the\n",
              "recommendation of Dr.[**Last Name (STitle) 3315**]. She will have a phenytoin level\n",
              "checked prior to this appointment. She was instructed to pick up\n",
              "a CD with all of her imaging results on the [**Location (un) **] of the\n",
              "[**Hospital Ward Name 23**] building next week prior to her follow-up appointments;\n",
              "arrangements were made for her pathology slides to be sent to\n",
              "Dr[**Last Name (STitle) 104206**] office. She was continued on Phenytoin and Decadron\n",
              "for seizure prophylaxis and instructed not to drive or return to\n",
              "work until seen by Dr.[**Last Name (STitle) **].\n",
              "\n",
              "The patient was also noted to have a new thyroid nodule which\n",
              "will need to be followed-up as an outpatient. She was maintained\n",
              "on half of her home dose of Atenolol and her Lisinopril was\n",
              "held; she maintained good blood pressures on this regimen and\n",
              "was instructed to follow-up with her PCP for repeat blood\n",
              "pressure checks.\n",
              "\n",
              "\n",
              "Medications on Admission:\n",
              "Lisinopril 20 mg po daily\n",
              "Omeprazole 20 mg po daily\n",
              "Atenolol 100 mg po bid\n",
              "Levothyroxine 50 mcg po daily (last filled in [**8-17**])\n",
              "\n",
              "\n",
              "Discharge Medications:\n",
              "1. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6\n",
              "hours) as needed for fever/pain.\n",
              "2. phenytoin 50 mg Tablet, Chewable Sig: Two (2) Tablet,\n",
              "Chewable PO TID (3 times a day): Please have a phenytoin level\n",
              "checked at your visit with Dr.[**Last Name (STitle) 724**].\n",
              "Disp:*180 Tablet, Chewable(s)* Refills:*0*\n",
              "3. atenolol 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a\n",
              "day): This is a lower dose than you were taking previously.\n",
              "Disp:*60 Tablet(s)* Refills:*2*\n",
              "4. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1)\n",
              "Capsule, Delayed Release(E.C.) PO DAILY (Daily): Continue this\n",
              "medication whie you are taking Decadron (your steroid).\n",
              "Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*2*\n",
              "5. levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY\n",
              "(Daily).\n",
              "6. dexamethasone 4 mg Tablet Sig: One (1) Tablet PO Q12H (every\n",
              "12 hours).\n",
              "Disp:*60 Tablet(s)* Refills:*2*\n",
              "7. Outpatient Lab Work\n",
              "Please have a dilantin level checked on Tuesday, [**10-27**]\n",
              "prior to your visit with Dr.[**Last Name (STitle) **].\n",
              "\n",
              "\n",
              "Discharge Disposition:\n",
              "Home With Service\n",
              "\n",
              "Facility:\n",
              "[**Location (un) 86**] VNA\n",
              "\n",
              "Discharge Diagnosis:\n",
              "Left Parietal Tumor\n",
              "Metastatic Carcinoma\n",
              "\n",
              "Discharge Condition:\n",
              "Mental Status: Clear and coherent.\n",
              "Level of Consciousness: Alert and interactive.\n",
              "Activity Status: Ambulatory - requires assistance or aid (walker\n",
              "or cane).\n",
              "\n",
              "Discharge Instructions:\n",
              "You were admitted to the hospital with seizures and were found\n",
              "to have a brain mass that is thought to be a metastatic\n",
              "carcinoma that may have originated in your lung. You underwent\n",
              "resection of the mass and were started on two new medications,\n",
              "Dilantin and Decadron, to prevent further seizures. You will\n",
              "need to follow-up with a neuro-oncologist at [**Hospital3 328**] for\n",
              "further management of these medications and your underlying\n",
              "cancer.\n",
              "\n",
              "The following instructions are related to your recent surgery:\n",
              "\n",
              "Exercise should be limited to walking; no lifting, straining, or\n",
              "excessive bending.\n",
              "\n",
              "You have been prescribed Dilantin (Phenytoin) for anti-seizure\n",
              "medicine. Please take it as prescribed and follow up with\n",
              "laboratory blood drawing in one week.  This can be drawn at\n",
              "Dr.[**Last Name (STitle) **] office at 08:30 on the [**Location (un) **] in the [**Hospital3 328**]\n",
              "Yawkey Building.\n",
              "\n",
              "You are being sent home on a steroid medication. These\n",
              "medications can cause stomach irritation.  Make sure to take\n",
              "your steroid medication with meals, or a glass of milk.\n",
              "\n",
              "Clearance to drive and return to work will be addressed at your\n",
              "office visit with your neuro-oncologist.\n",
              "\n",
              "CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE\n",
              "FOLLOWING\n",
              "??????\tNew onset of tremors or seizures.\n",
              "??????\tAny confusion or change in mental status.\n",
              "??????\tAny numbness, tingling, weakness in your extremities.\n",
              "??????\tPain or headache that is continually increasing, or not\n",
              "relieved by pain medication.\n",
              "??????\tAny signs of infection at the wound site: increasing redness,\n",
              "increased swelling, increased tenderness, or drainage.\n",
              "??????\tFever greater than or equal to 101?????? F.\n",
              "\n",
              "Followup Instructions:\n",
              "Please follow-up with your new neuro-oncologist, Dr.[**Last Name (STitle) 53939**]\n",
              "[**Name (STitle) **], at the [**Hospital3 328**] on Thursday, [**10-29**] at 9:00AM.\n",
              "You should have a Dilantin level checked 30 minutes before this\n",
              "visit as noted above. Please also keep the following appointment\n",
              "with your primary care doctor.\n",
              "\n",
              "Name: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] [**Last Name (NamePattern1) **], MD\n",
              "Specialty: Internal Medicine\n",
              "When: Wednesday [**10-28**] at 9:30am\n",
              "Location: [**Hospital6 9657**] PHYSICIAN GROUP\n",
              "Address: [**Location (un) **] [**Apartment Address(1) 25389**], [**Location (un) **],[**Numeric Identifier 1700**]\n",
              "Phone: [**Telephone/Fax (1) 24396**]\n",
              "\n"
            ]
          },
          "metadata": {},
          "execution_count": 37
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "displacy.render(nlp(nod_lymph_pelvic_filtered_df.iloc[0]['TEXT']), style=\"ent\", jupyter='True')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "tEjbUJjZ1ypc",
        "outputId": "8630312e-0e7d-49f1-b57e-18e5bf54c699"
      },
      "execution_count": 38,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Admission\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Date:  [**2195-10-14**]              Discharge Date:   [**2195-10-23**]</br></br>Date of Birth:  [**2133-8-29**]             \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Sex\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ":   F</br></br>Service: MEDICINE</br></br>Allergies:</br>No Known \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Allergies\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " / \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Adverse\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Drug Reactions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>Attending:[**First \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Name3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    LF\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ") 2195**]</br>Chief Complaint:</br>Seizure</br></br>Major \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Surgical\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " or \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Invasive Procedure:\n",
              "Left parietal mass\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " removal</br></br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    History\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of Present Illness:</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " is a 62 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    year\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " old \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    woman\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " who presents to [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Hospital1 18**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    evaluation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " after having a 2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    minute\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " witnessed tonic clonic</br>seizure</br>while at work. She was \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    post-ictal\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " upon \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    EMS\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    arrival\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and was not</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    reponding\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to any \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    commands\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " but was protecting her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    airway\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She was</br>trasnferred to [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Hospital1 18**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for further care and in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ER\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " while being</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    evaluated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " she had another \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizure\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She had a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    CT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    head\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " that</br>showed a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left parietal brain lesion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neurosurgery\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " was</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    consulted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". Prior to arriving to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    consult\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " she was</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intubated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sedated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    airway\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    protection\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". Unable to obtain</br>review of systems given \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patients\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " recent \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intubation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and no family</br>available to dicuss.</br></br>Past Medical History:</br>Poorly differentiated \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Nodular Lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", &gt;20years ago in \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pelvis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ",</br>s/p \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    XRT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", in \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    remission\n",
              "Hypertension\n",
              "Hyperlipidemia\n",
              "CKD\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    baseline\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    creat\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 1.2-.14</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Anemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    unclear\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    etiology\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (extensive w/u with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    labs\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    BMB\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    GI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " w/u</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", may be [**3-11**] CKD)</br>s/p TAH/BSO for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pelvic mass/metrorrhagia '[**85**]\n",
              "Thyroiditis\n",
              "\n",
              "\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Social History:\n",
              "\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "The \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " lives in [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Location 669**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Husband\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    son\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She is</br>employed in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Cafeteria\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    [**Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (un) 86**] Public School.</br>Tobacco: [**6-12**] cigarettes \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " x 20 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    years\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br></br>Family History:</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Mother\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " - \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Died\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    age\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 86 from \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    CAD\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Father\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " - \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Died\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " in 80s from &quot;poisoned ETOH&quot;</br>- \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    no\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    family history\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Gastrointestinal disease\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>Physical Exam:</br>PHYSICAL EXAM:</br>Gen: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intubated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sedated\n",
              "HEENT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Pupils\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ":  PERRL  \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    EOMs\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " unable to obtain</br>Neck: Supple.</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Lungs\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    CTA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>Cardiac: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RRR\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". S1/S2.</br>Abd: Soft, \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    NT\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    BS+\n",
              "Extrem\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Warm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    well-perfused\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>Neuro:</br>Mental status: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intuabted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    sedated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", no commands</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Orientation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": unable to obtain</br>Language: unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Cranial Nerves\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ":</br>I: Not tested</br>II: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Pupils\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " equally \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    round\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    reactive to light\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", 3mm to</br>2mm \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>III, \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    IV\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    VI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>V, VII: unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>VIII: unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>IX, X: unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>[**Doctor First Name 81**]: unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>XII: unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>Motor: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MAE\n",
              "\n",
              "\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Sensation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>Toes downgoing \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bilaterally\n",
              "\n",
              "Coordination\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": unable to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assess\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>Pertinent Results:</br>[**10-14**] CT head noncontrast: 2-cm \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    rounded\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hypodensity\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left\n",
              "parietooccipital region\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " concerning for underlying \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intra-axial\n",
              "mass with\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    edema\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br></br>[**10-14**] \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MRI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with and without contrast: 3 x 2.8 cm \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cystic mass\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with</br>internal enhancing \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mural nodule\n",
              "\n",
              "[**10-15**] CT Torso\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with and without contrast: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Scattered\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    enlarged\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and</br>necrotic lymph nodes</br></br>[**10-15**] CTA \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    head\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Hypoattenuating left parietal lesion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " is</br>redemonstrated,</br>suspicious for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neoplasm\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Narrowing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left supraclinoid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " ICA.</br></br>[**10-16**] \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Postop\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " CT head: 1. \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Post-surgical\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " changes from \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left parietal\n",
              "craniotomy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " including \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mild frontoparietal pneumocephalus\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ",</br>post-operative \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hemorrhage\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    subcutaneous air\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". 2. Minimal</br>subfalcine herniation. \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    No sign\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transtentorial\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " or \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tonsillar\n",
              "herniation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". 3. No \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hemorrhage\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " outside of the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    surgical bed\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " or</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    evidence\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    acute large territorial infarction\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>[**10-17**] \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Postop MRI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with and without contrast: 1. Two small \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    foci\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of</br>contrast enhancement along the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    inferior margin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left\n",
              "occipitoparietal surgical cavity\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Recommend\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " continued \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    follow-up\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>2. Stable 4-mm \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    enhancing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lesion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left precentral cortex\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    slow diffusion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", which has similar \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    signal\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    characteristics\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to</br>the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    resected\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " larger \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mass\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>Discharge Labs: [**2195-10-21**] 06:00AM</br>WBC-9.5 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RBC-3.04* Hgb-9.2* Hct-27.3* MCV-90\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Plt \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Ct-184\n",
              "Glucose-88\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    UreaN-20\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Creat-0.9 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Na-138\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    K-3.8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Cl-105 HCO3-24</br>AnGap-13</br></br>Brief Hospital Course:</br>[**Known firstname \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Known lastname\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 104205**] was \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intubated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    emergency department\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for</br>seizure \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    control\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admitted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Neurosurgery service\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Q1\n",
              "hour\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neuro checks\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".  She was continued on \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dilantin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MRI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with and without contrast was performed and demonstrated a</br>large cystic lesion in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    left posterior temporal lobe\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".  CT</br>torso performed for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metastatic\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " work up demonstrated \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    multiple\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    enlarged\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    scattered\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    necrotic lymph nodes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". On [**10-16**] she remained</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intubated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and was prepared to be taken to the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    OR\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    resection\n",
              "of her\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lesion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She had an \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MRI\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " WAND study and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    CTA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    operative\n",
              "planning\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and was taken to the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    operating room\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    resection\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on</br>the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    afternoon\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of [**10-16**]. Post-operatively she was \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    transferred\n",
              "intubated\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    ICU\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>Her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    post\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    operative course\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " was notable for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    agitation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    controlled\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    propofol\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", and then \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    extubation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on [**10-18**], with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mild\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    post\n",
              "extubation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    confusion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She developed \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hyponatremia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " which resolved</br>with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    fluid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    intake\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She was then transferred to the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    general\n",
              "medicine service\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She had no further \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " throughout the</br>remainder of her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hospital stay\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>The \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient's\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    biopsy\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    results\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " were \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    consistent with\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metastatic\n",
              "carcinoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", likely of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lung origin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". Given she was already seen at</br>the [**Hospital3 328**] for her prior \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lymphoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anemia\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", she</br>preferred to pursue further \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    evaluation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    treatment\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " there. She</br>was scheduled to see \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dr.[**Last Name (STitle) **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " one \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    week\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " after \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    discharge\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " at the</br>recommendation of Dr.[**Last Name (STitle) 3315**]. She will have a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    phenytoin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    level\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>checked prior to this \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    appointment\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She was instructed to pick up</br>a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    CD\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with all of her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    imaging\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " results on the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    [**Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (un) **] of the</br>[**Hospital Ward Name 23**] building next week prior to her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    follow-up\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    appointments\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ";</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    arrangements\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " were made for her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pathology slides\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to be sent to</br>Dr[**Last Name (STitle) 104206**] office. She was continued on \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Phenytoin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Decadron\n",
              "for\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizure\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prophylaxis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and instructed not to drive or \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    return to\n",
              "work\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " until seen by \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dr.[**Last Name (STitle) **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>The \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    patient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " was also noted to have a new \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    thyroid nodule\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " which</br>will need to be \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    followed-up\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " as an \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    outpatient\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". She was maintained</br>on half of her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    home dose\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Atenolol\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Lisinopril\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " was</br>held; she maintained good \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    blood pressures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on this \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    regimen\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and</br>was instructed to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    follow-up\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with her \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PCP\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    repeat blood\n",
              "pressure checks\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br></br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Admission:\n",
              "Lisinopril 20 mg\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>Omeprazole 20 mg po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Atenolol\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 100 mg po bid</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Levothyroxine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 50 mcg po \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (last filled in [**8-17**])</br></br></br>Discharge Medications:</br>1. \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    acetaminophen\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 325 mg Tablet Sig: 1-2 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablets\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Q6H\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (every 6</br>hours) as needed for fever/pain.</br>2. \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    phenytoin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 50 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Chewable\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Sig: Two (2) \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ",</br>Chewable \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    TID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (3 times a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    day\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "): Please have a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    phenytoin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    level\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>checked at your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    visit\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dr.[**Last Name (STitle) 724**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Disp:*180\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Chewable(s)* Refills:*0*\n",
              "3\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    atenolol\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 50 mg Tablet Sig: One (1) \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    BID\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (2 times a</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    day\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "): This is a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lower dose\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " than you were taking previously.</br>Disp:*60 Tablet(s)* \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Refills:*2*\n",
              "4\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    omeprazole\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 20 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Capsule\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Delayed Release(E.C.\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ") Sig: One (1)</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Capsule\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Delayed Release(E.C.\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ") \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " DAILY (\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "): Continue this</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medication whie\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " you are taking \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Decadron\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    steroid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ").</br>Disp:*30 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Capsule\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Delayed\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Release(E.C.)(s\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ")* \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Refills:*2*\n",
              "5\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    levothyroxine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 50 mcg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Sig: One (1) \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet PO\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " DAILY</br>(\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Daily\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ").</br>6. \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    dexamethasone\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " 4 mg \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " Sig: One (1) \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tablet PO Q12H\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (every</br>12 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hours\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ").</br>Disp:*60 Tablet(s)* \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Refills:*2*\n",
              "7\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Outpatient Lab Work\n",
              "Please\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " have a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    dilantin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    level\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " checked on \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Tuesday\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", [**10-27**]</br>prior to your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    visit\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dr.[**Last Name (STitle) **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br></br>Discharge Disposition:</br>Home With \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Service\n",
              "\n",
              "Facility:\n",
              "[**Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (un) 86**] \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    VNA\n",
              "\n",
              "Discharge Diagnosis\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ":</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Left Parietal Tumor\n",
              "Metastatic Carcinoma\n",
              "\n",
              "Discharge Condition\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ":</br>Mental Status: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Clear\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    coherent\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>Level of Consciousness: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Alert\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    interactive\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>Activity Status: \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Ambulatory\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " - \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    requires\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    assistance\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " or aid (\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    walker\n",
              "or\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    cane\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ").</br></br>Discharge Instructions:</br>You were \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    admitted\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    hospital\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and were found</br>to have a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    brain mass\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " that is thought to be a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    metastatic\n",
              "carcinoma\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " that may have originated in your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    lung\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". You underwent</br>resection of the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mass\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and were started on two new \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ",</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dilantin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Decadron\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", to prevent further \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". You will</br>need to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    follow-up\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neuro-oncologist\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " at [**Hospital3 328**] for</br>further \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    management\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of these \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    underlying\n",
              "cancer\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>The following \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    instructions\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " are related to your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    recent surgery\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ":</br></br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Exercise\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " should be limited to \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    walking\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "; no lifting, \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    straining\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", or</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    excessive\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    bending\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>You have been \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prescribed\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dilantin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Phenytoin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ") for \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    anti-seizure\n",
              "medicine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". Please take it as \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    prescribed\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " and follow \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    up with\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    laboratory blood drawing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " in one \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    week\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".  This can be drawn at</br>Dr.[**Last Name (STitle) **] \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    office\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " at 08:30 on the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    [**Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (un) **] in the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    [**Hospital3 328**]\n",
              "Yawkey Building\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>You are being sent \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    home\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    steroid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medication\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ". These</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medications\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " can cause \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    stomach irritation\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".  Make sure to take</br>your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    steroid\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    medication\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    meals\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", or a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    glass\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    milk\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Clearance\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " to drive and \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    return to work\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " will be addressed at your</br>office visit with your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neuro-oncologist\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br></br>CALL YOUR \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    SURGEON\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " IMMEDIATELY IF YOU EXPERIENCE ANY OF \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    THE\n",
              "FOLLOWING\n",
              "??\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "????\tNew onset of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tremors\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " or \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    seizures\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>??????\tAny \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    confusion\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " or change in \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    mental status\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>??????\tAny numbness, \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tingling\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    weakness\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " in \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    your extremities\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>??????\tPain or \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    headache\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " that is continually \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increasing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", or not</br>relieved by \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    pain medication\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>??????\tAny signs of \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    infection\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " at the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    wound site\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increasing\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    redness\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ",</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increased\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    swelling\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    increased\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    tenderness\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", or \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    drainage\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ".</br>??????\tFever greater than or equal to 101?????? \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    F.\n",
              "\n",
              "Followup Instructions:\n",
              "Please\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    follow-up\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " with your new \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    neuro-oncologist\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dr.[**Last Name (STitle) 53939**]\n",
              "[**Name (STitle) **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", at the \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    [**Hospital3 328**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " on \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Thursday\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", [**10-29**] at 9:00AM.</br>You should have a \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Dilantin\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    level\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " checked 30 \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    minutes\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " before this</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    visit\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " as noted above. Please also keep the following \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    appointment\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              "</br>with your \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    primary care\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " doctor.</br></br>Name: [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **First Name8\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (NamePattern2) **] [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Last Name (NamePattern1) **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Last Name (NamePattern1) **]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", \n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    MD\n",
              "Specialty: Internal Medicine\n",
              "When: Wednesday [**10-28**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " at 9:30am</br>\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ": [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Hospital6 9657**] PHYSICIAN\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " GROUP</br>Address: [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (un) **] [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Apartment Address(1) 25389**]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              ", [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Location\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (un) **],[**Numeric Identifier 1700**]</br>Phone: [\n",
              "<mark class=\"entity\" style=\"background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    **Telephone/Fax\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ENTITY</span>\n",
              "</mark>\n",
              " (1) 24396**]</br></br></br></div></span>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Use medically trained NLP to extract specific entities\n",
        "#!pip install en_ner_bc5cdr_sm\n",
        "import spacy\n",
        "import en_ner_bc5cdr_sm\n",
        "\n",
        "nlp = spacy.load(\"en_ner_bc5cdr_sm\")\n",
        "doc = nlp(nod_lymph_pelvic_filtered_df.iloc[0]['TEXT'])\n",
        "print([(X.text, X.label_) for X in doc.ents])\n",
        "displacy.render(nlp(nod_lymph_pelvic_filtered_df.iloc[0]['TEXT']), style=\"ent\", jupyter='True')\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 384
        },
        "id": "GDXdI-7m16Wj",
        "outputId": "d65186be-7b88-4658-edea-81101eb7b56b"
      },
      "execution_count": 48,
      "outputs": [
        {
          "output_type": "error",
          "ename": "ModuleNotFoundError",
          "evalue": "No module named 'en_ner_bc5cdr_sm'",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-48-b2d9a7c8edc1>\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0;31m#!pip install en_ner_bc5cdr_sm\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      2\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mspacy\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 3\u001b[0;31m \u001b[0;32mimport\u001b[0m \u001b[0men_ner_bc5cdr_sm\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      4\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0mnlp\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mspacy\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"en_ner_bc5cdr_sm\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mModuleNotFoundError\u001b[0m: No module named 'en_ner_bc5cdr_sm'",
            "",
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0;32m\nNOTE: If your import is failing due to a missing package, you can\nmanually install dependencies using either !pip or !apt.\n\nTo view examples of installing some common dependencies, click the\n\"Open Examples\" button below.\n\u001b[0;31m---------------------------------------------------------------------------\u001b[0m\n"
          ],
          "errorDetails": {
            "actions": [
              {
                "action": "open_url",
                "actionText": "Open Examples",
                "url": "/notebooks/snippets/importing_libraries.ipynb"
              }
            ]
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# First create corpus of entities for Word2Vec to use as input\n",
        "\n",
        "import pandas as pd\n",
        "\n",
        "# Assuming 'nod_lymph_pelvic_filtered_df' is already defined as in our previous code\n",
        "\n",
        "def create_corpus(df):\n",
        "    corpus = []\n",
        "    for index, row in df.iterrows():\n",
        "        tokens = row['tokens']\n",
        "        corpus.append(tokens)\n",
        "    return corpus\n",
        "\n",
        "# Create the corpus\n",
        "nod_lymph_pelvic_corpus = create_corpus(nod_lymph_pelvic_filtered_df)\n",
        "\n",
        "# Example of accessing the corpus (first document's tokens)\n",
        "print(len(nod_lymph_pelvic_corpus))\n",
        "print(nod_lymph_pelvic_corpus[:10])\n",
        "\n",
        "1111"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wBK9Javr5gm2",
        "outputId": "cbfb67fc-a834-4231-bc79-67eb465e24eb"
      },
      "execution_count": 54,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[['admission', 'date', ' ', '             ', 'discharge', 'date', '  ', '\\n\\n', 'date', 'birth', ' ', '            ', 'sex', '  ', 'f', '\\n\\n', 'service', 'medicine', '\\n\\n', 'allergies', '\\n', 'known', 'allergies', 'adverse', 'drug', 'reactions', '\\n\\n', 'attendingfirst', 'name3', 'lf', '\\n', 'chief', 'complaint', '\\n', 'seizure', '\\n\\n', 'major', 'surgical', 'invasive', 'procedure', '\\n', 'left', 'parietal', 'mass', 'removal', '\\n\\n', 'history', 'present', 'illness', '\\n', 'patient', 'year', 'old', 'woman', 'presents', 'hospital1', '\\n', 'evaluation', 'having', 'minute', 'witnessed', 'tonic', 'clonic', '\\n', 'seizure', '\\n', 'work', 'postictal', 'ems', 'arrival', '\\n', 'reponding', 'commands', 'protecting', 'airway', '\\n', 'trasnferred', 'hospital1', 'care', 'er', '\\n', 'evaluated', 'seizure', 'ct', 'head', '\\n', 'showed', 'left', 'parietal', 'brain', 'lesion', 'neurosurgery', '\\n', 'consulted', 'prior', 'arriving', 'consult', 'patient', '\\n', 'intubated', 'sedated', 'airway', 'protection', 'unable', 'obtain', '\\n', 'review', 'systems', 'given', 'patients', 'recent', 'intubation', 'family', '\\n', 'available', 'dicuss', '\\n\\n', 'past', 'medical', 'history', '\\n', 'poorly', 'differentiated', 'nodular', 'lymphoma', '20years', 'ago', 'pelvis', '\\n', 'sp', 'xrt', 'remission', '\\n', 'hypertension', '\\n', 'hyperlipidemia', '\\n', 'ckd', 'baseline', 'creat', '1214', '\\n', 'anemia', 'unclear', 'etiology', 'extensive', 'wu', 'labs', 'bmb', 'gi', 'wu', '\\n', 'neg', 'ckd', '\\n', 'sp', 'tahbso', 'pelvic', 'massmetrorrhagia', '\\n', 'thyroiditis', '\\n\\n', 'social', 'history', '\\n', 'patient', 'lives', 'location', 'husband', 'son', '\\n', 'employed', 'cafeteria', 'location', 'un', 'public', 'school', '\\n', 'tobacco', 'cigarettes', 'daily', 'x', 'years', '\\n\\n\\n', 'family', 'history', '\\n', 'mother', 'died', 'age', 'cad', '\\n', 'father', 'died', '80s', 'poisoned', 'etoh', '\\n', 'family', 'history', 'gastrointestinal', 'disease', '\\n\\n', 'physical', 'exam', '\\n', 'physical', 'exam', '\\n', 'gen', 'intubated', 'sedated', '\\n', 'heent', 'pupils', ' ', 'perrl', ' ', 'eoms', 'unable', 'obtain', '\\n', 'neck', 'supple', '\\n', 'lungs', 'cta', 'bilaterally', '\\n', 'cardiac', 'rrr', 's1s2', '\\n', 'abd', 'soft', 'nt', 'bs', '\\n', 'extrem', 'warm', 'wellperfused', '\\n', 'neuro', '\\n', 'mental', 'status', 'intuabted', 'sedated', 'commands', '\\n', 'orientation', 'unable', 'obtain', '\\n', 'language', 'unable', 'assess', '\\n\\n', 'cranial', 'nerves', '\\n', 'tested', '\\n', 'ii', 'pupils', 'equally', 'round', 'reactive', 'light', 'mm', '\\n', 'mm', 'bilaterally', '\\n', 'iii', 'iv', 'vi', 'unable', 'assess', '\\n', 'v', 'vii', 'unable', 'assess', '\\n', 'viii', 'unable', 'assess', '\\n', 'ix', 'x', 'unable', 'assess', '\\n', 'doctor', 'unable', 'assess', '\\n', 'xii', 'unable', 'assess', '\\n\\n', 'motor', 'mae', '\\n\\n', 'sensation', 'unable', 'assess', '\\n\\n', 'toes', 'downgoing', 'bilaterally', '\\n\\n', 'coordination', 'unable', 'assess', '\\n\\n', 'pertinent', 'results', '\\n', 'ct', 'head', 'noncontrast', '2cm', 'rounded', 'hypodensity', 'left', '\\n', 'parietooccipital', 'region', 'concerning', 'underlying', 'intraaxial', '\\n', 'mass', 'edema', '\\n\\n', 'mri', 'contrast', 'x', 'cm', 'cystic', 'mass', '\\n', 'internal', 'enhancing', 'mural', 'nodule', '\\n\\n', 'ct', 'torso', 'contrast', 'scattered', 'enlarged', '\\n', 'necrotic', 'lymph', 'nodes', '\\n\\n', 'cta', 'head', 'hypoattenuating', 'left', 'parietal', 'lesion', '\\n', 'redemonstrated', '\\n', 'suspicious', 'neoplasm', 'narrowing', 'left', 'supraclinoid', 'ica', '\\n\\n', 'postop', 'ct', 'head', 'postsurgical', 'changes', 'left', 'parietal', '\\n', 'craniotomy', 'including', 'mild', 'frontoparietal', 'pneumocephalus', '\\n', 'postoperative', 'hemorrhage', 'subcutaneous', 'air', 'minimal', '\\n', 'subfalcine', 'herniation', 'sign', 'transtentorial', 'tonsillar', '\\n', 'herniation', 'hemorrhage', 'outside', 'surgical', 'bed', '\\n', 'evidence', 'acute', 'large', 'territorial', 'infarction', '\\n\\n', 'postop', 'mri', 'contrast', 'small', 'foci', '\\n', 'contrast', 'enhancement', 'inferior', 'margin', 'left', '\\n', 'occipitoparietal', 'surgical', 'cavity', 'recommend', 'continued', 'followup', '\\n', 'stable', '4mm', 'enhancing', 'lesion', 'left', 'precentral', 'cortex', '\\n', 'slow', 'diffusion', 'similar', 'signal', 'characteristics', '\\n', 'resected', 'larger', 'mass', '\\n\\n', 'discharge', 'labs', '0600am', '\\n', 'wbc95', 'rbc304', 'hgb92', 'hct273', 'mcv90', 'plt', 'ct184', '\\n', 'glucose88', 'urean20', 'creat09', 'na138', 'k38', 'cl105', 'hco3', '\\n', 'angap13', '\\n\\n', 'brief', 'hospital', 'course', '\\n', 'known', 'firstname', 'known', 'lastname', 'intubated', 'emergency', 'department', '\\n', 'seizure', 'control', 'admitted', 'neurosurgery', 'service', 'q1', '\\n', 'hour', 'neuro', 'checks', ' ', 'continued', 'dilantin', 'seizures', '\\n', 'mri', 'contrast', 'performed', 'demonstrated', '\\n', 'large', 'cystic', 'lesion', 'left', 'posterior', 'temporal', 'lobe', ' ', 'ct', '\\n', 'torso', 'performed', 'metastatic', 'work', 'demonstrated', 'multiple', '\\n', 'enlarged', 'scattered', 'necrotic', 'lymph', 'nodes', 'remained', '\\n', 'intubated', 'prepared', 'taken', 'resection', '\\n', 'lesion', 'mri', 'wand', 'study', 'cta', 'operative', '\\n', 'planning', 'taken', 'operating', 'room', 'resection', '\\n', 'afternoon', 'postoperatively', 'transferred', '\\n', 'intubated', 'icu', '\\n\\n', 'post', 'operative', 'course', 'notable', 'agitation', 'controlled', '\\n', 'propofol', 'extubation', 'mild', 'post', '\\n', 'extubation', 'confusion', 'developed', 'hyponatremia', 'resolved', '\\n', 'po', 'fluid', 'intake', 'transferred', 'general', '\\n', 'medicine', 'service', 'seizures', '\\n', 'remainder', 'hospital', 'stay', '\\n\\n', 'patient', 'biopsy', 'results', 'consistent', 'metastatic', '\\n', 'carcinoma', 'likely', 'lung', 'origin', 'given', 'seen', '\\n', 'hospital3', 'prior', 'lymphoma', 'anemia', '\\n', 'preferred', 'pursue', 'evaluation', 'treatment', '\\n', 'scheduled', 'drlast', 'stitle', 'week', 'discharge', '\\n', 'recommendation', 'drlast', 'stitle', 'phenytoin', 'level', '\\n', 'checked', 'prior', 'appointment', 'instructed', 'pick', '\\n', 'cd', 'imaging', 'results', 'location', 'un', '\\n', 'hospital', 'ward', 'building', 'week', 'prior', 'followup', 'appointments', '\\n', 'arrangements', 'pathology', 'slides', 'sent', '\\n', 'drlast', 'stitle', 'office', 'continued', 'phenytoin', 'decadron', '\\n', 'seizure', 'prophylaxis', 'instructed', 'drive', 'return', '\\n', 'work', 'seen', 'drlast', 'stitle', '\\n\\n', 'patient', 'noted', 'new', 'thyroid', 'nodule', '\\n', 'need', 'followedup', 'outpatient', 'maintained', '\\n', 'half', 'home', 'dose', 'atenolol', 'lisinopril', '\\n', 'held', 'maintained', 'good', 'blood', 'pressures', 'regimen', '\\n', 'instructed', 'followup', 'pcp', 'repeat', 'blood', '\\n', 'pressure', 'checks', '\\n\\n\\n', 'medications', 'admission', '\\n', 'lisinopril', 'mg', 'po', 'daily', '\\n', 'omeprazole', 'mg', 'po', 'daily', '\\n', 'atenolol', 'mg', 'po', 'bid', '\\n', 'levothyroxine', 'mcg', 'po', 'daily', 'filled', '\\n\\n\\n', 'discharge', 'medications', '\\n', 'acetaminophen', 'mg', 'tablet', 'sig', 'tablets', 'po', 'q6h', '\\n', 'hours', 'needed', 'feverpain', '\\n', 'phenytoin', 'mg', 'tablet', 'chewable', 'sig', 'tablet', '\\n', 'chewable', 'po', 'tid', 'times', 'day', 'phenytoin', 'level', '\\n', 'checked', 'visit', 'drlast', 'stitle', '\\n', 'disp180', 'tablet', 'chewables', 'refills0', '\\n', 'atenolol', 'mg', 'tablet', 'sig', 'tablet', 'po', 'bid', 'times', '\\n', 'day', 'lower', 'dose', 'taking', 'previously', '\\n', 'disp60', 'tablets', 'refills2', '\\n', 'omeprazole', 'mg', 'capsule', 'delayed', 'releaseec', 'sig', '\\n', 'capsule', 'delayed', 'releaseec', 'po', 'daily', 'daily', 'continue', '\\n', 'medication', 'whie', 'taking', 'decadron', 'steroid', '\\n', 'disp30', 'capsule', 'delayed', 'releaseecs', 'refills2', '\\n', 'levothyroxine', 'mcg', 'tablet', 'sig', 'tablet', 'po', 'daily', '\\n', 'daily', '\\n', 'dexamethasone', 'mg', 'tablet', 'sig', 'tablet', 'po', 'q12h', '\\n', 'hours', '\\n', 'disp60', 'tablets', 'refills2', '\\n', 'outpatient', 'lab', 'work', '\\n', 'dilantin', 'level', 'checked', 'tuesday', '\\n', 'prior', 'visit', 'drlast', 'stitle', '\\n\\n\\n', 'discharge', 'disposition', '\\n', 'home', 'service', '\\n\\n', 'facility', '\\n', 'location', 'un', 'vna', '\\n\\n', 'discharge', 'diagnosis', '\\n', 'left', 'parietal', 'tumor', '\\n', 'metastatic', 'carcinoma', '\\n\\n', 'discharge', 'condition', '\\n', 'mental', 'status', 'clear', 'coherent', '\\n', 'level', 'consciousness', 'alert', 'interactive', '\\n', 'activity', 'status', 'ambulatory', 'requires', 'assistance', 'aid', 'walker', '\\n', 'cane', '\\n\\n', 'discharge', 'instructions', '\\n', 'admitted', 'hospital', 'seizures', 'found', '\\n', 'brain', 'mass', 'thought', 'metastatic', '\\n', 'carcinoma', 'originated', 'lung', 'underwent', '\\n', 'resection', 'mass', 'started', 'new', 'medications', '\\n', 'dilantin', 'decadron', 'prevent', 'seizures', '\\n', 'need', 'followup', 'neurooncologist', 'hospital3', '\\n', 'management', 'medications', 'underlying', '\\n', 'cancer', '\\n\\n', 'following', 'instructions', 'related', 'recent', 'surgery', '\\n\\n', 'exercise', 'limited', 'walking', 'lifting', 'straining', '\\n', 'excessive', 'bending', '\\n\\n', 'prescribed', 'dilantin', 'phenytoin', 'antiseizure', '\\n', 'medicine', 'prescribed', 'follow', '\\n', 'laboratory', 'blood', 'drawing', 'week', ' ', 'drawn', '\\n', 'drlast', 'stitle', 'office', '0830', 'location', 'un', 'hospital3', '\\n', 'yawkey', 'building', '\\n\\n', 'sent', 'home', 'steroid', 'medication', '\\n', 'medications', 'cause', 'stomach', 'irritation', ' ', 'sure', '\\n', 'steroid', 'medication', 'meals', 'glass', 'milk', '\\n\\n', 'clearance', 'drive', 'return', 'work', 'addressed', '\\n', 'office', 'visit', 'neurooncologist', '\\n\\n', 'surgeon', 'immediately', 'experience', '\\n', 'following', '\\n', '\\t', 'new', 'onset', 'tremors', 'seizures', '\\n', '\\t', 'confusion', 'change', 'mental', 'status', '\\n', '\\t', 'numbness', 'tingling', 'weakness', 'extremities', '\\n', '\\t', 'pain', 'headache', 'continually', 'increasing', '\\n', 'relieved', 'pain', 'medication', '\\n', '\\t', 'signs', 'infection', 'wound', 'site', 'increasing', 'redness', '\\n', 'increased', 'swelling', 'increased', 'tenderness', 'drainage', '\\n', '\\t', 'fever', 'greater', 'equal', 'f', '\\n\\n', 'followup', 'instructions', '\\n', 'followup', 'new', 'neurooncologist', 'drlast', 'stitle', '\\n', 'stitle', 'hospital3', 'thursday', '900am', '\\n', 'dilantin', 'level', 'checked', 'minutes', '\\n', 'visit', 'noted', 'following', 'appointment', '\\n', 'primary', 'care', 'doctor', '\\n\\n', 'name8', 'namepattern2', 'namepattern1', 'namepattern1', 'md', '\\n', 'specialty', 'internal', 'medicine', '\\n', 'wednesday', '930am', '\\n', 'location', 'hospital6', 'physician', 'group', '\\n', 'address', 'location', 'un', 'apartment', 'address1', 'location', 'un', 'numeric', 'identifier', '\\n', 'phone', 'telephonefax', '\\n\\n\\n']]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Find the max, min and median word count in the corpus\n",
        "\n",
        "import pandas as pd\n",
        "\n",
        "# Assuming nod_lymph_pelvic_corpus is defined as in the previous code\n",
        "\n",
        "def word_counts(corpus):\n",
        "    word_counts = [len(doc) for doc in corpus]\n",
        "    return word_counts\n",
        "\n",
        "word_counts_list = word_counts(nod_lymph_pelvic_corpus)\n",
        "print(f\"Max word count: {max(word_counts_list)}\")\n",
        "print(f\"Min word count: {min(word_counts_list)}\")\n",
        "\n",
        "import statistics\n",
        "print(f\"Median word count: {statistics.median(word_counts_list)}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "W-LmUJqU62dC",
        "outputId": "f0ec247a-16d7-424e-d8e2-9ef0090b2846"
      },
      "execution_count": 55,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Max word count: 1112\n",
            "Min word count: 1112\n",
            "Median word count: 1112\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# create the Word2Vec model using nod_lymph_pelvic_corpus\n",
        "\n",
        "from gensim.models import Word2Vec\n",
        "\n",
        "# Train the Word2Vec model\n",
        "model_nlpc = Word2Vec(sentences=nod_lymph_pelvic_corpus, vector_size=100, window=5, min_count=1, workers=4)\n",
        "model_nlpc.wv.key_to_index.keys()\n",
        "\n",
        "# we can now access word vectors using model.wv['word']\n",
        "# Example:\n",
        "vector = model_nlpc.wv['lymphoma']\n",
        "#print(vector)\n",
        "\n",
        "# Save the model\n",
        "model_nlpc.save(\"nod_lymph_pelvic_word2vec.model\")\n"
      ],
      "metadata": {
        "id": "KBTrQDf67Qlq"
      },
      "execution_count": 57,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#find words that are similar to \"lymphoma\" using the model we just created\n",
        "model_nlpc.wv.most_similar('lymphoma')\n",
        "#model_nlpc.wv.similar_by_word('lymphoma')\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "88MLvKQy8KLl",
        "outputId": "2600f4de-8654-4f74-9d4f-5854bc2b62fd"
      },
      "execution_count": 60,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[('home', 0.2858303189277649),\n",
              " ('developed', 0.27788618206977844),\n",
              " ('ica', 0.2612297832965851),\n",
              " ('posterior', 0.25031208992004395),\n",
              " ('unclear', 0.24001245200634003),\n",
              " ('underlying', 0.22475427389144897),\n",
              " ('protection', 0.22473981976509094),\n",
              " ('cm', 0.22034509479999542),\n",
              " ('small', 0.2074917107820511),\n",
              " ('            ', 0.20455162227153778)]"
            ]
          },
          "metadata": {},
          "execution_count": 60
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#find similarity between \"lymphoma\" and \"nodular\"\n",
        "model_nlpc.wv.similarity('lymphoma', 'nodular')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ujS0SHbU80bZ",
        "outputId": "63321ade-8cb0-475b-d773-b8969c82a595"
      },
      "execution_count": 66,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0.004744329"
            ]
          },
          "metadata": {},
          "execution_count": 66
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#find similarity between \"tumor\" and \"carcinoma\"\n",
        "model_nlpc.wv.similarity('tumor', 'carcinoma')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "KdD8KdIy8-sC",
        "outputId": "b7e99b6b-408d-40cb-cec8-e3ebda3d31e6"
      },
      "execution_count": 67,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0.13639985"
            ]
          },
          "metadata": {},
          "execution_count": 67
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "#find similarity between \"blood\" and \"pressure\"\n",
        "model_nlpc.wv.similarity('blood', 'pressure')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "vrl3SuH_9j4w",
        "outputId": "026ce216-8e67-4474-f547-9630703e3008"
      },
      "execution_count": 70,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "0.02682482"
            ]
          },
          "metadata": {},
          "execution_count": 70
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# create a t-SNE plot and visualize it\n",
        "\n",
        "from sklearn.manifold import TSNE\n",
        "import numpy as np\n",
        "\n",
        "# Assuming model_nlpc is your trained Word2Vec model\n",
        "# Get the word vectors\n",
        "word_vectors = model_nlpc.wv\n",
        "\n",
        "# Select a subset of words (optional, for better visualization)\n",
        "vocab = list(word_vectors.key_to_index)[:500] # Example: first 500 words\n",
        "\n",
        "# Extract vectors for the selected words\n",
        "vectors = np.array([word_vectors[word] for word in vocab])\n",
        "\n",
        "# Apply t-SNE\n",
        "tsne = TSNE(n_components=2, random_state=0, perplexity=15)  # Adjust perplexity if needed\n",
        "tsne_results = tsne.fit_transform(vectors)\n",
        "\n",
        "# Visualize\n",
        "import matplotlib.pyplot as plt\n",
        "plt.figure(figsize=(12, 8))\n",
        "plt.scatter(tsne_results[:, 0], tsne_results[:, 1])\n",
        "\n",
        "# Add labels (optional, might be crowded for large vocabularies)\n",
        "for i, word in enumerate(vocab):\n",
        "    plt.annotate(word, xy=(tsne_results[i, 0], tsne_results[i, 1]), size=8)\n",
        "\n",
        "plt.title('t-SNE Visualization of Word Embeddings')\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 734
        },
        "id": "wj5Wjnb2-FYz",
        "outputId": "2210566a-3859-49ec-f8d7-306380f442b7"
      },
      "execution_count": 78,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/IPython/core/pylabtools.py:151: UserWarning: Glyph 9 (\t) missing from font(s) DejaVu Sans.\n",
            "  fig.canvas.print_figure(bytes_io, **kw)\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1200x800 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# generate random sample of words from our model's vocab\n",
        "\n",
        "import random\n",
        "\n",
        "# Assuming model_nlpc is your trained Word2Vec model\n",
        "# Get the vocabulary\n",
        "vocab = list(model_nlpc.wv.key_to_index)\n",
        "\n",
        "# Generate a random sample of words\n",
        "sample_size = 50  # Adjust the sample size as needed\n",
        "random_words = random.sample(vocab, sample_size)\n",
        "\n",
        "random_words\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8-5B3b5CAYTh",
        "outputId": "8c72a42d-784c-4617-ffbd-36b3ff86aefa"
      },
      "execution_count": 79,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['held',\n",
              " 'head',\n",
              " 'mcv90',\n",
              " 'redemonstrated',\n",
              " 'wand',\n",
              " 'acute',\n",
              " 'x',\n",
              " 'extremities',\n",
              " 'addressed',\n",
              " 'noncontrast',\n",
              " 'cortex',\n",
              " 'greater',\n",
              " 'bed',\n",
              " 'service',\n",
              " 'subcutaneous',\n",
              " 'physician',\n",
              " 'ambulatory',\n",
              " 'viii',\n",
              " 'facility',\n",
              " 'etiology',\n",
              " 'nodule',\n",
              " 'years',\n",
              " '            ',\n",
              " 'origin',\n",
              " 'commands',\n",
              " 'releaseec',\n",
              " 'cancer',\n",
              " 'frontoparietal',\n",
              " 'ckd',\n",
              " 'characteristics',\n",
              " 'taking',\n",
              " '4mm',\n",
              " 'atenolol',\n",
              " 'hours',\n",
              " 'laboratory',\n",
              " 'rounded',\n",
              " 'airway',\n",
              " 'lungs',\n",
              " 'straining',\n",
              " 'mg',\n",
              " 'reactions',\n",
              " 'herniation',\n",
              " 'downgoing',\n",
              " 'subfalcine',\n",
              " 'new',\n",
              " 'mcg',\n",
              " 'phenytoin',\n",
              " 'checked',\n",
              " 'posterior',\n",
              " 'related']"
            ]
          },
          "metadata": {},
          "execution_count": 79
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Take a random sample of 50 words from our models vocabulary\n",
        "# and plot the results in t-SNE graphs\n",
        "\n",
        "import matplotlib.pyplot as plt\n",
        "import numpy as np\n",
        "\n",
        "# Get the vocabulary\n",
        "vocab = list(model_nlpc.wv.key_to_index)\n",
        "\n",
        "# Generate a random sample of words\n",
        "sample_size = 50  # Adjust the sample size as needed\n",
        "random_words = random.sample(vocab, sample_size)\n",
        "\n",
        "# Extract vectors for the random sample\n",
        "vectors = np.array([model_nlpc.wv[word] for word in random_words])\n",
        "\n",
        "# Apply t-SNE\n",
        "tsne = TSNE(n_components=2, random_state=0, perplexity=15)\n",
        "tsne_results = tsne.fit_transform(vectors)\n",
        "\n",
        "# Visualize\n",
        "plt.figure(figsize=(12, 8))\n",
        "plt.scatter(tsne_results[:, 0], tsne_results[:, 1])\n",
        "\n",
        "# Add labels\n",
        "for i, word in enumerate(random_words):\n",
        "    plt.annotate(word, xy=(tsne_results[i, 0], tsne_results[i, 1]), size=8)\n",
        "\n",
        "plt.title('t-SNE Visualization of Randomly Sampled Word Embeddings')\n",
        "plt.show()\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 699
        },
        "id": "k7DH2ZLBArGu",
        "outputId": "acb29d25-ac17-4ab0-dbb6-388e660df69f"
      },
      "execution_count": 80,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1200x800 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    }
  ]
}